id	sid	tid	token	lemma	pos
cajgh-313	1	1	cajgh_template	cajgh_template	ADJ
cajgh-313	1	2	new	new	ADJ
cajgh-313	1	3	articles	article	NOUN
cajgh-313	1	4	in	in	ADP
cajgh-313	1	5	this	this	DET
cajgh-313	1	6	journal	journal	NOUN
cajgh-313	1	7	are	be	AUX
cajgh-313	1	8	licensed	license	VERB
cajgh-313	1	9	under	under	ADP
cajgh-313	1	10	a	a	DET
cajgh-313	1	11	creative	creative	ADJ
cajgh-313	1	12	commons	common	NOUN
cajgh-313	1	13	attribution	attribution	NOUN
cajgh-313	1	14	4.0	4.0	NUM
cajgh-313	1	15	united	unite	VERB
cajgh-313	1	16	states	states	PROPN
cajgh-313	1	17	license	license	NOUN
cajgh-313	1	18	.	.	PUNCT
cajgh-313	2	1	this	this	DET
cajgh-313	2	2	journal	journal	NOUN
cajgh-313	2	3	is	be	AUX
cajgh-313	2	4	published	publish	VERB
cajgh-313	2	5	by	by	ADP
cajgh-313	2	6	theuniversity	theuniversity	NOUN
cajgh-313	2	7	library	library	NOUN
cajgh-313	2	8	system	system	NOUN
cajgh-313	2	9	of	of	ADP
cajgh-313	2	10	the	the	DET
cajgh-313	2	11	university	university	PROPN
cajgh-313	2	12	of	of	ADP
cajgh-313	2	13	pittsburgh	pittsburgh	PROPN
cajgh-313	2	14	as	as	ADP
cajgh-313	2	15	part	part	NOUN
cajgh-313	2	16	of	of	ADP
cajgh-313	2	17	its	its	PRON
cajgh-313	2	18	d	d	NOUN
cajgh-313	2	19	-	-	PUNCT
cajgh-313	2	20	scribe	scribe	VERB
cajgh-313	2	21	digital	digital	ADJ
cajgh-313	2	22	publishing	publishing	NOUN
cajgh-313	2	23	program	program	NOUN
cajgh-313	2	24	and	and	CCONJ
cajgh-313	2	25	is	be	AUX
cajgh-313	2	26	cosponsored	cosponsor	VERB
cajgh-313	2	27	by	by	ADP
cajgh-313	2	28	the	the	DET
cajgh-313	2	29	university	university	PROPN
cajgh-313	2	30	of	of	ADP
cajgh-313	2	31	pittsburgh	pittsburgh	PROPN
cajgh-313	2	32	press	press	NOUN
cajgh-313	2	33	.	.	PUNCT
cajgh-313	3	1	sero	sero	NOUN
cajgh-313	3	2	-	-	PUNCT
cajgh-313	3	3	occurrence	occurrence	NOUN
cajgh-313	3	4	of	of	ADP
cajgh-313	3	5	hbv	hbv	NOUN
cajgh-313	3	6	/	/	SYM
cajgh-313	3	7	hcv	hcv	NOUN
cajgh-313	3	8	coinfection	coinfection	NOUN
cajgh-313	3	9	and	and	CCONJ
cajgh-313	3	10	levels	level	NOUN
cajgh-313	3	11	of	of	ADP
cajgh-313	3	12	liver	liver	NOUN
cajgh-313	3	13	enzymes	enzyme	NOUN
cajgh-313	3	14	among	among	ADP
cajgh-313	3	15	patients	patient	NOUN
cajgh-313	3	16	at	at	ADP
cajgh-313	3	17	a	a	DET
cajgh-313	3	18	tertiary	tertiary	ADJ
cajgh-313	3	19	care	care	NOUN
cajgh-313	3	20	hospital	hospital	NOUN
cajgh-313	3	21	in	in	ADP
cajgh-313	3	22	central	central	ADJ
cajgh-313	3	23	india	india	PROPN
cajgh-313	3	24	:	:	PUNCT
cajgh-313	3	25	a	a	DET
cajgh-313	3	26	pilot	pilot	NOUN
cajgh-313	3	27	study	study	NOUN
cajgh-313	3	28	prabha	prabha	NOUN
cajgh-313	3	29	desikan1	desikan1	PROPN
cajgh-313	3	30	,	,	PUNCT
cajgh-313	3	31	aseem	aseem	PROPN
cajgh-313	3	32	rangnekar1	rangnekar1	PROPN
cajgh-313	3	33	,	,	PUNCT
cajgh-313	3	34	zeba	zeba	PROPN
cajgh-313	3	35	khan1	khan1	PROPN
cajgh-313	3	36	,	,	PUNCT
cajgh-313	3	37	nikita	nikita	PROPN
cajgh-313	3	38	panwalkar1	panwalkar1	PROPN
cajgh-313	3	39	,	,	PUNCT
cajgh-313	3	40	protiti	protiti	ADJ
cajgh-313	3	41	bose1	bose1	NOUN
cajgh-313	3	42	,	,	PUNCT
cajgh-313	3	43	hanni	hanni	PROPN
cajgh-313	3	44	vasudev	vasudev	PROPN
cajgh-313	3	45	gulwani2	gulwani2	PROPN
cajgh-313	3	46	,	,	PUNCT
cajgh-313	3	47	sukhpreet	sukhpreet	NOUN
cajgh-313	3	48	kaur2	kaur2	NOUN
cajgh-313	3	49	1department	1department	NUM
cajgh-313	3	50	of	of	ADP
cajgh-313	3	51	microbiology	microbiology	NOUN
cajgh-313	3	52	,	,	PUNCT
cajgh-313	3	53	bhopal	bhopal	NOUN
cajgh-313	3	54	memorial	memorial	ADJ
cajgh-313	3	55	hospital	hospital	NOUN
cajgh-313	3	56	and	and	CCONJ
cajgh-313	3	57	research	research	NOUN
cajgh-313	3	58	centre	centre	NOUN
cajgh-313	3	59	,	,	PUNCT
cajgh-313	3	60	india	india	PROPN
cajgh-313	3	61	;	;	PUNCT
cajgh-313	3	62	2department	2department	NUM
cajgh-313	3	63	of	of	ADP
cajgh-313	3	64	pathology	pathology	NOUN
cajgh-313	3	65	,	,	PUNCT
cajgh-313	3	66	bhopal	bhopal	NOUN
cajgh-313	3	67	memorial	memorial	ADJ
cajgh-313	3	68	hospital	hospital	NOUN
cajgh-313	3	69	and	and	CCONJ
cajgh-313	3	70	research	research	NOUN
cajgh-313	3	71	centre	centre	NOUN
cajgh-313	3	72	,	,	PUNCT
cajgh-313	3	73	india	india	PROPN
cajgh-313	3	74	vol	vol	NOUN
cajgh-313	3	75	.	.	PROPN
cajgh-313	3	76	8	8	NUM
cajgh-313	3	77	,	,	PUNCT
cajgh-313	3	78	no	no	INTJ
cajgh-313	3	79	.	.	NOUN
cajgh-313	3	80	1	1	NUM
cajgh-313	3	81	(	(	PUNCT
cajgh-313	3	82	2019	2019	NUM
cajgh-313	3	83	)	)	PUNCT
cajgh-313	3	84	|	|	ADV
cajgh-313	3	85	issn	issn	VERB
cajgh-313	3	86	2166	2166	NUM
cajgh-313	3	87	-	-	SYM
cajgh-313	3	88	7403	7403	NUM
cajgh-313	3	89	(	(	PUNCT
cajgh-313	3	90	online	online	ADJ
cajgh-313	3	91	)	)	PUNCT
cajgh-313	3	92	doi	doi	NOUN
cajgh-313	3	93	10.5195	10.5195	NUM
cajgh-313	3	94	/	/	SYM
cajgh-313	3	95	cajgh.2019.313	cajgh.2019.313	PROPN
cajgh-313	3	96	|	|	ADV
cajgh-313	3	97	http://cajgh.pitt.edu	http://cajgh.pitt.edu	VERB
cajgh-313	3	98	http://www.library.pitt.edu/	http://www.library.pitt.edu/	PROPN
cajgh-313	3	99	http://www.pitt.edu/	http://www.pitt.edu/	NOUN
cajgh-313	3	100	http://www.library.pitt.edu/articles/digpubtype/index.html	http://www.library.pitt.edu/articles/digpubtype/index.html	PUNCT
cajgh-313	4	1	http://www.upress.pitt.edu/upressindex.aspx	http://www.upress.pitt.edu/upressindex.aspx	NUM
cajgh-313	4	2	http://creativecommons.org/licenses/by/3.0/us/	http://creativecommons.org/licenses/by/3.0/us/	NOUN
cajgh-313	4	3	desikan	desikan	VERB
cajgh-313	4	4	this	this	DET
cajgh-313	4	5	work	work	NOUN
cajgh-313	4	6	is	be	AUX
cajgh-313	4	7	licensed	license	VERB
cajgh-313	4	8	under	under	ADP
cajgh-313	4	9	a	a	DET
cajgh-313	4	10	creative	creative	ADJ
cajgh-313	4	11	commons	common	NOUN
cajgh-313	4	12	attribution	attribution	NOUN
cajgh-313	4	13	4.0	4.0	NUM
cajgh-313	4	14	united	unite	VERB
cajgh-313	4	15	states	states	PROPN
cajgh-313	4	16	license	license	NOUN
cajgh-313	4	17	.	.	PUNCT
cajgh-313	5	1	this	this	DET
cajgh-313	5	2	journal	journal	NOUN
cajgh-313	5	3	is	be	AUX
cajgh-313	5	4	published	publish	VERB
cajgh-313	5	5	by	by	ADP
cajgh-313	5	6	theuniversity	theuniversity	NOUN
cajgh-313	5	7	library	library	NOUN
cajgh-313	5	8	system	system	NOUN
cajgh-313	5	9	of	of	ADP
cajgh-313	5	10	the	the	DET
cajgh-313	5	11	university	university	PROPN
cajgh-313	5	12	of	of	ADP
cajgh-313	5	13	pittsburgh	pittsburgh	PROPN
cajgh-313	5	14	as	as	ADP
cajgh-313	5	15	part	part	NOUN
cajgh-313	5	16	of	of	ADP
cajgh-313	5	17	its	its	PRON
cajgh-313	5	18	d	d	NOUN
cajgh-313	5	19	-	-	PUNCT
cajgh-313	5	20	scribe	scribe	VERB
cajgh-313	5	21	digital	digital	ADJ
cajgh-313	5	22	publishing	publishing	NOUN
cajgh-313	5	23	program	program	NOUN
cajgh-313	5	24	and	and	CCONJ
cajgh-313	5	25	is	be	AUX
cajgh-313	5	26	cosponsored	cosponsor	VERB
cajgh-313	5	27	by	by	ADP
cajgh-313	5	28	the	the	DET
cajgh-313	5	29	university	university	PROPN
cajgh-313	5	30	of	of	ADP
cajgh-313	5	31	pittsburgh	pittsburgh	PROPN
cajgh-313	5	32	press	press	NOUN
cajgh-313	5	33	.	.	PUNCT
cajgh-313	6	1	central	central	ADJ
cajgh-313	6	2	asian	asian	ADJ
cajgh-313	6	3	journal	journal	NOUN
cajgh-313	6	4	of	of	ADP
cajgh-313	6	5	global	global	ADJ
cajgh-313	6	6	health	health	NOUN
cajgh-313	6	7	volume	volume	NOUN
cajgh-313	6	8	8	8	NUM
cajgh-313	6	9	,	,	PUNCT
cajgh-313	6	10	no	no	INTJ
cajgh-313	6	11	.	.	NOUN
cajgh-313	6	12	1	1	NUM
cajgh-313	6	13	(	(	PUNCT
cajgh-313	6	14	2019	2019	NUM
cajgh-313	6	15	)	)	PUNCT
cajgh-313	6	16	|	|	ADV
cajgh-313	6	17	issn	issn	VERB
cajgh-313	6	18	2166	2166	NUM
cajgh-313	6	19	-	-	SYM
cajgh-313	6	20	7403	7403	NUM
cajgh-313	6	21	(	(	PUNCT
cajgh-313	6	22	online	online	ADJ
cajgh-313	6	23	)	)	PUNCT
cajgh-313	6	24	|	|	ADV
cajgh-313	6	25	doi	doi	X
cajgh-313	6	26	10.5195	10.5195	NUM
cajgh-313	6	27	/	/	SYM
cajgh-313	6	28	cajgh.2019.313|http://cajgh.pitt.edu	cajgh.2019.313|http://cajgh.pitt.edu	NOUN
cajgh-313	6	29	abstract	abstract	ADJ
cajgh-313	6	30	introduction	introduction	NOUN
cajgh-313	6	31	:	:	PUNCT
cajgh-313	7	1	hepatitis	hepatitis	PROPN
cajgh-313	7	2	b	b	PROPN
cajgh-313	7	3	and	and	CCONJ
cajgh-313	7	4	c	c	PROPN
cajgh-313	7	5	viral	viral	ADJ
cajgh-313	7	6	infections	infection	NOUN
cajgh-313	7	7	share	share	VERB
cajgh-313	7	8	common	common	ADJ
cajgh-313	7	9	modes	mode	NOUN
cajgh-313	7	10	of	of	ADP
cajgh-313	7	11	transmission	transmission	NOUN
cajgh-313	7	12	and	and	CCONJ
cajgh-313	7	13	account	account	VERB
cajgh-313	7	14	for	for	ADP
cajgh-313	7	15	a	a	DET
cajgh-313	7	16	large	large	ADJ
cajgh-313	7	17	proportion	proportion	NOUN
cajgh-313	7	18	of	of	ADP
cajgh-313	7	19	liver	liver	NOUN
cajgh-313	7	20	disease	disease	NOUN
cajgh-313	7	21	burden	burden	NOUN
cajgh-313	7	22	across	across	ADP
cajgh-313	7	23	the	the	DET
cajgh-313	7	24	globe	globe	NOUN
cajgh-313	7	25	.	.	PUNCT
cajgh-313	8	1	patients	patient	NOUN
cajgh-313	8	2	with	with	ADP
cajgh-313	8	3	hepatitis	hepatitis	PROPN
cajgh-313	8	4	b	b	PROPN
cajgh-313	8	5	(	(	PUNCT
cajgh-313	8	6	hbv	hbv	NOUN
cajgh-313	8	7	)	)	PUNCT
cajgh-313	8	8	and	and	CCONJ
cajgh-313	8	9	hepatitis	hepatitis	PROPN
cajgh-313	8	10	c	c	PROPN
cajgh-313	8	11	virus	virus	NOUN
cajgh-313	8	12	(	(	PUNCT
cajgh-313	8	13	hcv	hcv	PROPN
cajgh-313	8	14	)	)	PUNCT
cajgh-313	8	15	co	co	NOUN
cajgh-313	8	16	-	-	NOUN
cajgh-313	8	17	infection	infection	NOUN
cajgh-313	8	18	may	may	AUX
cajgh-313	8	19	have	have	VERB
cajgh-313	8	20	more	more	ADV
cajgh-313	8	21	severe	severe	ADJ
cajgh-313	8	22	liver	liver	NOUN
cajgh-313	8	23	disease	disease	NOUN
cajgh-313	8	24	and	and	CCONJ
cajgh-313	8	25	are	be	AUX
cajgh-313	8	26	potentially	potentially	ADV
cajgh-313	8	27	at	at	ADP
cajgh-313	8	28	higher	high	ADJ
cajgh-313	8	29	risk	risk	NOUN
cajgh-313	8	30	for	for	ADP
cajgh-313	8	31	developing	develop	VERB
cajgh-313	8	32	hepatocellular	hepatocellular	ADJ
cajgh-313	8	33	carcinoma	carcinoma	NOUN
cajgh-313	8	34	.	.	PUNCT
cajgh-313	9	1	the	the	DET
cajgh-313	9	2	aim	aim	NOUN
cajgh-313	9	3	of	of	ADP
cajgh-313	9	4	this	this	DET
cajgh-313	9	5	study	study	NOUN
cajgh-313	9	6	was	be	AUX
cajgh-313	9	7	to	to	PART
cajgh-313	9	8	assess	assess	VERB
cajgh-313	9	9	the	the	DET
cajgh-313	9	10	sero	sero	NOUN
cajgh-313	9	11	-	-	PUNCT
cajgh-313	9	12	occurrence	occurrence	NOUN
cajgh-313	9	13	of	of	ADP
cajgh-313	9	14	hbv	hbv	NOUN
cajgh-313	9	15	/	/	SYM
cajgh-313	9	16	hcv	hcv	X
cajgh-313	9	17	co	co	NOUN
cajgh-313	9	18	-	-	NOUN
cajgh-313	9	19	infection	infection	NOUN
cajgh-313	9	20	by	by	ADP
cajgh-313	9	21	examining	examine	VERB
cajgh-313	9	22	the	the	DET
cajgh-313	9	23	medical	medical	ADJ
cajgh-313	9	24	records	record	NOUN
cajgh-313	9	25	of	of	ADP
cajgh-313	9	26	tertiary	tertiary	ADJ
cajgh-313	9	27	care	care	NOUN
cajgh-313	9	28	hospital	hospital	NOUN
cajgh-313	9	29	patients	patient	NOUN
cajgh-313	9	30	in	in	ADP
cajgh-313	9	31	central	central	ADJ
cajgh-313	9	32	india	india	PROPN
cajgh-313	9	33	and	and	CCONJ
cajgh-313	9	34	determine	determine	VERB
cajgh-313	9	35	the	the	DET
cajgh-313	9	36	extent	extent	NOUN
cajgh-313	9	37	of	of	ADP
cajgh-313	9	38	liver	liver	NOUN
cajgh-313	9	39	damage	damage	NOUN
cajgh-313	9	40	based	base	VERB
cajgh-313	9	41	on	on	ADP
cajgh-313	9	42	liver	liver	NOUN
cajgh-313	9	43	function	function	NOUN
cajgh-313	9	44	tests	test	NOUN
cajgh-313	9	45	(	(	PUNCT
cajgh-313	9	46	lfts	lft	NOUN
cajgh-313	9	47	)	)	PUNCT
cajgh-313	9	48	.	.	PUNCT
cajgh-313	10	1	methods	method	NOUN
cajgh-313	10	2	:	:	PUNCT
cajgh-313	10	3	patients	patient	NOUN
cajgh-313	10	4	with	with	ADP
cajgh-313	10	5	a	a	DET
cajgh-313	10	6	positive	positive	ADJ
cajgh-313	10	7	test	test	NOUN
cajgh-313	10	8	for	for	ADP
cajgh-313	10	9	hbv	hbv	NOUN
cajgh-313	10	10	surface	surface	NOUN
cajgh-313	10	11	antigen	antigen	NOUN
cajgh-313	10	12	(	(	PUNCT
cajgh-313	10	13	hbsag	hbsag	NOUN
cajgh-313	10	14	)	)	PUNCT
cajgh-313	10	15	over	over	ADP
cajgh-313	10	16	a	a	DET
cajgh-313	10	17	period	period	NOUN
cajgh-313	10	18	of	of	ADP
cajgh-313	10	19	10	10	NUM
cajgh-313	10	20	years	year	NOUN
cajgh-313	10	21	were	be	AUX
cajgh-313	10	22	identified	identify	VERB
cajgh-313	10	23	from	from	ADP
cajgh-313	10	24	laboratory	laboratory	NOUN
cajgh-313	10	25	records	record	NOUN
cajgh-313	10	26	in	in	ADP
cajgh-313	10	27	a	a	DET
cajgh-313	10	28	tertiary	tertiary	ADJ
cajgh-313	10	29	care	care	NOUN
cajgh-313	10	30	facility	facility	NOUN
cajgh-313	10	31	in	in	ADP
cajgh-313	10	32	central	central	PROPN
cajgh-313	10	33	india	india	PROPN
cajgh-313	10	34	.	.	PUNCT
cajgh-313	11	1	records	record	NOUN
cajgh-313	11	2	of	of	ADP
cajgh-313	11	3	51,075	51,075	NUM
cajgh-313	11	4	consecutive	consecutive	ADJ
cajgh-313	11	5	non	non	ADJ
cajgh-313	11	6	-	-	ADJ
cajgh-313	11	7	duplicate	duplicate	ADJ
cajgh-313	11	8	blood	blood	NOUN
cajgh-313	11	9	samples	sample	NOUN
cajgh-313	11	10	were	be	AUX
cajgh-313	11	11	then	then	ADV
cajgh-313	11	12	screened	screen	VERB
cajgh-313	11	13	for	for	ADP
cajgh-313	11	14	a	a	DET
cajgh-313	11	15	positive	positive	ADJ
cajgh-313	11	16	hbv	hbv	NOUN
cajgh-313	11	17	and	and	CCONJ
cajgh-313	11	18	hcv	hcv	NOUN
cajgh-313	11	19	tests	test	NOUN
cajgh-313	11	20	.	.	PUNCT
cajgh-313	12	1	lft	lft	PROPN
cajgh-313	12	2	,	,	PUNCT
cajgh-313	12	3	liver	liver	NOUN
cajgh-313	12	4	enzymes	enzyme	NOUN
cajgh-313	12	5	,	,	PUNCT
cajgh-313	12	6	and	and	CCONJ
cajgh-313	12	7	bilirubin	bilirubin	NOUN
cajgh-313	12	8	data	datum	NOUN
cajgh-313	12	9	were	be	AUX
cajgh-313	12	10	also	also	ADV
cajgh-313	12	11	extracted	extract	VERB
cajgh-313	12	12	.	.	PUNCT
cajgh-313	13	1	means	mean	NOUN
cajgh-313	13	2	and	and	CCONJ
cajgh-313	13	3	standard	standard	ADJ
cajgh-313	13	4	deviations	deviation	NOUN
cajgh-313	13	5	were	be	AUX
cajgh-313	13	6	determined	determine	VERB
cajgh-313	13	7	for	for	ADP
cajgh-313	13	8	continuous	continuous	ADJ
cajgh-313	13	9	variables	variable	NOUN
cajgh-313	13	10	,	,	PUNCT
cajgh-313	13	11	and	and	CCONJ
cajgh-313	13	12	the	the	DET
cajgh-313	13	13	difference	difference	NOUN
cajgh-313	13	14	in	in	ADP
cajgh-313	13	15	means	mean	NOUN
cajgh-313	13	16	was	be	AUX
cajgh-313	13	17	compared	compare	VERB
cajgh-313	13	18	using	use	VERB
cajgh-313	13	19	a	a	DET
cajgh-313	13	20	independent	independent	ADJ
cajgh-313	13	21	samples	sample	NOUN
cajgh-313	13	22	t	t	NOUN
cajgh-313	13	23	-	-	PUNCT
cajgh-313	13	24	test	test	NOUN
cajgh-313	13	25	.	.	PUNCT
cajgh-313	14	1	associations	association	NOUN
cajgh-313	14	2	between	between	ADP
cajgh-313	14	3	hbv	hbv	NOUN
cajgh-313	14	4	/	/	SYM
cajgh-313	14	5	hcv	hcv	X
cajgh-313	14	6	co	co	NOUN
cajgh-313	14	7	-	-	NOUN
cajgh-313	14	8	infection	infection	NOUN
cajgh-313	14	9	status	status	NOUN
cajgh-313	14	10	and	and	CCONJ
cajgh-313	14	11	demographic	demographic	ADJ
cajgh-313	14	12	variables	variable	NOUN
cajgh-313	14	13	were	be	AUX
cajgh-313	14	14	calculated	calculate	VERB
cajgh-313	14	15	using	use	VERB
cajgh-313	14	16	pearson	pearson	PROPN
cajgh-313	14	17	’s	’s	PART
cajgh-313	14	18	chi	chi	ADJ
cajgh-313	14	19	-	-	PUNCT
cajgh-313	14	20	squared	square	VERB
cajgh-313	14	21	test	test	NOUN
cajgh-313	14	22	.	.	PUNCT
cajgh-313	15	1	a	a	DET
cajgh-313	15	2	p	p	NOUN
cajgh-313	15	3	-	-	PUNCT
cajgh-313	15	4	value	value	NOUN
cajgh-313	15	5	less	less	ADJ
cajgh-313	15	6	than	than	ADP
cajgh-313	15	7	0.05	0.05	NUM
cajgh-313	15	8	was	be	AUX
cajgh-313	15	9	considered	consider	VERB
cajgh-313	15	10	statistically	statistically	ADV
cajgh-313	15	11	significant	significant	ADJ
cajgh-313	15	12	.	.	PUNCT
cajgh-313	16	1	results	result	NOUN
cajgh-313	16	2	:	:	PUNCT
cajgh-313	16	3	in	in	ADP
cajgh-313	16	4	this	this	DET
cajgh-313	16	5	study	study	NOUN
cajgh-313	16	6	,	,	PUNCT
cajgh-313	16	7	1674	1674	NUM
cajgh-313	16	8	(	(	PUNCT
cajgh-313	16	9	3.27	3.27	NUM
cajgh-313	16	10	%	%	NOUN
cajgh-313	16	11	)	)	PUNCT
cajgh-313	16	12	screened	screen	VERB
cajgh-313	16	13	patients	patient	NOUN
cajgh-313	16	14	were	be	AUX
cajgh-313	16	15	positive	positive	ADJ
cajgh-313	16	16	for	for	ADP
cajgh-313	16	17	hbsag	hbsag	NOUN
cajgh-313	16	18	and	and	CCONJ
cajgh-313	16	19	the	the	DET
cajgh-313	16	20	sero	sero	NOUN
cajgh-313	16	21	-	-	PUNCT
cajgh-313	16	22	occurrence	occurrence	NOUN
cajgh-313	16	23	of	of	ADP
cajgh-313	16	24	co	co	NOUN
cajgh-313	16	25	-	-	NOUN
cajgh-313	16	26	infection	infection	NOUN
cajgh-313	16	27	with	with	ADP
cajgh-313	16	28	hcv	hcv	PROPN
cajgh-313	16	29	in	in	ADP
cajgh-313	16	30	hbsag	hbsag	ADJ
cajgh-313	16	31	positive	positive	ADJ
cajgh-313	16	32	patients	patient	NOUN
cajgh-313	16	33	was	be	AUX
cajgh-313	16	34	reported	report	VERB
cajgh-313	16	35	in	in	ADP
cajgh-313	16	36	28	28	NUM
cajgh-313	16	37	individuals	individual	NOUN
cajgh-313	16	38	(	(	PUNCT
cajgh-313	16	39	1.67	1.67	NUM
cajgh-313	16	40	%	%	NOUN
cajgh-313	16	41	)	)	PUNCT
cajgh-313	16	42	.	.	PUNCT
cajgh-313	17	1	there	there	PRON
cajgh-313	17	2	was	be	VERB
cajgh-313	17	3	no	no	DET
cajgh-313	17	4	significant	significant	ADJ
cajgh-313	17	5	gender	gender	NOUN
cajgh-313	17	6	difference	difference	NOUN
cajgh-313	17	7	for	for	ADP
cajgh-313	17	8	hbv	hbv	NOUN
cajgh-313	17	9	/	/	SYM
cajgh-313	17	10	hcv	hcv	NOUN
cajgh-313	17	11	coinfection	coinfection	NOUN
cajgh-313	17	12	(	(	PUNCT
cajgh-313	17	13	p>0.05	p>0.05	PROPN
cajgh-313	17	14	)	)	PUNCT
cajgh-313	17	15	.	.	PUNCT
cajgh-313	18	1	hbv	hbv	NOUN
cajgh-313	18	2	/	/	SYM
cajgh-313	18	3	hcv	hcv	X
cajgh-313	18	4	co	co	NOUN
cajgh-313	18	5	-	-	NOUN
cajgh-313	18	6	infection	infection	NOUN
cajgh-313	18	7	was	be	AUX
cajgh-313	18	8	observed	observe	VERB
cajgh-313	18	9	more	more	ADV
cajgh-313	18	10	frequently	frequently	ADV
cajgh-313	18	11	in	in	ADP
cajgh-313	18	12	the	the	DET
cajgh-313	18	13	31	31	NUM
cajgh-313	18	14	-	-	SYM
cajgh-313	18	15	60	60	NUM
cajgh-313	18	16	year	year	NOUN
cajgh-313	18	17	old	old	ADJ
cajgh-313	18	18	age	age	NOUN
cajgh-313	18	19	group	group	NOUN
cajgh-313	18	20	(	(	PUNCT
cajgh-313	18	21	p=0.001	p=0.001	NUM
cajgh-313	18	22	)	)	PUNCT
cajgh-313	18	23	.	.	PUNCT
cajgh-313	19	1	hbv	hbv	NOUN
cajgh-313	19	2	/	/	SYM
cajgh-313	19	3	hcv	hcv	X
cajgh-313	19	4	co	co	ADJ
cajgh-313	19	5	-	-	ADJ
cajgh-313	19	6	infected	infected	ADJ
cajgh-313	19	7	patients	patient	NOUN
cajgh-313	19	8	had	have	VERB
cajgh-313	19	9	significantly	significantly	ADV
cajgh-313	19	10	higher	high	ADJ
cajgh-313	19	11	levels	level	NOUN
cajgh-313	19	12	of	of	ADP
cajgh-313	19	13	liver	liver	NOUN
cajgh-313	19	14	enzymes	enzyme	NOUN
cajgh-313	19	15	and	and	CCONJ
cajgh-313	19	16	bilirubin	bilirubin	NOUN
cajgh-313	19	17	than	than	ADP
cajgh-313	19	18	those	those	PRON
cajgh-313	19	19	with	with	ADP
cajgh-313	19	20	hbsag	hbsag	ADJ
cajgh-313	19	21	mono	mono	NOUN
cajgh-313	19	22	-	-	PUNCT
cajgh-313	19	23	infection	infection	NOUN
cajgh-313	19	24	(	(	PUNCT
cajgh-313	19	25	p=0.001	p=0.001	NUM
cajgh-313	19	26	)	)	PUNCT
cajgh-313	19	27	.	.	PUNCT
cajgh-313	20	1	conclusion	conclusion	NOUN
cajgh-313	20	2	:	:	PUNCT
cajgh-313	20	3	liver	liver	NOUN
cajgh-313	20	4	function	function	NOUN
cajgh-313	20	5	tests	test	NOUN
cajgh-313	20	6	are	be	AUX
cajgh-313	20	7	potentially	potentially	ADV
cajgh-313	20	8	important	important	ADJ
cajgh-313	20	9	predictors	predictor	NOUN
cajgh-313	20	10	for	for	ADP
cajgh-313	20	11	hbv	hbv	NOUN
cajgh-313	20	12	/	/	SYM
cajgh-313	20	13	hcv	hcv	NOUN
cajgh-313	20	14	coinfection	coinfection	NOUN
cajgh-313	20	15	.	.	PUNCT
cajgh-313	21	1	screening	screen	VERB
cajgh-313	21	2	for	for	ADP
cajgh-313	21	3	hcv	hcv	PROPN
cajgh-313	21	4	co	co	NOUN
cajgh-313	21	5	-	-	NOUN
cajgh-313	21	6	infection	infection	NOUN
cajgh-313	21	7	in	in	ADP
cajgh-313	21	8	hbsag	hbsag	ADJ
cajgh-313	21	9	-	-	PUNCT
cajgh-313	21	10	positive	positive	ADJ
cajgh-313	21	11	patients	patient	NOUN
cajgh-313	21	12	is	be	AUX
cajgh-313	21	13	recommended	recommend	VERB
cajgh-313	21	14	in	in	ADP
cajgh-313	21	15	india	india	PROPN
cajgh-313	21	16	.	.	PUNCT
cajgh-313	22	1	detection	detection	NOUN
cajgh-313	22	2	of	of	ADP
cajgh-313	22	3	co	co	NOUN
cajgh-313	22	4	-	-	NOUN
cajgh-313	22	5	infection	infection	NOUN
cajgh-313	22	6	may	may	AUX
cajgh-313	22	7	enable	enable	VERB
cajgh-313	22	8	timely	timely	ADJ
cajgh-313	22	9	preventive	preventive	ADJ
cajgh-313	22	10	/	/	SYM
cajgh-313	22	11	therapeutic	therapeutic	ADJ
cajgh-313	22	12	interventions	intervention	NOUN
cajgh-313	22	13	aimed	aim	VERB
cajgh-313	22	14	at	at	ADP
cajgh-313	22	15	preventing	prevent	VERB
cajgh-313	22	16	progression	progression	NOUN
cajgh-313	22	17	to	to	ADP
cajgh-313	22	18	hepatocellular	hepatocellular	ADJ
cajgh-313	22	19	carcinoma	carcinoma	NOUN
cajgh-313	22	20	.	.	PUNCT
cajgh-313	23	1	keywords	keyword	NOUN
cajgh-313	23	2	:	:	PUNCT
cajgh-313	23	3	hepatitis	hepatitis	PROPN
cajgh-313	23	4	b	b	PROPN
cajgh-313	23	5	;	;	PUNCT
cajgh-313	23	6	hepatitis	hepatitis	NOUN
cajgh-313	23	7	c	c	NOUN
cajgh-313	23	8	;	;	PUNCT
cajgh-313	23	9	co	co	NOUN
cajgh-313	23	10	-	-	NOUN
cajgh-313	23	11	infection	infection	NOUN
cajgh-313	23	12	;	;	PUNCT
cajgh-313	23	13	india	india	PROPN
cajgh-313	23	14	sero	sero	NOUN
cajgh-313	23	15	-	-	PUNCT
cajgh-313	23	16	occurrence	occurrence	NOUN
cajgh-313	23	17	of	of	ADP
cajgh-313	23	18	hbv	hbv	NOUN
cajgh-313	23	19	/	/	SYM
cajgh-313	23	20	hcv	hcv	NOUN
cajgh-313	23	21	coinfection	coinfection	NOUN
cajgh-313	23	22	and	and	CCONJ
cajgh-313	23	23	levels	level	NOUN
cajgh-313	23	24	of	of	ADP
cajgh-313	23	25	liver	liver	NOUN
cajgh-313	23	26	enzymes	enzyme	NOUN
cajgh-313	23	27	among	among	ADP
cajgh-313	23	28	patients	patient	NOUN
cajgh-313	23	29	at	at	ADP
cajgh-313	23	30	a	a	DET
cajgh-313	23	31	tertiary	tertiary	ADJ
cajgh-313	23	32	care	care	NOUN
cajgh-313	23	33	hospital	hospital	NOUN
cajgh-313	23	34	in	in	ADP
cajgh-313	23	35	central	central	ADJ
cajgh-313	23	36	india	india	PROPN
cajgh-313	23	37	:	:	PUNCT
cajgh-313	23	38	a	a	DET
cajgh-313	23	39	pilot	pilot	NOUN
cajgh-313	23	40	study	study	NOUN
cajgh-313	23	41	prabha	prabha	NOUN
cajgh-313	23	42	desikan1	desikan1	PROPN
cajgh-313	23	43	,	,	PUNCT
cajgh-313	23	44	aseem	aseem	PROPN
cajgh-313	23	45	rangnekar1	rangnekar1	PROPN
cajgh-313	23	46	,	,	PUNCT
cajgh-313	23	47	zeba	zeba	PROPN
cajgh-313	23	48	khan1	khan1	PROPN
cajgh-313	23	49	,	,	PUNCT
cajgh-313	23	50	nikita	nikita	PROPN
cajgh-313	23	51	panwalkar1	panwalkar1	PROPN
cajgh-313	23	52	,	,	PUNCT
cajgh-313	23	53	protiti	protiti	ADJ
cajgh-313	23	54	bose1	bose1	NOUN
cajgh-313	23	55	,	,	PUNCT
cajgh-313	23	56	hanni	hanni	PROPN
cajgh-313	23	57	vasudev	vasudev	PROPN
cajgh-313	23	58	gulwani2	gulwani2	PROPN
cajgh-313	23	59	,	,	PUNCT
cajgh-313	23	60	sukhpreet	sukhpreet	NOUN
cajgh-313	23	61	kaur2	kaur2	NOUN
cajgh-313	24	1	1department	1department	NUM
cajgh-313	24	2	of	of	ADP
cajgh-313	24	3	microbiology	microbiology	NOUN
cajgh-313	24	4	,	,	PUNCT
cajgh-313	24	5	bhopal	bhopal	NOUN
cajgh-313	24	6	memorial	memorial	ADJ
cajgh-313	24	7	hospital	hospital	NOUN
cajgh-313	24	8	and	and	CCONJ
cajgh-313	24	9	research	research	NOUN
cajgh-313	24	10	centre	centre	NOUN
cajgh-313	24	11	,	,	PUNCT
cajgh-313	24	12	india	india	PROPN
cajgh-313	24	13	;	;	PUNCT
cajgh-313	24	14	2department	2department	NUM
cajgh-313	24	15	of	of	ADP
cajgh-313	24	16	pathology	pathology	NOUN
cajgh-313	24	17	,	,	PUNCT
cajgh-313	24	18	bhopal	bhopal	NOUN
cajgh-313	24	19	memorial	memorial	ADJ
cajgh-313	24	20	hospital	hospital	NOUN
cajgh-313	24	21	and	and	CCONJ
cajgh-313	24	22	research	research	NOUN
cajgh-313	24	23	centre	centre	NOUN
cajgh-313	24	24	,	,	PUNCT
cajgh-313	24	25	india	india	PROPN
cajgh-313	24	26	research	research	PROPN
cajgh-313	24	27	introduction	introduction	NOUN
cajgh-313	24	28	chronic	chronic	ADJ
cajgh-313	24	29	liver	liver	NOUN
cajgh-313	24	30	disease	disease	NOUN
cajgh-313	24	31	(	(	PUNCT
cajgh-313	24	32	cld	cld	NOUN
cajgh-313	24	33	)	)	PUNCT
cajgh-313	24	34	results	result	NOUN
cajgh-313	24	35	from	from	ADP
cajgh-313	24	36	an	an	DET
cajgh-313	24	37	inflammatory	inflammatory	ADJ
cajgh-313	24	38	injury	injury	NOUN
cajgh-313	24	39	to	to	ADP
cajgh-313	24	40	the	the	DET
cajgh-313	24	41	liver	liver	NOUN
cajgh-313	24	42	,	,	PUNCT
cajgh-313	24	43	persisting	persist	VERB
cajgh-313	24	44	for	for	ADP
cajgh-313	24	45	six	six	NUM
cajgh-313	24	46	or	or	CCONJ
cajgh-313	24	47	more	more	ADJ
cajgh-313	24	48	months	month	NOUN
cajgh-313	24	49	without	without	ADP
cajgh-313	24	50	complete	complete	ADJ
cajgh-313	24	51	resolution	resolution	NOUN
cajgh-313	24	52	.	.	PUNCT
cajgh-313	25	1	cld	cld	NOUN
cajgh-313	25	2	can	can	AUX
cajgh-313	25	3	result	result	VERB
cajgh-313	25	4	from	from	ADP
cajgh-313	25	5	a	a	DET
cajgh-313	25	6	spectrum	spectrum	NOUN
cajgh-313	25	7	of	of	ADP
cajgh-313	25	8	diseases	disease	NOUN
cajgh-313	25	9	including	include	VERB
cajgh-313	25	10	chronic	chronic	ADJ
cajgh-313	25	11	hepatitis	hepatitis	NOUN
cajgh-313	25	12	,	,	PUNCT
cajgh-313	25	13	liver	liver	NOUN
cajgh-313	25	14	cirrhosis	cirrhosis	NOUN
cajgh-313	25	15	,	,	PUNCT
cajgh-313	25	16	and	and	CCONJ
cajgh-313	25	17	hepatocellular	hepatocellular	ADJ
cajgh-313	25	18	carcinoma	carcinoma	NOUN
cajgh-313	25	19	(	(	PUNCT
cajgh-313	25	20	hcc)1	hcc)1	PROPN
cajgh-313	25	21	.	.	PUNCT
cajgh-313	25	22	chronic	chronic	ADJ
cajgh-313	25	23	hepatitis	hepatitis	PROPN
cajgh-313	25	24	b	b	PROPN
cajgh-313	25	25	virus	virus	NOUN
cajgh-313	25	26	(	(	PUNCT
cajgh-313	25	27	hbv	hbv	NOUN
cajgh-313	25	28	)	)	PUNCT
cajgh-313	25	29	and	and	CCONJ
cajgh-313	25	30	hepatitis	hepatitis	PROPN
cajgh-313	25	31	c	c	PROPN
cajgh-313	25	32	virus	virus	NOUN
cajgh-313	25	33	(	(	PUNCT
cajgh-313	25	34	hcv	hcv	PROPN
cajgh-313	25	35	)	)	PUNCT
cajgh-313	25	36	infections	infection	NOUN
cajgh-313	25	37	are	be	AUX
cajgh-313	25	38	significant	significant	ADJ
cajgh-313	25	39	public	public	ADJ
cajgh-313	25	40	health	health	NOUN
cajgh-313	25	41	issues	issue	NOUN
cajgh-313	25	42	globally	globally	ADV
cajgh-313	25	43	.	.	PUNCT
cajgh-313	26	1	compared	compare	VERB
cajgh-313	26	2	to	to	ADP
cajgh-313	26	3	hbv	hbv	PROPN
cajgh-313	26	4	mono	mono	NOUN
cajgh-313	26	5	-	-	PUNCT
cajgh-313	26	6	infected	infect	VERB
cajgh-313	26	7	patients	patient	NOUN
cajgh-313	26	8	,	,	PUNCT
cajgh-313	26	9	hbv	hbv	NOUN
cajgh-313	26	10	/	/	SYM
cajgh-313	26	11	hcv	hcv	X
cajgh-313	26	12	co	co	ADJ
cajgh-313	26	13	-	-	ADJ
cajgh-313	26	14	infected	infected	ADJ
cajgh-313	26	15	patients	patient	NOUN
cajgh-313	26	16	have	have	VERB
cajgh-313	26	17	higher	high	ADJ
cajgh-313	26	18	rates	rate	NOUN
cajgh-313	26	19	of	of	ADP
cajgh-313	26	20	cirrhosis	cirrhosis	NOUN
cajgh-313	26	21	(	(	PUNCT
cajgh-313	26	22	44	44	NUM
cajgh-313	26	23	%	%	NOUN
cajgh-313	26	24	vs.	vs.	ADP
cajgh-313	26	25	21	21	NUM
cajgh-313	26	26	%	%	NOUN
cajgh-313	26	27	)	)	PUNCT
cajgh-313	26	28	and	and	CCONJ
cajgh-313	26	29	decompensated	decompensate	VERB
cajgh-313	26	30	liver	liver	NOUN
cajgh-313	26	31	disease	disease	NOUN
cajgh-313	26	32	(	(	PUNCT
cajgh-313	26	33	24	24	NUM
cajgh-313	26	34	%	%	NOUN
cajgh-313	26	35	vs.	vs.	ADP
cajgh-313	26	36	6	6	NUM
cajgh-313	26	37	%	%	NOUN
cajgh-313	26	38	)	)	PUNCT
cajgh-313	26	39	.	.	PUNCT
cajgh-313	27	1	similarly	similarly	ADV
cajgh-313	27	2	,	,	PUNCT
cajgh-313	27	3	hbv	hbv	NOUN
cajgh-313	27	4	/	/	SYM
cajgh-313	27	5	hcv	hcv	X
cajgh-313	27	6	co	co	ADJ
cajgh-313	27	7	-	-	ADJ
cajgh-313	27	8	infected	infected	ADJ
cajgh-313	27	9	patients	patient	NOUN
cajgh-313	27	10	compared	compare	VERB
cajgh-313	27	11	to	to	PART
cajgh-313	27	12	hcv	hcv	VERB
cajgh-313	27	13	mono	mono	NOUN
cajgh-313	27	14	-	-	PUNCT
cajgh-313	27	15	infected	infect	VERB
cajgh-313	27	16	patients	patient	NOUN
cajgh-313	27	17	,	,	PUNCT
cajgh-313	27	18	have	have	VERB
cajgh-313	27	19	a	a	DET
cajgh-313	27	20	higher	high	ADJ
cajgh-313	27	21	rate	rate	NOUN
cajgh-313	27	22	of	of	ADP
cajgh-313	27	23	cirrhosis	cirrhosis	NOUN
cajgh-313	27	24	(	(	PUNCT
cajgh-313	27	25	95	95	NUM
cajgh-313	27	26	%	%	NOUN
cajgh-313	27	27	vs.	vs.	ADP
cajgh-313	27	28	49	49	NUM
cajgh-313	27	29	%	%	NOUN
cajgh-313	27	30	)	)	PUNCT
cajgh-313	27	31	and	and	CCONJ
cajgh-313	27	32	more	more	ADV
cajgh-313	27	33	advanced	advanced	ADJ
cajgh-313	27	34	decompensated	decompensate	VERB
cajgh-313	27	35	liver	liver	NOUN
cajgh-313	27	36	disease	disease	NOUN
cajgh-313	27	37	(	(	PUNCT
cajgh-313	27	38	child	child	NOUN
cajgh-313	27	39	-	-	PUNCT
cajgh-313	27	40	pugh	pugh	PROPN
cajgh-313	27	41	class	class	PROPN
cajgh-313	27	42	http://www.library.pitt.edu/	http://www.library.pitt.edu/	PROPN
cajgh-313	27	43	http://www.pitt.edu/	http://www.pitt.edu/	NOUN
cajgh-313	27	44	http://www.library.pitt.edu/articles/digpubtype/index.html	http://www.library.pitt.edu/articles/digpubtype/index.html	PUNCT
cajgh-313	27	45	http://www.upress.pitt.edu/upressindex.aspx	http://www.upress.pitt.edu/upressindex.aspx	NUM
cajgh-313	27	46	central	central	ADJ
cajgh-313	27	47	asian	asian	ADJ
cajgh-313	27	48	journal	journal	NOUN
cajgh-313	27	49	of	of	ADP
cajgh-313	27	50	global	global	ADJ
cajgh-313	27	51	health	health	NOUN
cajgh-313	27	52	this	this	DET
cajgh-313	27	53	work	work	NOUN
cajgh-313	27	54	is	be	AUX
cajgh-313	27	55	licensed	license	VERB
cajgh-313	27	56	under	under	ADP
cajgh-313	27	57	a	a	DET
cajgh-313	27	58	creative	creative	ADJ
cajgh-313	27	59	commons	common	NOUN
cajgh-313	27	60	attribution	attribution	NOUN
cajgh-313	27	61	4.0	4.0	NUM
cajgh-313	27	62	united	unite	VERB
cajgh-313	27	63	states	states	PROPN
cajgh-313	27	64	license	license	NOUN
cajgh-313	27	65	.	.	PUNCT
cajgh-313	28	1	this	this	DET
cajgh-313	28	2	journal	journal	NOUN
cajgh-313	28	3	is	be	AUX
cajgh-313	28	4	published	publish	VERB
cajgh-313	28	5	by	by	ADP
cajgh-313	28	6	theuniversity	theuniversity	NOUN
cajgh-313	28	7	library	library	NOUN
cajgh-313	28	8	system	system	NOUN
cajgh-313	28	9	of	of	ADP
cajgh-313	28	10	the	the	DET
cajgh-313	28	11	university	university	PROPN
cajgh-313	28	12	of	of	ADP
cajgh-313	28	13	pittsburgh	pittsburgh	PROPN
cajgh-313	28	14	as	as	ADP
cajgh-313	28	15	part	part	NOUN
cajgh-313	28	16	of	of	ADP
cajgh-313	28	17	its	its	PRON
cajgh-313	28	18	d	d	NOUN
cajgh-313	28	19	-	-	PUNCT
cajgh-313	28	20	scribe	scribe	VERB
cajgh-313	28	21	digital	digital	ADJ
cajgh-313	28	22	publishing	publishing	NOUN
cajgh-313	28	23	program	program	NOUN
cajgh-313	28	24	and	and	CCONJ
cajgh-313	28	25	is	be	AUX
cajgh-313	28	26	cosponsored	cosponsor	VERB
cajgh-313	28	27	by	by	ADP
cajgh-313	28	28	the	the	DET
cajgh-313	28	29	university	university	PROPN
cajgh-313	28	30	of	of	ADP
cajgh-313	28	31	pittsburgh	pittsburgh	PROPN
cajgh-313	28	32	press	press	NOUN
cajgh-313	28	33	.	.	PUNCT
cajgh-313	29	1	central	central	ADJ
cajgh-313	29	2	asian	asian	ADJ
cajgh-313	29	3	journal	journal	NOUN
cajgh-313	29	4	of	of	ADP
cajgh-313	29	5	global	global	ADJ
cajgh-313	29	6	health	health	NOUN
cajgh-313	29	7	volume	volume	NOUN
cajgh-313	29	8	8	8	NUM
cajgh-313	29	9	,	,	PUNCT
cajgh-313	29	10	no	no	INTJ
cajgh-313	29	11	.	.	NOUN
cajgh-313	29	12	1	1	NUM
cajgh-313	29	13	(	(	PUNCT
cajgh-313	29	14	2019	2019	NUM
cajgh-313	29	15	)	)	PUNCT
cajgh-313	29	16	|	|	ADV
cajgh-313	29	17	issn	issn	VERB
cajgh-313	29	18	2166	2166	NUM
cajgh-313	29	19	-	-	SYM
cajgh-313	29	20	7403	7403	NUM
cajgh-313	29	21	(	(	PUNCT
cajgh-313	29	22	online	online	ADJ
cajgh-313	29	23	)	)	PUNCT
cajgh-313	29	24	|	|	ADV
cajgh-313	29	25	doi	doi	X
cajgh-313	29	26	10.5195	10.5195	NUM
cajgh-313	29	27	/	/	SYM
cajgh-313	29	28	cajgh.2019.313|http://cajgh.pitt.edu	cajgh.2019.313|http://cajgh.pitt.edu	NOUN
cajgh-313	29	29	c	c	NOUN
cajgh-313	29	30	37	37	NUM
cajgh-313	29	31	%	%	NOUN
cajgh-313	29	32	vs.	vs.	ADP
cajgh-313	29	33	0%)2	0%)2	PROPN
cajgh-313	29	34	.	.	PUNCT
cajgh-313	30	1	epidemiologic	epidemiologic	ADJ
cajgh-313	30	2	studies	study	NOUN
cajgh-313	30	3	in	in	ADP
cajgh-313	30	4	patients	patient	NOUN
cajgh-313	30	5	with	with	ADP
cajgh-313	30	6	dual	dual	ADJ
cajgh-313	30	7	hbv	hbv	NOUN
cajgh-313	30	8	/	/	SYM
cajgh-313	30	9	hcv	hcv	NOUN
cajgh-313	30	10	infection	infection	NOUN
cajgh-313	30	11	demonstrated	demonstrate	VERB
cajgh-313	30	12	an	an	DET
cajgh-313	30	13	increased	increased	ADJ
cajgh-313	30	14	risk	risk	NOUN
cajgh-313	30	15	of	of	ADP
cajgh-313	30	16	hcc	hcc	PROPN
cajgh-313	30	17	,	,	PUNCT
cajgh-313	30	18	which	which	PRON
cajgh-313	30	19	has	have	AUX
cajgh-313	30	20	been	be	AUX
cajgh-313	30	21	confirmed	confirm	VERB
cajgh-313	30	22	by	by	ADP
cajgh-313	30	23	three	three	NUM
cajgh-313	30	24	published	publish	VERB
cajgh-313	30	25	meta	meta	X
cajgh-313	30	26	-	-	PUNCT
cajgh-313	30	27	analyses3	analyses3	PROPN
cajgh-313	30	28	-	-	PUNCT
cajgh-313	30	29	5	5	PROPN
cajgh-313	30	30	.	.	PUNCT
cajgh-313	30	31	evidence	evidence	NOUN
cajgh-313	30	32	suggests	suggest	VERB
cajgh-313	30	33	that	that	SCONJ
cajgh-313	30	34	hbv	hbv	NOUN
cajgh-313	30	35	is	be	AUX
cajgh-313	30	36	capable	capable	ADJ
cajgh-313	30	37	of	of	ADP
cajgh-313	30	38	initiating	initiate	VERB
cajgh-313	30	39	the	the	DET
cajgh-313	30	40	neoplastic	neoplastic	ADJ
cajgh-313	30	41	process	process	NOUN
cajgh-313	30	42	,	,	PUNCT
cajgh-313	30	43	while	while	SCONJ
cajgh-313	30	44	hcv	hcv	PROPN
cajgh-313	30	45	can	can	AUX
cajgh-313	30	46	act	act	VERB
cajgh-313	30	47	as	as	ADP
cajgh-313	30	48	a	a	DET
cajgh-313	30	49	promoter	promoter	NOUN
cajgh-313	30	50	,	,	PUNCT
cajgh-313	30	51	and	and	CCONJ
cajgh-313	30	52	that	that	SCONJ
cajgh-313	30	53	the	the	DET
cajgh-313	30	54	two	two	NUM
cajgh-313	30	55	conditions	condition	NOUN
cajgh-313	30	56	may	may	AUX
cajgh-313	30	57	be	be	AUX
cajgh-313	30	58	synergistic	synergistic	ADJ
cajgh-313	30	59	in	in	ADP
cajgh-313	30	60	leading	lead	VERB
cajgh-313	30	61	to	to	ADP
cajgh-313	30	62	hcc	hcc	PROPN
cajgh-313	30	63	development3	development3	PROPN
cajgh-313	30	64	.	.	PUNCT
cajgh-313	31	1	the	the	DET
cajgh-313	31	2	estimated	estimate	VERB
cajgh-313	31	3	global	global	ADJ
cajgh-313	31	4	prevalence	prevalence	NOUN
cajgh-313	31	5	of	of	ADP
cajgh-313	31	6	hbv	hbv	NOUN
cajgh-313	31	7	/	/	SYM
cajgh-313	31	8	hcv	hcv	X
cajgh-313	31	9	co	co	NOUN
cajgh-313	31	10	-	-	NOUN
cajgh-313	31	11	infection	infection	NOUN
cajgh-313	31	12	is	be	AUX
cajgh-313	31	13	approximately	approximately	ADV
cajgh-313	31	14	5	5	NUM
cajgh-313	31	15	-	-	SYM
cajgh-313	31	16	20	20	NUM
cajgh-313	31	17	%	%	NOUN
cajgh-313	31	18	in	in	ADP
cajgh-313	31	19	hbsag	hbsag	ADJ
cajgh-313	31	20	positive	positive	ADJ
cajgh-313	31	21	patients	patient	NOUN
cajgh-313	31	22	and	and	CCONJ
cajgh-313	31	23	2	2	NUM
cajgh-313	31	24	-	-	SYM
cajgh-313	31	25	10	10	NUM
cajgh-313	31	26	%	%	NOUN
cajgh-313	31	27	in	in	ADP
cajgh-313	31	28	hcv	hcv	X
cajgh-313	31	29	positive	positive	ADJ
cajgh-313	31	30	patients6	patients6	NOUN
cajgh-313	31	31	.	.	PUNCT
cajgh-313	32	1	in	in	ADP
cajgh-313	32	2	india	india	PROPN
cajgh-313	32	3	,	,	PUNCT
cajgh-313	32	4	the	the	DET
cajgh-313	32	5	prevalence	prevalence	NOUN
cajgh-313	32	6	of	of	ADP
cajgh-313	32	7	hbv	hbv	NOUN
cajgh-313	32	8	and	and	CCONJ
cajgh-313	32	9	hcv	hcv	PROPN
cajgh-313	32	10	coinfection	coinfection	NOUN
cajgh-313	32	11	ranges	range	VERB
cajgh-313	32	12	from	from	ADP
cajgh-313	32	13	1.89	1.89	NUM
cajgh-313	32	14	%	%	NOUN
cajgh-313	32	15	to	to	ADP
cajgh-313	32	16	56	56	NUM
cajgh-313	32	17	%	%	NOUN
cajgh-313	32	18	depending	depend	VERB
cajgh-313	32	19	on	on	ADP
cajgh-313	32	20	the	the	DET
cajgh-313	32	21	region7,8	region7,8	PROPN
cajgh-313	32	22	,	,	PUNCT
cajgh-313	32	23	which	which	PRON
cajgh-313	32	24	may	may	AUX
cajgh-313	32	25	be	be	AUX
cajgh-313	32	26	related	relate	VERB
cajgh-313	32	27	to	to	ADP
cajgh-313	32	28	a	a	DET
cajgh-313	32	29	lack	lack	NOUN
cajgh-313	32	30	of	of	ADP
cajgh-313	32	31	awareness	awareness	NOUN
cajgh-313	32	32	of	of	ADP
cajgh-313	32	33	hbv	hbv	NOUN
cajgh-313	32	34	vaccine	vaccine	NOUN
cajgh-313	32	35	availability	availability	NOUN
cajgh-313	32	36	by	by	ADP
cajgh-313	32	37	the	the	DET
cajgh-313	32	38	general	general	ADJ
cajgh-313	32	39	public9	public9	NOUN
cajgh-313	32	40	.	.	PUNCT
cajgh-313	33	1	hbv	hbv	NOUN
cajgh-313	33	2	/	/	SYM
cajgh-313	33	3	hcv	hcv	X
cajgh-313	33	4	co	co	NOUN
cajgh-313	33	5	-	-	NOUN
cajgh-313	33	6	infection	infection	NOUN
cajgh-313	33	7	is	be	AUX
cajgh-313	33	8	more	more	ADV
cajgh-313	33	9	frequent	frequent	ADJ
cajgh-313	33	10	in	in	ADP
cajgh-313	33	11	high	high	ADJ
cajgh-313	33	12	-	-	PUNCT
cajgh-313	33	13	risk	risk	NOUN
cajgh-313	33	14	populations	population	NOUN
cajgh-313	33	15	of	of	ADP
cajgh-313	33	16	various	various	ADJ
cajgh-313	33	17	ages	age	NOUN
cajgh-313	33	18	,	,	PUNCT
cajgh-313	33	19	including	include	VERB
cajgh-313	33	20	intravenous	intravenous	ADJ
cajgh-313	33	21	drug	drug	NOUN
cajgh-313	33	22	users	user	NOUN
cajgh-313	33	23	,	,	PUNCT
cajgh-313	33	24	patients	patient	NOUN
cajgh-313	33	25	receiving	receive	VERB
cajgh-313	33	26	hemodialysis	hemodialysis	NOUN
cajgh-313	33	27	,	,	PUNCT
cajgh-313	33	28	patients	patient	NOUN
cajgh-313	33	29	undergoing	undergo	VERB
cajgh-313	33	30	organ	organ	NOUN
cajgh-313	33	31	transplantation	transplantation	NOUN
cajgh-313	33	32	,	,	PUNCT
cajgh-313	33	33	hiv	hiv	PROPN
cajgh-313	33	34	-	-	PUNCT
cajgh-313	33	35	positive	positive	ADJ
cajgh-313	33	36	patients	patient	NOUN
cajgh-313	33	37	,	,	PUNCT
cajgh-313	33	38	and	and	CCONJ
cajgh-313	33	39	β	β	X
cajgh-313	33	40	-	-	PUNCT
cajgh-313	33	41	thalassemia	thalassemia	NOUN
cajgh-313	33	42	patients10	patients10	NOUN
cajgh-313	33	43	.	.	PUNCT
cajgh-313	34	1	previous	previous	ADJ
cajgh-313	34	2	studies	study	NOUN
cajgh-313	34	3	reported	report	VERB
cajgh-313	34	4	that	that	SCONJ
cajgh-313	34	5	age	age	NOUN
cajgh-313	34	6	below	below	ADP
cajgh-313	34	7	40	40	NUM
cajgh-313	34	8	,	,	PUNCT
cajgh-313	34	9	asian	asian	ADJ
cajgh-313	34	10	race	race	NOUN
cajgh-313	34	11	,	,	PUNCT
cajgh-313	34	12	injection	injection	NOUN
cajgh-313	34	13	drug	drug	NOUN
cajgh-313	34	14	use	use	NOUN
cajgh-313	34	15	,	,	PUNCT
cajgh-313	34	16	a	a	DET
cajgh-313	34	17	greater	great	ADJ
cajgh-313	34	18	number	number	NOUN
cajgh-313	34	19	of	of	ADP
cajgh-313	34	20	lifetime	lifetime	NOUN
cajgh-313	34	21	sexual	sexual	ADJ
cajgh-313	34	22	partners	partner	NOUN
cajgh-313	34	23	,	,	PUNCT
cajgh-313	34	24	inadequate	inadequate	ADJ
cajgh-313	34	25	sterilization	sterilization	NOUN
cajgh-313	34	26	of	of	ADP
cajgh-313	34	27	medical	medical	ADJ
cajgh-313	34	28	equipment	equipment	NOUN
cajgh-313	34	29	,	,	PUNCT
cajgh-313	34	30	unprotected	unprotected	ADJ
cajgh-313	34	31	sex	sex	NOUN
cajgh-313	34	32	,	,	PUNCT
cajgh-313	34	33	and	and	CCONJ
cajgh-313	34	34	the	the	DET
cajgh-313	34	35	use	use	NOUN
cajgh-313	34	36	of	of	ADP
cajgh-313	34	37	unscreened	unscreened	ADJ
cajgh-313	34	38	blood	blood	NOUN
cajgh-313	34	39	and	and	CCONJ
cajgh-313	34	40	blood	blood	NOUN
cajgh-313	34	41	products	product	NOUN
cajgh-313	34	42	are	be	AUX
cajgh-313	34	43	independent	independent	ADJ
cajgh-313	34	44	risk	risk	NOUN
cajgh-313	34	45	factors	factor	NOUN
cajgh-313	34	46	for	for	ADP
cajgh-313	34	47	hbv	hbv	NOUN
cajgh-313	34	48	/	/	SYM
cajgh-313	34	49	hcv	hcv	X
cajgh-313	34	50	dual	dual	ADJ
cajgh-313	34	51	infection10,11	infection10,11	NOUN
cajgh-313	34	52	.	.	PUNCT
cajgh-313	35	1	in	in	ADP
cajgh-313	35	2	india	india	PROPN
cajgh-313	35	3	,	,	PUNCT
cajgh-313	35	4	the	the	DET
cajgh-313	35	5	most	most	ADV
cajgh-313	35	6	commonly	commonly	ADV
cajgh-313	35	7	reported	report	VERB
cajgh-313	35	8	modes	mode	NOUN
cajgh-313	35	9	of	of	ADP
cajgh-313	35	10	transmission	transmission	NOUN
cajgh-313	35	11	of	of	ADP
cajgh-313	35	12	hbv	hbv	NOUN
cajgh-313	35	13	and	and	CCONJ
cajgh-313	35	14	hcv	hcv	PROPN
cajgh-313	35	15	are	be	AUX
cajgh-313	35	16	sexual	sexual	ADJ
cajgh-313	35	17	transmission	transmission	NOUN
cajgh-313	35	18	,	,	PUNCT
cajgh-313	35	19	blood	blood	NOUN
cajgh-313	35	20	transfusion	transfusion	NOUN
cajgh-313	35	21	,	,	PUNCT
cajgh-313	35	22	and	and	CCONJ
cajgh-313	35	23	intravenous	intravenous	ADJ
cajgh-313	35	24	drug	drug	NOUN
cajgh-313	35	25	use12	use12	NOUN
cajgh-313	35	26	.	.	PUNCT
cajgh-313	36	1	moreover	moreover	ADV
cajgh-313	36	2	,	,	PUNCT
cajgh-313	36	3	because	because	SCONJ
cajgh-313	36	4	of	of	ADP
cajgh-313	36	5	the	the	DET
cajgh-313	36	6	shared	share	VERB
cajgh-313	36	7	modes	mode	NOUN
cajgh-313	36	8	of	of	ADP
cajgh-313	36	9	transmission	transmission	NOUN
cajgh-313	36	10	,	,	PUNCT
cajgh-313	36	11	hbv	hbv	NOUN
cajgh-313	36	12	/	/	SYM
cajgh-313	36	13	hcv	hcv	X
cajgh-313	36	14	co	co	NOUN
cajgh-313	36	15	-	-	NOUN
cajgh-313	36	16	infections	infection	NOUN
cajgh-313	36	17	are	be	AUX
cajgh-313	36	18	common	common	ADJ
cajgh-313	36	19	in	in	ADP
cajgh-313	36	20	endemic	endemic	ADJ
cajgh-313	36	21	areas	area	NOUN
cajgh-313	36	22	and	and	CCONJ
cajgh-313	36	23	among	among	ADP
cajgh-313	36	24	subjects	subject	NOUN
cajgh-313	36	25	with	with	ADP
cajgh-313	36	26	a	a	DET
cajgh-313	36	27	high	high	ADJ
cajgh-313	36	28	risk	risk	NOUN
cajgh-313	36	29	of	of	ADP
cajgh-313	36	30	parenteral	parenteral	ADJ
cajgh-313	36	31	transmission13,14	transmission13,14	ADV
cajgh-313	36	32	study	study	NOUN
cajgh-313	36	33	findings	finding	NOUN
cajgh-313	36	34	report	report	VERB
cajgh-313	36	35	a	a	DET
cajgh-313	36	36	greater	great	ADJ
cajgh-313	36	37	likelihood	likelihood	NOUN
cajgh-313	36	38	of	of	ADP
cajgh-313	36	39	the	the	DET
cajgh-313	36	40	progression	progression	NOUN
cajgh-313	36	41	from	from	ADP
cajgh-313	36	42	chronic	chronic	ADJ
cajgh-313	36	43	hepatitis	hepatitis	NOUN
cajgh-313	36	44	to	to	ADP
cajgh-313	36	45	cirrhosis	cirrhosis	VERB
cajgh-313	36	46	and	and	CCONJ
cajgh-313	36	47	hcc	hcc	PROPN
cajgh-313	36	48	in	in	ADP
cajgh-313	36	49	patients	patient	NOUN
cajgh-313	36	50	with	with	ADP
cajgh-313	36	51	hbv	hbv	NOUN
cajgh-313	36	52	/	/	SYM
cajgh-313	36	53	hcv	hcv	X
cajgh-313	36	54	co	co	NOUN
cajgh-313	36	55	-	-	NOUN
cajgh-313	36	56	infection	infection	NOUN
cajgh-313	36	57	compared	compare	VERB
cajgh-313	36	58	to	to	ADP
cajgh-313	36	59	infection	infection	NOUN
cajgh-313	36	60	by	by	ADP
cajgh-313	36	61	hbv	hbv	NOUN
cajgh-313	36	62	or	or	CCONJ
cajgh-313	36	63	hcv	hcv	PROPN
cajgh-313	36	64	alone	alone	ADV
cajgh-313	36	65	;	;	PUNCT
cajgh-313	36	66	this	this	DET
cajgh-313	36	67	combination	combination	NOUN
cajgh-313	36	68	of	of	ADP
cajgh-313	36	69	cirrhosis	cirrhosis	NOUN
cajgh-313	36	70	and	and	CCONJ
cajgh-313	36	71	hcc	hcc	PROPN
cajgh-313	36	72	is	be	AUX
cajgh-313	36	73	particularly	particularly	ADV
cajgh-313	36	74	difficult	difficult	ADJ
cajgh-313	36	75	to	to	PART
cajgh-313	36	76	clinically	clinically	ADV
cajgh-313	36	77	manage15	manage15	NOUN
cajgh-313	36	78	.	.	PUNCT
cajgh-313	37	1	measurement	measurement	NOUN
cajgh-313	37	2	of	of	ADP
cajgh-313	37	3	liver	liver	NOUN
cajgh-313	37	4	enzymes	enzyme	NOUN
cajgh-313	37	5	function	function	NOUN
cajgh-313	37	6	(	(	PUNCT
cajgh-313	37	7	i.e.	i.e.	X
cajgh-313	37	8	alanine	alanine	NOUN
cajgh-313	37	9	transaminase	transaminase	NOUN
cajgh-313	37	10	(	(	PUNCT
cajgh-313	37	11	alt	alt	PROPN
cajgh-313	37	12	)	)	PUNCT
cajgh-313	37	13	,	,	PUNCT
cajgh-313	37	14	aspartate	aspartate	NOUN
cajgh-313	37	15	transaminase	transaminase	NOUN
cajgh-313	37	16	(	(	PUNCT
cajgh-313	37	17	ast	ast	NOUN
cajgh-313	37	18	)	)	PUNCT
cajgh-313	37	19	,	,	PUNCT
cajgh-313	37	20	and	and	CCONJ
cajgh-313	37	21	alkaline	alkaline	ADJ
cajgh-313	37	22	phosphatase	phosphatase	NOUN
cajgh-313	37	23	(	(	PUNCT
cajgh-313	37	24	alp	alp	PROPN
cajgh-313	37	25	)	)	PUNCT
cajgh-313	37	26	)	)	PUNCT
cajgh-313	37	27	is	be	AUX
cajgh-313	37	28	an	an	DET
cajgh-313	37	29	inexpensive	inexpensive	ADJ
cajgh-313	37	30	and	and	CCONJ
cajgh-313	37	31	non	non	ADJ
cajgh-313	37	32	-	-	ADJ
cajgh-313	37	33	invasive	invasive	ADJ
cajgh-313	37	34	method	method	NOUN
cajgh-313	37	35	of	of	ADP
cajgh-313	37	36	assessing	assess	VERB
cajgh-313	37	37	liver	liver	NOUN
cajgh-313	37	38	disease	disease	NOUN
cajgh-313	37	39	.	.	PUNCT
cajgh-313	38	1	measurement	measurement	NOUN
cajgh-313	38	2	of	of	ADP
cajgh-313	38	3	liver	liver	NOUN
cajgh-313	38	4	enzymes	enzyme	NOUN
cajgh-313	38	5	reflect	reflect	VERB
cajgh-313	38	6	the	the	DET
cajgh-313	38	7	activity	activity	NOUN
cajgh-313	38	8	of	of	ADP
cajgh-313	38	9	hepatotropic	hepatotropic	NOUN
cajgh-313	38	10	viruses	virus	NOUN
cajgh-313	38	11	and	and	CCONJ
cajgh-313	38	12	the	the	DET
cajgh-313	38	13	degree	degree	NOUN
cajgh-313	38	14	of	of	ADP
cajgh-313	38	15	damage	damage	NOUN
cajgh-313	38	16	to	to	ADP
cajgh-313	38	17	the	the	DET
cajgh-313	38	18	liver	liver	NOUN
cajgh-313	38	19	during	during	ADP
cajgh-313	38	20	therapy	therapy	NOUN
cajgh-313	38	21	with	with	ADP
cajgh-313	38	22	various	various	ADJ
cajgh-313	38	23	hepatotoxic	hepatotoxic	NOUN
cajgh-313	38	24	drugs16	drugs16	NOUN
cajgh-313	38	25	.	.	PUNCT
cajgh-313	39	1	to	to	ADP
cajgh-313	39	2	our	our	PRON
cajgh-313	39	3	knowledge	knowledge	NOUN
cajgh-313	39	4	,	,	PUNCT
cajgh-313	39	5	very	very	ADV
cajgh-313	39	6	limited	limited	ADJ
cajgh-313	39	7	data	datum	NOUN
cajgh-313	39	8	about	about	ADP
cajgh-313	39	9	the	the	DET
cajgh-313	39	10	sero	sero	NOUN
cajgh-313	39	11	-	-	PUNCT
cajgh-313	39	12	occurrence	occurrence	NOUN
cajgh-313	39	13	of	of	ADP
cajgh-313	39	14	hbv	hbv	NOUN
cajgh-313	39	15	/	/	SYM
cajgh-313	39	16	hcv	hcv	NOUN
cajgh-313	39	17	coinfection	coinfection	NOUN
cajgh-313	39	18	are	be	AUX
cajgh-313	39	19	available	available	ADJ
cajgh-313	39	20	from	from	ADP
cajgh-313	39	21	central	central	PROPN
cajgh-313	39	22	india	india	PROPN
cajgh-313	39	23	.	.	PUNCT
cajgh-313	40	1	the	the	DET
cajgh-313	40	2	objectives	objective	NOUN
cajgh-313	40	3	of	of	ADP
cajgh-313	40	4	this	this	DET
cajgh-313	40	5	study	study	NOUN
cajgh-313	40	6	are	be	AUX
cajgh-313	40	7	to	to	ADP
cajgh-313	40	8	(	(	PUNCT
cajgh-313	40	9	1	1	X
cajgh-313	40	10	)	)	PUNCT
cajgh-313	40	11	identify	identify	VERB
cajgh-313	40	12	the	the	DET
cajgh-313	40	13	prevalence	prevalence	NOUN
cajgh-313	40	14	of	of	ADP
cajgh-313	40	15	sero	sero	NOUN
cajgh-313	40	16	-	-	PUNCT
cajgh-313	40	17	occurrence	occurrence	NOUN
cajgh-313	40	18	of	of	ADP
cajgh-313	40	19	hbv	hbv	NOUN
cajgh-313	40	20	/	/	SYM
cajgh-313	40	21	hcv	hcv	NOUN
cajgh-313	40	22	coinfection	coinfection	NOUN
cajgh-313	40	23	in	in	ADP
cajgh-313	40	24	a	a	DET
cajgh-313	40	25	large	large	ADJ
cajgh-313	40	26	tertiary	tertiary	ADJ
cajgh-313	40	27	care	care	NOUN
cajgh-313	40	28	facility	facility	NOUN
cajgh-313	40	29	,	,	PUNCT
cajgh-313	40	30	and	and	CCONJ
cajgh-313	40	31	(	(	PUNCT
cajgh-313	40	32	2	2	X
cajgh-313	40	33	)	)	PUNCT
cajgh-313	40	34	determine	determine	VERB
cajgh-313	40	35	the	the	DET
cajgh-313	40	36	extent	extent	NOUN
cajgh-313	40	37	of	of	ADP
cajgh-313	40	38	liver	liver	NOUN
cajgh-313	40	39	damage	damage	NOUN
cajgh-313	40	40	in	in	ADP
cajgh-313	40	41	patients	patient	NOUN
cajgh-313	40	42	with	with	ADP
cajgh-313	40	43	hbv	hbv	NOUN
cajgh-313	40	44	/	/	SYM
cajgh-313	40	45	hcv	hcv	X
cajgh-313	40	46	co	co	NOUN
cajgh-313	40	47	-	-	NOUN
cajgh-313	40	48	infection	infection	NOUN
cajgh-313	40	49	.	.	PUNCT
cajgh-313	41	1	methods	method	NOUN
cajgh-313	41	2	study	study	VERB
cajgh-313	41	3	design	design	NOUN
cajgh-313	41	4	and	and	CCONJ
cajgh-313	41	5	data	datum	NOUN
cajgh-313	41	6	collection	collection	NOUN
cajgh-313	41	7	:	:	PUNCT
cajgh-313	41	8	the	the	DET
cajgh-313	41	9	study	study	NOUN
cajgh-313	41	10	was	be	AUX
cajgh-313	41	11	carried	carry	VERB
cajgh-313	41	12	out	out	ADP
cajgh-313	41	13	in	in	ADP
cajgh-313	41	14	the	the	DET
cajgh-313	41	15	department	department	NOUN
cajgh-313	41	16	of	of	ADP
cajgh-313	41	17	microbiology	microbiology	NOUN
cajgh-313	41	18	,	,	PUNCT
cajgh-313	41	19	bhopal	bhopal	NOUN
cajgh-313	41	20	memorial	memorial	ADJ
cajgh-313	41	21	hospital	hospital	PROPN
cajgh-313	41	22	&	&	CCONJ
cajgh-313	41	23	research	research	PROPN
cajgh-313	41	24	centre	centre	PROPN
cajgh-313	41	25	(	(	PUNCT
cajgh-313	41	26	bmhrc	bmhrc	NOUN
cajgh-313	41	27	)	)	PUNCT
cajgh-313	41	28	,	,	PUNCT
cajgh-313	41	29	bhopal	bhopal	NOUN
cajgh-313	41	30	,	,	PUNCT
cajgh-313	41	31	and	and	CCONJ
cajgh-313	41	32	madhya	madhya	PROPN
cajgh-313	41	33	pradesh	pradesh	PROPN
cajgh-313	41	34	,	,	PUNCT
cajgh-313	41	35	india	india	PROPN
cajgh-313	41	36	.	.	PUNCT
cajgh-313	42	1	bmhrc	bmhrc	PROPN
cajgh-313	42	2	is	be	AUX
cajgh-313	42	3	a	a	DET
cajgh-313	42	4	tertiary	tertiary	ADJ
cajgh-313	42	5	care	care	NOUN
cajgh-313	42	6	hospital	hospital	NOUN
cajgh-313	42	7	and	and	CCONJ
cajgh-313	42	8	serves	serve	VERB
cajgh-313	42	9	a	a	DET
cajgh-313	42	10	population	population	NOUN
cajgh-313	42	11	of	of	ADP
cajgh-313	42	12	more	more	ADJ
cajgh-313	42	13	than	than	ADP
cajgh-313	42	14	two	two	NUM
cajgh-313	42	15	million	million	NUM
cajgh-313	42	16	residents	resident	NOUN
cajgh-313	42	17	.	.	PUNCT
cajgh-313	43	1	records	record	NOUN
cajgh-313	43	2	of	of	ADP
cajgh-313	43	3	patients	patient	NOUN
cajgh-313	43	4	and	and	CCONJ
cajgh-313	43	5	test	test	NOUN
cajgh-313	43	6	results	result	NOUN
cajgh-313	43	7	were	be	AUX
cajgh-313	43	8	maintained	maintain	VERB
cajgh-313	43	9	in	in	ADP
cajgh-313	43	10	lab	lab	NOUN
cajgh-313	43	11	registers	register	NOUN
cajgh-313	43	12	as	as	ADV
cajgh-313	43	13	well	well	ADV
cajgh-313	43	14	as	as	ADP
cajgh-313	43	15	a	a	DET
cajgh-313	43	16	hospital	hospital	NOUN
cajgh-313	43	17	information	information	NOUN
cajgh-313	43	18	system	system	NOUN
cajgh-313	43	19	(	(	PUNCT
cajgh-313	43	20	his	his	NOUN
cajgh-313	43	21	)	)	PUNCT
cajgh-313	43	22	of	of	ADP
cajgh-313	43	23	the	the	DET
cajgh-313	43	24	bmhrc	bmhrc	NOUN
cajgh-313	43	25	.	.	PUNCT
cajgh-313	44	1	laboratory	laboratory	NOUN
cajgh-313	44	2	records	record	NOUN
cajgh-313	44	3	from	from	ADP
cajgh-313	44	4	january	january	PROPN
cajgh-313	44	5	2006	2006	NUM
cajgh-313	44	6	to	to	ADP
cajgh-313	44	7	december	december	PROPN
cajgh-313	44	8	2016	2016	NUM
cajgh-313	44	9	were	be	AUX
cajgh-313	44	10	reviewed	review	VERB
cajgh-313	44	11	retrospectively	retrospectively	ADV
cajgh-313	44	12	for	for	ADP
cajgh-313	44	13	demographic	demographic	ADJ
cajgh-313	44	14	and	and	CCONJ
cajgh-313	44	15	hbsag	hbsag	ADJ
cajgh-313	44	16	data	datum	NOUN
cajgh-313	44	17	.	.	PUNCT
cajgh-313	45	1	lab	lab	NOUN
cajgh-313	45	2	records	record	NOUN
cajgh-313	45	3	were	be	AUX
cajgh-313	45	4	also	also	ADV
cajgh-313	45	5	reviewed	review	VERB
cajgh-313	45	6	for	for	ADP
cajgh-313	45	7	anti	anti	ADJ
cajgh-313	45	8	-	-	ADJ
cajgh-313	45	9	hcv	hcv	ADJ
cajgh-313	45	10	sero	sero	NOUN
cajgh-313	45	11	-	-	PUNCT
cajgh-313	45	12	positivity	positivity	NOUN
cajgh-313	45	13	among	among	ADP
cajgh-313	45	14	hbsag	hbsag	ADJ
cajgh-313	45	15	positive	positive	ADJ
cajgh-313	45	16	samples	sample	NOUN
cajgh-313	45	17	.	.	PUNCT
cajgh-313	46	1	this	this	DET
cajgh-313	46	2	study	study	NOUN
cajgh-313	46	3	was	be	AUX
cajgh-313	46	4	limited	limit	VERB
cajgh-313	46	5	to	to	ADP
cajgh-313	46	6	samples	sample	NOUN
cajgh-313	46	7	from	from	ADP
cajgh-313	46	8	patients	patient	NOUN
cajgh-313	46	9	who	who	PRON
cajgh-313	46	10	visited	visit	VERB
cajgh-313	46	11	either	either	DET
cajgh-313	46	12	outpatient	outpatient	NOUN
cajgh-313	46	13	(	(	PUNCT
cajgh-313	46	14	opd	opd	PROPN
cajgh-313	46	15	)	)	PUNCT
cajgh-313	46	16	or	or	CCONJ
cajgh-313	46	17	inpatient	inpatient	NOUN
cajgh-313	46	18	departments	department	NOUN
cajgh-313	46	19	(	(	PUNCT
cajgh-313	46	20	ipd	ipd	PROPN
cajgh-313	46	21	)	)	PUNCT
cajgh-313	46	22	of	of	ADP
cajgh-313	46	23	bmhrc	bmhrc	NOUN
cajgh-313	46	24	,	,	PUNCT
cajgh-313	46	25	and	and	CCONJ
cajgh-313	46	26	who	who	PRON
cajgh-313	46	27	were	be	AUX
cajgh-313	46	28	diagnosed	diagnose	VERB
cajgh-313	46	29	as	as	ADP
cajgh-313	46	30	hbsag	hbsag	NOUN
cajgh-313	46	31	and	and	CCONJ
cajgh-313	46	32	anti	anti	ADJ
cajgh-313	46	33	-	-	ADJ
cajgh-313	46	34	hcv	hcv	ADJ
cajgh-313	46	35	positive	positive	ADJ
cajgh-313	46	36	.	.	PUNCT
cajgh-313	47	1	samples	sample	NOUN
cajgh-313	47	2	with	with	ADP
cajgh-313	47	3	incomplete	incomplete	ADJ
cajgh-313	47	4	liver	liver	NOUN
cajgh-313	47	5	function	function	NOUN
cajgh-313	47	6	panel	panel	NOUN
cajgh-313	47	7	or	or	CCONJ
cajgh-313	47	8	demographic	demographic	ADJ
cajgh-313	47	9	data	datum	NOUN
cajgh-313	47	10	were	be	AUX
cajgh-313	47	11	excluded	exclude	VERB
cajgh-313	47	12	.	.	PUNCT
cajgh-313	48	1	all	all	DET
cajgh-313	48	2	the	the	DET
cajgh-313	48	3	investigations	investigation	NOUN
cajgh-313	48	4	for	for	ADP
cajgh-313	48	5	hbsag	hbsag	NOUN
cajgh-313	48	6	and	and	CCONJ
cajgh-313	48	7	anti	anti	ADJ
cajgh-313	48	8	-	-	ADJ
cajgh-313	48	9	hcv	hcv	ADJ
cajgh-313	48	10	were	be	AUX
cajgh-313	48	11	completed	complete	VERB
cajgh-313	48	12	by	by	ADP
cajgh-313	48	13	enzyme	enzyme	NOUN
cajgh-313	48	14	linked	link	VERB
cajgh-313	48	15	immunosorbent	immunosorbent	ADJ
cajgh-313	48	16	assay	assay	PROPN
cajgh-313	48	17	(	(	PUNCT
cajgh-313	48	18	elisa	elisa	NOUN
cajgh-313	48	19	)	)	PUNCT
cajgh-313	48	20	as	as	ADP
cajgh-313	48	21	part	part	NOUN
cajgh-313	48	22	of	of	ADP
cajgh-313	48	23	routine	routine	ADJ
cajgh-313	48	24	laboratory	laboratory	NOUN
cajgh-313	48	25	work	work	NOUN
cajgh-313	48	26	flow	flow	NOUN
cajgh-313	48	27	,	,	PUNCT
cajgh-313	48	28	in	in	ADP
cajgh-313	48	29	accordance	accordance	NOUN
cajgh-313	48	30	with	with	ADP
cajgh-313	48	31	the	the	DET
cajgh-313	48	32	manufacturer	manufacturer	NOUN
cajgh-313	48	33	’s	’s	PART
cajgh-313	48	34	instructions	instruction	NOUN
cajgh-313	48	35	.	.	PUNCT
cajgh-313	49	1	liver	liver	NOUN
cajgh-313	49	2	enzyme	enzyme	NOUN
cajgh-313	49	3	tests	test	NOUN
cajgh-313	49	4	were	be	AUX
cajgh-313	49	5	done	do	VERB
cajgh-313	49	6	by	by	ADP
cajgh-313	49	7	biochemical	biochemical	ADJ
cajgh-313	49	8	assays	assay	NOUN
cajgh-313	49	9	,	,	PUNCT
cajgh-313	49	10	and	and	CCONJ
cajgh-313	49	11	included	include	VERB
cajgh-313	49	12	alanine	alanine	NOUN
cajgh-313	49	13	transaminase	transaminase	NOUN
cajgh-313	49	14	(	(	PUNCT
cajgh-313	49	15	alt	alt	PROPN
cajgh-313	49	16	)	)	PUNCT
cajgh-313	49	17	,	,	PUNCT
cajgh-313	49	18	aspartate	aspartate	NOUN
cajgh-313	49	19	transaminase	transaminase	NOUN
cajgh-313	49	20	(	(	PUNCT
cajgh-313	49	21	ast	ast	NOUN
cajgh-313	49	22	)	)	PUNCT
cajgh-313	49	23	,	,	PUNCT
cajgh-313	49	24	alkaline	alkaline	NOUN
cajgh-313	49	25	phosphatase	phosphatase	NOUN
cajgh-313	49	26	(	(	PUNCT
cajgh-313	49	27	alp	alp	PROPN
cajgh-313	49	28	)	)	PUNCT
cajgh-313	49	29	,	,	PUNCT
cajgh-313	49	30	bilirubin	bilirubin	NOUN
cajgh-313	49	31	total	total	NOUN
cajgh-313	49	32	(	(	PUNCT
cajgh-313	49	33	bt	bt	NOUN
cajgh-313	49	34	)	)	PUNCT
cajgh-313	49	35	,	,	PUNCT
cajgh-313	49	36	bilirubin	bilirubin	NOUN
cajgh-313	49	37	indirect	indirect	ADJ
cajgh-313	49	38	(	(	PUNCT
cajgh-313	49	39	bi	bi	NOUN
cajgh-313	49	40	)	)	PUNCT
cajgh-313	49	41	,	,	PUNCT
cajgh-313	49	42	and	and	CCONJ
cajgh-313	49	43	bilirubin	bilirubin	NOUN
cajgh-313	49	44	direct	direct	ADJ
cajgh-313	49	45	(	(	PUNCT
cajgh-313	49	46	bd	bd	PROPN
cajgh-313	49	47	)	)	PUNCT
cajgh-313	49	48	.	.	PUNCT
cajgh-313	50	1	the	the	DET
cajgh-313	50	2	http://www.library.pitt.edu/	http://www.library.pitt.edu/	PROPN
cajgh-313	50	3	http://www.pitt.edu/	http://www.pitt.edu/	NOUN
cajgh-313	50	4	http://www.library.pitt.edu/articles/digpubtype/index.html	http://www.library.pitt.edu/articles/digpubtype/index.html	X
cajgh-313	50	5	http://www.upress.pitt.edu/upressindex.aspx	http://www.upress.pitt.edu/upressindex.aspx	PRON
cajgh-313	50	6	desikan	desikan	NOUN
cajgh-313	50	7	this	this	DET
cajgh-313	50	8	work	work	NOUN
cajgh-313	50	9	is	be	AUX
cajgh-313	50	10	licensed	license	VERB
cajgh-313	50	11	under	under	ADP
cajgh-313	50	12	a	a	DET
cajgh-313	50	13	creative	creative	ADJ
cajgh-313	50	14	commons	common	NOUN
cajgh-313	50	15	attribution	attribution	NOUN
cajgh-313	50	16	4.0	4.0	NUM
cajgh-313	50	17	united	unite	VERB
cajgh-313	50	18	states	states	PROPN
cajgh-313	50	19	license	license	NOUN
cajgh-313	50	20	.	.	PUNCT
cajgh-313	51	1	this	this	DET
cajgh-313	51	2	journal	journal	NOUN
cajgh-313	51	3	is	be	AUX
cajgh-313	51	4	published	publish	VERB
cajgh-313	51	5	by	by	ADP
cajgh-313	51	6	theuniversity	theuniversity	NOUN
cajgh-313	51	7	library	library	NOUN
cajgh-313	51	8	system	system	NOUN
cajgh-313	51	9	of	of	ADP
cajgh-313	51	10	the	the	DET
cajgh-313	51	11	university	university	PROPN
cajgh-313	51	12	of	of	ADP
cajgh-313	51	13	pittsburgh	pittsburgh	PROPN
cajgh-313	51	14	as	as	ADP
cajgh-313	51	15	part	part	NOUN
cajgh-313	51	16	of	of	ADP
cajgh-313	51	17	its	its	PRON
cajgh-313	51	18	d	d	NOUN
cajgh-313	51	19	-	-	PUNCT
cajgh-313	51	20	scribe	scribe	VERB
cajgh-313	51	21	digital	digital	ADJ
cajgh-313	51	22	publishing	publishing	NOUN
cajgh-313	51	23	program	program	NOUN
cajgh-313	51	24	and	and	CCONJ
cajgh-313	51	25	is	be	AUX
cajgh-313	51	26	cosponsored	cosponsor	VERB
cajgh-313	51	27	by	by	ADP
cajgh-313	51	28	the	the	DET
cajgh-313	51	29	university	university	PROPN
cajgh-313	51	30	of	of	ADP
cajgh-313	51	31	pittsburgh	pittsburgh	PROPN
cajgh-313	51	32	press	press	NOUN
cajgh-313	51	33	.	.	PUNCT
cajgh-313	52	1	central	central	ADJ
cajgh-313	52	2	asian	asian	ADJ
cajgh-313	52	3	journal	journal	NOUN
cajgh-313	52	4	of	of	ADP
cajgh-313	52	5	global	global	ADJ
cajgh-313	52	6	health	health	NOUN
cajgh-313	52	7	volume	volume	NOUN
cajgh-313	52	8	8	8	NUM
cajgh-313	52	9	,	,	PUNCT
cajgh-313	52	10	no	no	INTJ
cajgh-313	52	11	.	.	NOUN
cajgh-313	52	12	1	1	NUM
cajgh-313	52	13	(	(	PUNCT
cajgh-313	52	14	2019	2019	NUM
cajgh-313	52	15	)	)	PUNCT
cajgh-313	52	16	|	|	ADV
cajgh-313	52	17	issn	issn	VERB
cajgh-313	52	18	2166	2166	NUM
cajgh-313	52	19	-	-	SYM
cajgh-313	52	20	7403	7403	NUM
cajgh-313	52	21	(	(	PUNCT
cajgh-313	52	22	online	online	ADJ
cajgh-313	52	23	)	)	PUNCT
cajgh-313	52	24	|	|	ADV
cajgh-313	52	25	doi	doi	X
cajgh-313	52	26	10.5195	10.5195	NUM
cajgh-313	52	27	/	/	SYM
cajgh-313	52	28	cajgh.2019.313|http://cajgh.pitt.edu	cajgh.2019.313|http://cajgh.pitt.edu	NOUN
cajgh-313	52	29	study	study	NOUN
cajgh-313	52	30	was	be	AUX
cajgh-313	52	31	approved	approve	VERB
cajgh-313	52	32	by	by	ADP
cajgh-313	52	33	the	the	DET
cajgh-313	52	34	institutional	institutional	ADJ
cajgh-313	52	35	ethical	ethical	PROPN
cajgh-313	52	36	committee	committee	NOUN
cajgh-313	52	37	of	of	ADP
cajgh-313	52	38	bmhrc	bmhrc	PROPN
cajgh-313	52	39	.	.	PUNCT
cajgh-313	53	1	statistical	statistical	ADJ
cajgh-313	53	2	analysis	analysis	NOUN
cajgh-313	53	3	data	datum	NOUN
cajgh-313	53	4	were	be	AUX
cajgh-313	53	5	analyzed	analyze	VERB
cajgh-313	53	6	using	use	VERB
cajgh-313	53	7	openepi	openepi	PROPN
cajgh-313	53	8	online	online	ADJ
cajgh-313	53	9	software17	software17	NOUN
cajgh-313	53	10	.	.	PUNCT
cajgh-313	54	1	differences	difference	NOUN
cajgh-313	54	2	in	in	ADP
cajgh-313	54	3	variable	variable	ADJ
cajgh-313	54	4	distribution	distribution	NOUN
cajgh-313	54	5	were	be	AUX
cajgh-313	54	6	evaluated	evaluate	VERB
cajgh-313	54	7	by	by	ADP
cajgh-313	54	8	pearson	pearson	PROPN
cajgh-313	54	9	’s	’s	PART
cajgh-313	54	10	chi	chi	ADJ
cajgh-313	54	11	-	-	PUNCT
cajgh-313	54	12	squared	square	VERB
cajgh-313	54	13	test	test	NOUN
cajgh-313	54	14	,	,	PUNCT
cajgh-313	54	15	and	and	CCONJ
cajgh-313	54	16	a	a	DET
cajgh-313	54	17	p	p	NOUN
cajgh-313	54	18	-	-	PUNCT
cajgh-313	54	19	value	value	NOUN
cajgh-313	54	20	of	of	ADP
cajgh-313	54	21	less	less	ADJ
cajgh-313	54	22	than	than	ADP
cajgh-313	54	23	0.05	0.05	NUM
cajgh-313	54	24	was	be	AUX
cajgh-313	54	25	considered	consider	VERB
cajgh-313	54	26	statistically	statistically	ADV
cajgh-313	54	27	significant	significant	ADJ
cajgh-313	54	28	.	.	PUNCT
cajgh-313	55	1	means	mean	NOUN
cajgh-313	55	2	and	and	CCONJ
cajgh-313	55	3	standard	standard	ADJ
cajgh-313	55	4	deviations	deviation	NOUN
cajgh-313	55	5	were	be	AUX
cajgh-313	55	6	reported	report	VERB
cajgh-313	55	7	for	for	ADP
cajgh-313	55	8	continuous	continuous	ADJ
cajgh-313	55	9	variables	variable	NOUN
cajgh-313	55	10	,	,	PUNCT
cajgh-313	55	11	and	and	CCONJ
cajgh-313	55	12	differences	difference	NOUN
cajgh-313	55	13	in	in	ADP
cajgh-313	55	14	means	mean	NOUN
cajgh-313	55	15	were	be	AUX
cajgh-313	55	16	compared	compare	VERB
cajgh-313	55	17	with	with	ADP
cajgh-313	55	18	an	an	DET
cajgh-313	55	19	independent	independent	ADJ
cajgh-313	55	20	samples	sample	NOUN
cajgh-313	55	21	t	t	NOUN
cajgh-313	55	22	-	-	PUNCT
cajgh-313	55	23	test	test	NOUN
cajgh-313	55	24	.	.	PUNCT
cajgh-313	56	1	we	we	PRON
cajgh-313	56	2	defined	define	VERB
cajgh-313	56	3	abnormal	abnormal	ADJ
cajgh-313	56	4	liver	liver	NOUN
cajgh-313	56	5	enzyme	enzyme	NOUN
cajgh-313	56	6	cut	cut	NOUN
cajgh-313	56	7	-	-	PUNCT
cajgh-313	56	8	offs	off	NOUN
cajgh-313	56	9	according	accord	VERB
cajgh-313	56	10	to	to	ADP
cajgh-313	56	11	the	the	DET
cajgh-313	56	12	national	national	ADJ
cajgh-313	56	13	health	health	PROPN
cajgh-313	56	14	and	and	CCONJ
cajgh-313	56	15	nutrition	nutrition	NOUN
cajgh-313	56	16	examination	examination	NOUN
cajgh-313	56	17	survey	survey	NOUN
cajgh-313	56	18	(	(	PUNCT
cajgh-313	56	19	nhanes	nhane	NOUN
cajgh-313	56	20	)	)	PUNCT
cajgh-313	56	21	criteria	criteria	PROPN
cajgh-313	56	22	iii18	iii18	PROPN
cajgh-313	56	23	.	.	PUNCT
cajgh-313	57	1	abnormal	abnormal	ADJ
cajgh-313	57	2	values	value	NOUN
cajgh-313	57	3	of	of	ADP
cajgh-313	57	4	liver	liver	NOUN
cajgh-313	57	5	enzymes	enzyme	NOUN
cajgh-313	57	6	and	and	CCONJ
cajgh-313	57	7	bilirubin	bilirubin	NOUN
cajgh-313	57	8	levels	level	NOUN
cajgh-313	57	9	were	be	AUX
cajgh-313	57	10	defined	define	VERB
cajgh-313	57	11	as	as	ADP
cajgh-313	57	12	alt	alt	ADJ
cajgh-313	57	13	/	/	SYM
cajgh-313	57	14	ast≥50	ast≥50	NOUN
cajgh-313	57	15	iu	iu	ADP
cajgh-313	57	16	/	/	SYM
cajgh-313	57	17	ml	ml	PROPN
cajgh-313	57	18	,	,	PUNCT
cajgh-313	57	19	alp≥129	alp≥129	PROPN
cajgh-313	57	20	iu	iu	PROPN
cajgh-313	57	21	/	/	SYM
cajgh-313	57	22	ml.bt	ml.bt	ADJ
cajgh-313	57	23	/	/	SYM
cajgh-313	57	24	bi	bi	ADJ
cajgh-313	57	25	≥1.1	≥1.1	PROPN
cajgh-313	57	26	mg	mg	PROPN
cajgh-313	57	27	/	/	SYM
cajgh-313	57	28	dl	dl	PROPN
cajgh-313	57	29	,	,	PUNCT
cajgh-313	57	30	and	and	CCONJ
cajgh-313	57	31	bd≥	bd≥	NOUN
cajgh-313	57	32	0.3	0.3	NUM
cajgh-313	57	33	mg	mg	PROPN
cajgh-313	57	34	/	/	SYM
cajgh-313	57	35	dl	dl	PROPN
cajgh-313	57	36	.	.	PROPN
cajgh-313	57	37	results	result	VERB
cajgh-313	57	38	a	a	DET
cajgh-313	57	39	total	total	NOUN
cajgh-313	57	40	of	of	ADP
cajgh-313	57	41	51,075	51,075	NUM
cajgh-313	57	42	consecutive	consecutive	ADJ
cajgh-313	57	43	non	non	ADJ
cajgh-313	57	44	-	-	ADJ
cajgh-313	57	45	duplicate	duplicate	ADJ
cajgh-313	57	46	blood	blood	NOUN
cajgh-313	57	47	samples	sample	NOUN
cajgh-313	57	48	were	be	AUX
cajgh-313	57	49	collected	collect	VERB
cajgh-313	57	50	over	over	ADP
cajgh-313	57	51	a	a	DET
cajgh-313	57	52	period	period	NOUN
cajgh-313	57	53	of	of	ADP
cajgh-313	57	54	ten	ten	NUM
cajgh-313	57	55	years	year	NOUN
cajgh-313	57	56	for	for	ADP
cajgh-313	57	57	hbsag	hbsag	NOUN
cajgh-313	57	58	testing	testing	NOUN
cajgh-313	57	59	.	.	PUNCT
cajgh-313	58	1	out	out	ADP
cajgh-313	58	2	of	of	ADP
cajgh-313	58	3	these	these	DET
cajgh-313	58	4	samples	sample	NOUN
cajgh-313	58	5	,	,	PUNCT
cajgh-313	58	6	1674	1674	NUM
cajgh-313	58	7	(	(	PUNCT
cajgh-313	58	8	3.27	3.27	NUM
cajgh-313	58	9	%	%	NOUN
cajgh-313	58	10	)	)	PUNCT
cajgh-313	58	11	were	be	AUX
cajgh-313	58	12	positive	positive	ADJ
cajgh-313	58	13	for	for	ADP
cajgh-313	58	14	hbsag	hbsag	NOUN
cajgh-313	58	15	,	,	PUNCT
cajgh-313	58	16	and	and	CCONJ
cajgh-313	58	17	295	295	NUM
cajgh-313	58	18	(	(	PUNCT
cajgh-313	58	19	0.57	0.57	NUM
cajgh-313	58	20	%	%	NOUN
cajgh-313	58	21	)	)	PUNCT
cajgh-313	58	22	were	be	AUX
cajgh-313	58	23	found	find	VERB
cajgh-313	58	24	to	to	PART
cajgh-313	58	25	be	be	AUX
cajgh-313	58	26	positive	positive	ADJ
cajgh-313	58	27	for	for	ADP
cajgh-313	58	28	anti	anti	ADJ
cajgh-313	58	29	-	-	ADJ
cajgh-313	58	30	hcv	hcv	ADJ
cajgh-313	58	31	.	.	PUNCT
cajgh-313	59	1	among	among	ADP
cajgh-313	59	2	individuals	individual	NOUN
cajgh-313	59	3	positive	positive	ADJ
cajgh-313	59	4	for	for	ADP
cajgh-313	59	5	hbsag	hbsag	NOUN
cajgh-313	59	6	or	or	CCONJ
cajgh-313	59	7	anti	anti	ADJ
cajgh-313	59	8	-	-	ADJ
cajgh-313	59	9	hcv	hcv	ADJ
cajgh-313	59	10	,	,	PUNCT
cajgh-313	59	11	28	28	NUM
cajgh-313	59	12	(	(	PUNCT
cajgh-313	59	13	1.67	1.67	NUM
cajgh-313	59	14	%	%	NOUN
cajgh-313	59	15	)	)	PUNCT
cajgh-313	59	16	samples	sample	NOUN
cajgh-313	59	17	were	be	AUX
cajgh-313	59	18	identified	identify	VERB
cajgh-313	59	19	as	as	ADP
cajgh-313	59	20	positive	positive	ADJ
cajgh-313	59	21	for	for	ADP
cajgh-313	59	22	both	both	PRON
cajgh-313	59	23	,	,	PUNCT
cajgh-313	59	24	hbsag	hbsag	ADJ
cajgh-313	59	25	and	and	CCONJ
cajgh-313	59	26	anti	anti	ADJ
cajgh-313	59	27	-	-	ADJ
cajgh-313	59	28	hcv	hcv	ADJ
cajgh-313	59	29	.	.	PUNCT
cajgh-313	60	1	serooccurrence	serooccurrence	NOUN
cajgh-313	60	2	rates	rate	NOUN
cajgh-313	60	3	are	be	AUX
cajgh-313	60	4	summarized	summarize	VERB
cajgh-313	60	5	in	in	ADP
cajgh-313	60	6	table	table	NOUN
cajgh-313	60	7	1	1	NUM
cajgh-313	60	8	.	.	PUNCT
cajgh-313	60	9	ages	age	NOUN
cajgh-313	60	10	of	of	ADP
cajgh-313	60	11	patients	patient	NOUN
cajgh-313	60	12	positive	positive	ADJ
cajgh-313	60	13	for	for	ADP
cajgh-313	60	14	hbv	hbv	NOUN
cajgh-313	60	15	ranged	range	VERB
cajgh-313	60	16	from	from	ADP
cajgh-313	60	17	12	12	NUM
cajgh-313	60	18	-	-	SYM
cajgh-313	60	19	75	75	NUM
cajgh-313	60	20	years	year	NOUN
cajgh-313	60	21	of	of	ADP
cajgh-313	60	22	age	age	NOUN
cajgh-313	60	23	(	(	PUNCT
cajgh-313	60	24	median=54	median=54	NOUN
cajgh-313	60	25	years	year	NOUN
cajgh-313	60	26	,	,	PUNCT
cajgh-313	60	27	iqr	iqr	NOUN
cajgh-313	60	28	:	:	PUNCT
cajgh-313	60	29	15	15	NUM
cajgh-313	60	30	)	)	PUNCT
cajgh-313	60	31	,	,	PUNCT
cajgh-313	60	32	and	and	CCONJ
cajgh-313	60	33	29	29	NUM
cajgh-313	60	34	-	-	SYM
cajgh-313	60	35	74	74	NUM
cajgh-313	60	36	years	year	NOUN
cajgh-313	60	37	of	of	ADP
cajgh-313	60	38	age	age	NOUN
cajgh-313	60	39	(	(	PUNCT
cajgh-313	60	40	median=45	median=45	NOUN
cajgh-313	60	41	years	year	NOUN
cajgh-313	60	42	,	,	PUNCT
cajgh-313	60	43	iqr	iqr	NOUN
cajgh-313	60	44	:	:	PUNCT
cajgh-313	60	45	26	26	NUM
cajgh-313	60	46	)	)	PUNCT
cajgh-313	60	47	for	for	ADP
cajgh-313	60	48	hbv	hbv	NOUN
cajgh-313	60	49	/	/	SYM
cajgh-313	60	50	hcv	hcv	X
cajgh-313	60	51	co	co	ADJ
cajgh-313	60	52	-	-	ADJ
cajgh-313	60	53	infected	infected	ADJ
cajgh-313	60	54	individuals	individual	NOUN
cajgh-313	60	55	.	.	PUNCT
cajgh-313	61	1	hbv	hbv	NOUN
cajgh-313	61	2	/	/	SYM
cajgh-313	61	3	hcv	hcv	X
cajgh-313	61	4	co	co	NOUN
cajgh-313	61	5	-	-	NOUN
cajgh-313	61	6	infection	infection	NOUN
cajgh-313	61	7	was	be	AUX
cajgh-313	61	8	more	more	ADV
cajgh-313	61	9	frequent	frequent	ADJ
cajgh-313	61	10	in	in	ADP
cajgh-313	61	11	males	male	NOUN
cajgh-313	61	12	at	at	ADP
cajgh-313	61	13	78.5	78.5	NUM
cajgh-313	61	14	%	%	NOUN
cajgh-313	61	15	(	(	PUNCT
cajgh-313	61	16	n=22	n=22	NOUN
cajgh-313	61	17	)	)	PUNCT
cajgh-313	61	18	than	than	ADP
cajgh-313	61	19	in	in	ADP
cajgh-313	61	20	females	female	NOUN
cajgh-313	61	21	at	at	ADP
cajgh-313	61	22	21.4	21.4	NUM
cajgh-313	61	23	%	%	NOUN
cajgh-313	61	24	(	(	PUNCT
cajgh-313	61	25	n=6	n=6	NOUN
cajgh-313	61	26	)	)	PUNCT
cajgh-313	61	27	,	,	PUNCT
cajgh-313	61	28	but	but	CCONJ
cajgh-313	61	29	the	the	DET
cajgh-313	61	30	difference	difference	NOUN
cajgh-313	61	31	was	be	AUX
cajgh-313	61	32	not	not	PART
cajgh-313	61	33	statistically	statistically	ADV
cajgh-313	61	34	significant	significant	ADJ
cajgh-313	61	35	(	(	PUNCT
cajgh-313	61	36	p=0.80	p=0.80	NOUN
cajgh-313	61	37	)	)	PUNCT
cajgh-313	61	38	.	.	PUNCT
cajgh-313	62	1	a	a	DET
cajgh-313	62	2	significantly	significantly	ADV
cajgh-313	62	3	higher	high	ADJ
cajgh-313	62	4	prevalence	prevalence	NOUN
cajgh-313	62	5	of	of	ADP
cajgh-313	62	6	hbv	hbv	NOUN
cajgh-313	62	7	/	/	SYM
cajgh-313	62	8	hcv	hcv	X
cajgh-313	62	9	co	co	NOUN
cajgh-313	62	10	-	-	NOUN
cajgh-313	62	11	infection	infection	NOUN
cajgh-313	62	12	was	be	AUX
cajgh-313	62	13	observed	observe	VERB
cajgh-313	62	14	in	in	ADP
cajgh-313	62	15	the	the	DET
cajgh-313	62	16	31	31	NUM
cajgh-313	62	17	-	-	SYM
cajgh-313	62	18	60	60	NUM
cajgh-313	62	19	years	year	NOUN
cajgh-313	62	20	(	(	PUNCT
cajgh-313	62	21	46.4	46.4	NUM
cajgh-313	62	22	%	%	NOUN
cajgh-313	62	23	)	)	PUNCT
cajgh-313	62	24	age	age	NOUN
cajgh-313	62	25	group	group	NOUN
cajgh-313	62	26	compared	compare	VERB
cajgh-313	62	27	to	to	ADP
cajgh-313	62	28	the	the	DET
cajgh-313	62	29	1	1	NUM
cajgh-313	62	30	-	-	SYM
cajgh-313	62	31	30	30	NUM
cajgh-313	62	32	years	year	NOUN
cajgh-313	62	33	(	(	PUNCT
cajgh-313	62	34	25.0	25.0	NUM
cajgh-313	62	35	%	%	NOUN
cajgh-313	62	36	)	)	PUNCT
cajgh-313	62	37	and	and	CCONJ
cajgh-313	62	38	>	>	SYM
cajgh-313	62	39	60	60	NUM
cajgh-313	62	40	years	year	NOUN
cajgh-313	62	41	(	(	PUNCT
cajgh-313	62	42	28.6	28.6	NUM
cajgh-313	62	43	%	%	NOUN
cajgh-313	62	44	)	)	PUNCT
cajgh-313	62	45	age	age	NOUN
cajgh-313	62	46	groups	group	NOUN
cajgh-313	62	47	(	(	PUNCT
cajgh-313	62	48	p=0.001	p=0.001	NUM
cajgh-313	62	49	)	)	PUNCT
cajgh-313	62	50	(	(	PUNCT
cajgh-313	62	51	table	table	NOUN
cajgh-313	62	52	1	1	NUM
cajgh-313	62	53	)	)	PUNCT
cajgh-313	62	54	.	.	PUNCT
cajgh-313	63	1	the	the	DET
cajgh-313	63	2	proportion	proportion	NOUN
cajgh-313	63	3	of	of	ADP
cajgh-313	63	4	sero	sero	NOUN
cajgh-313	63	5	-	-	PUNCT
cajgh-313	63	6	occurrence	occurrence	NOUN
cajgh-313	63	7	of	of	ADP
cajgh-313	63	8	hbv	hbv	NOUN
cajgh-313	63	9	/	/	SYM
cajgh-313	63	10	hcv	hcv	NOUN
cajgh-313	63	11	coinfection	coinfection	NOUN
cajgh-313	63	12	fluctuates	fluctuate	NOUN
cajgh-313	63	13	between	between	ADP
cajgh-313	63	14	2006	2006	NUM
cajgh-313	63	15	and	and	CCONJ
cajgh-313	63	16	2016	2016	NUM
cajgh-313	63	17	with	with	ADP
cajgh-313	63	18	the	the	DET
cajgh-313	63	19	highest	high	ADJ
cajgh-313	63	20	prevalence	prevalence	NOUN
cajgh-313	63	21	in	in	ADP
cajgh-313	63	22	2013	2013	NUM
cajgh-313	63	23	(	(	PUNCT
cajgh-313	63	24	figure	figure	NOUN
cajgh-313	63	25	1	1	NUM
cajgh-313	63	26	)	)	PUNCT
cajgh-313	63	27	.	.	PUNCT
cajgh-313	64	1	out	out	ADP
cajgh-313	64	2	of	of	ADP
cajgh-313	64	3	1674	1674	NUM
cajgh-313	64	4	hbsag	hbsag	ADJ
cajgh-313	64	5	positive	positive	ADJ
cajgh-313	64	6	samples	sample	NOUN
cajgh-313	64	7	,	,	PUNCT
cajgh-313	64	8	lft	lft	PROPN
cajgh-313	64	9	results	result	NOUN
cajgh-313	64	10	were	be	AUX
cajgh-313	64	11	available	available	ADJ
cajgh-313	64	12	for	for	ADP
cajgh-313	64	13	773	773	NUM
cajgh-313	64	14	samples	sample	NOUN
cajgh-313	64	15	.	.	PUNCT
cajgh-313	65	1	the	the	DET
cajgh-313	65	2	mean	mean	ADJ
cajgh-313	65	3	values	value	NOUN
cajgh-313	65	4	of	of	ADP
cajgh-313	65	5	serum	serum	NOUN
cajgh-313	65	6	levels	level	NOUN
cajgh-313	65	7	of	of	ADP
cajgh-313	65	8	alanine	alanine	NOUN
cajgh-313	65	9	transaminase	transaminase	NOUN
cajgh-313	65	10	(	(	PUNCT
cajgh-313	65	11	alt	alt	PROPN
cajgh-313	65	12	)	)	PUNCT
cajgh-313	65	13	,	,	PUNCT
cajgh-313	65	14	aspartate	aspartate	NOUN
cajgh-313	65	15	figure	figure	NOUN
cajgh-313	65	16	1	1	NUM
cajgh-313	65	17	.	.	PUNCT
cajgh-313	65	18	trends	trend	NOUN
cajgh-313	65	19	of	of	ADP
cajgh-313	65	20	sero	sero	NOUN
cajgh-313	65	21	-	-	PUNCT
cajgh-313	65	22	positivity	positivity	NOUN
cajgh-313	65	23	of	of	ADP
cajgh-313	65	24	hbsag	hbsag	NOUN
cajgh-313	65	25	,	,	PUNCT
cajgh-313	65	26	anti	anti	ADJ
cajgh-313	65	27	-	-	ADJ
cajgh-313	65	28	hcv	hcv	ADJ
cajgh-313	65	29	,	,	PUNCT
cajgh-313	65	30	and	and	CCONJ
cajgh-313	65	31	hbv	hbv	NOUN
cajgh-313	65	32	/	/	SYM
cajgh-313	65	33	hcv	hcv	X
cajgh-313	65	34	co	co	NOUN
cajgh-313	65	35	-	-	NOUN
cajgh-313	65	36	infection	infection	NOUN
cajgh-313	65	37	at	at	ADP
cajgh-313	65	38	bhopal	bhopal	PROPN
cajgh-313	65	39	memorial	memorial	ADJ
cajgh-313	65	40	hospital	hospital	NOUN
cajgh-313	65	41	and	and	CCONJ
cajgh-313	65	42	research	research	NOUN
cajgh-313	65	43	center	center	NOUN
cajgh-313	65	44	in	in	ADP
cajgh-313	65	45	central	central	ADJ
cajgh-313	65	46	india	india	PROPN
cajgh-313	65	47	2006	2006	NUM
cajgh-313	65	48	–	–	PUNCT
cajgh-313	65	49	2016	2016	NUM
cajgh-313	65	50	.	.	PUNCT
cajgh-313	66	1	http://www.library.pitt.edu/	http://www.library.pitt.edu/	PROPN
cajgh-313	66	2	http://www.pitt.edu/	http://www.pitt.edu/	NOUN
cajgh-313	66	3	http://www.library.pitt.edu/articles/digpubtype/index.html	http://www.library.pitt.edu/articles/digpubtype/index.html	PUNCT
cajgh-313	66	4	http://www.upress.pitt.edu/upressindex.aspx	http://www.upress.pitt.edu/upressindex.aspx	PRON
cajgh-313	66	5	desikan	desikan	NOUN
cajgh-313	66	6	this	this	DET
cajgh-313	66	7	work	work	NOUN
cajgh-313	66	8	is	be	AUX
cajgh-313	66	9	licensed	license	VERB
cajgh-313	66	10	under	under	ADP
cajgh-313	66	11	a	a	DET
cajgh-313	66	12	creative	creative	ADJ
cajgh-313	66	13	commons	common	NOUN
cajgh-313	66	14	attribution	attribution	NOUN
cajgh-313	66	15	4.0	4.0	NUM
cajgh-313	66	16	united	unite	VERB
cajgh-313	66	17	states	states	PROPN
cajgh-313	66	18	license	license	NOUN
cajgh-313	66	19	.	.	PUNCT
cajgh-313	67	1	this	this	DET
cajgh-313	67	2	journal	journal	NOUN
cajgh-313	67	3	is	be	AUX
cajgh-313	67	4	published	publish	VERB
cajgh-313	67	5	by	by	ADP
cajgh-313	67	6	theuniversity	theuniversity	NOUN
cajgh-313	67	7	library	library	NOUN
cajgh-313	67	8	system	system	NOUN
cajgh-313	67	9	of	of	ADP
cajgh-313	67	10	the	the	DET
cajgh-313	67	11	university	university	PROPN
cajgh-313	67	12	of	of	ADP
cajgh-313	67	13	pittsburgh	pittsburgh	PROPN
cajgh-313	67	14	as	as	ADP
cajgh-313	67	15	part	part	NOUN
cajgh-313	67	16	of	of	ADP
cajgh-313	67	17	its	its	PRON
cajgh-313	67	18	d	d	NOUN
cajgh-313	67	19	-	-	PUNCT
cajgh-313	67	20	scribe	scribe	VERB
cajgh-313	67	21	digital	digital	ADJ
cajgh-313	67	22	publishing	publishing	NOUN
cajgh-313	67	23	program	program	NOUN
cajgh-313	67	24	and	and	CCONJ
cajgh-313	67	25	is	be	AUX
cajgh-313	67	26	cosponsored	cosponsor	VERB
cajgh-313	67	27	by	by	ADP
cajgh-313	67	28	the	the	DET
cajgh-313	67	29	university	university	PROPN
cajgh-313	67	30	of	of	ADP
cajgh-313	67	31	pittsburgh	pittsburgh	PROPN
cajgh-313	67	32	press	press	NOUN
cajgh-313	67	33	.	.	PUNCT
cajgh-313	68	1	central	central	ADJ
cajgh-313	68	2	asian	asian	ADJ
cajgh-313	68	3	journal	journal	NOUN
cajgh-313	68	4	of	of	ADP
cajgh-313	68	5	global	global	ADJ
cajgh-313	68	6	health	health	NOUN
cajgh-313	68	7	volume	volume	NOUN
cajgh-313	68	8	8	8	NUM
cajgh-313	68	9	,	,	PUNCT
cajgh-313	68	10	no	no	INTJ
cajgh-313	68	11	.	.	NOUN
cajgh-313	68	12	1	1	NUM
cajgh-313	68	13	(	(	PUNCT
cajgh-313	68	14	2019	2019	NUM
cajgh-313	68	15	)	)	PUNCT
cajgh-313	68	16	|	|	ADV
cajgh-313	68	17	issn	issn	VERB
cajgh-313	68	18	2166	2166	NUM
cajgh-313	68	19	-	-	SYM
cajgh-313	68	20	7403	7403	NUM
cajgh-313	68	21	(	(	PUNCT
cajgh-313	68	22	online	online	ADJ
cajgh-313	68	23	)	)	PUNCT
cajgh-313	68	24	|	|	ADV
cajgh-313	68	25	doi	doi	X
cajgh-313	68	26	10.5195	10.5195	NUM
cajgh-313	68	27	/	/	SYM
cajgh-313	68	28	cajgh.2019.313|http://cajgh.pitt.edu	cajgh.2019.313|http://cajgh.pitt.edu	NOUN
cajgh-313	68	29	table	table	NOUN
cajgh-313	68	30	1	1	NUM
cajgh-313	68	31	.	.	PUNCT
cajgh-313	68	32	demographic	demographic	ADJ
cajgh-313	68	33	data	datum	NOUN
cajgh-313	68	34	on	on	ADP
cajgh-313	68	35	hbv	hbv	NOUN
cajgh-313	68	36	/	/	SYM
cajgh-313	68	37	hcv	hcv	NOUN
cajgh-313	68	38	distribution	distribution	NOUN
cajgh-313	68	39	in	in	ADP
cajgh-313	68	40	the	the	DET
cajgh-313	68	41	study	study	NOUN
cajgh-313	68	42	population	population	NOUN
cajgh-313	68	43	.	.	PUNCT
cajgh-313	69	1	transaminase	transaminase	NOUN
cajgh-313	69	2	(	(	PUNCT
cajgh-313	69	3	ast	ast	NOUN
cajgh-313	69	4	)	)	PUNCT
cajgh-313	69	5	,	,	PUNCT
cajgh-313	69	6	alkaline	alkaline	NOUN
cajgh-313	69	7	phosphatase	phosphatase	NOUN
cajgh-313	69	8	(	(	PUNCT
cajgh-313	69	9	alp	alp	PROPN
cajgh-313	69	10	)	)	PUNCT
cajgh-313	69	11	,	,	PUNCT
cajgh-313	69	12	bilirubin	bilirubin	NOUN
cajgh-313	69	13	total	total	NOUN
cajgh-313	69	14	(	(	PUNCT
cajgh-313	69	15	bt	bt	NOUN
cajgh-313	69	16	)	)	PUNCT
cajgh-313	69	17	,	,	PUNCT
cajgh-313	69	18	bilirubin	bilirubin	NOUN
cajgh-313	69	19	indirect	indirect	ADJ
cajgh-313	69	20	(	(	PUNCT
cajgh-313	69	21	bi	bi	NOUN
cajgh-313	69	22	)	)	PUNCT
cajgh-313	69	23	,	,	PUNCT
cajgh-313	69	24	and	and	CCONJ
cajgh-313	69	25	bilirubin	bilirubin	NOUN
cajgh-313	69	26	direct	direct	ADJ
cajgh-313	69	27	(	(	PUNCT
cajgh-313	69	28	bd	bd	NOUN
cajgh-313	69	29	)	)	PUNCT
cajgh-313	69	30	were	be	AUX
cajgh-313	69	31	114.4±403.8	114.4±403.8	ADJ
cajgh-313	69	32	iu	iu	ADP
cajgh-313	69	33	/	/	SYM
cajgh-313	69	34	l	l	NOUN
cajgh-313	69	35	,	,	PUNCT
cajgh-313	69	36	94.7±344.8	94.7±344.8	NUM
cajgh-313	69	37	iu	iu	NOUN
cajgh-313	69	38	/	/	SYM
cajgh-313	69	39	l	l	NOUN
cajgh-313	69	40	,	,	PUNCT
cajgh-313	69	41	101.4±71.6	101.4±71.6	PROPN
cajgh-313	69	42	iu	iu	ADP
cajgh-313	69	43	/	/	SYM
cajgh-313	69	44	ml	ml	NOUN
cajgh-313	69	45	,	,	PUNCT
cajgh-313	69	46	1.4±2.9mg	1.4±2.9mg	NUM
cajgh-313	69	47	/	/	SYM
cajgh-313	69	48	dl	dl	PROPN
cajgh-313	69	49	,	,	PUNCT
cajgh-313	69	50	0.7±2.7mg	0.7±2.7mg	NUM
cajgh-313	69	51	/	/	SYM
cajgh-313	69	52	dl	dl	PROPN
cajgh-313	69	53	,	,	PUNCT
cajgh-313	69	54	and	and	CCONJ
cajgh-313	69	55	0.7±1.7mg	0.7±1.7mg	NUM
cajgh-313	69	56	/	/	SYM
cajgh-313	69	57	dl	dl	PROPN
cajgh-313	69	58	respectively	respectively	ADV
cajgh-313	69	59	in	in	ADP
cajgh-313	69	60	hbsag	hbsag	ADJ
cajgh-313	69	61	positive	positive	ADJ
cajgh-313	69	62	patients	patient	NOUN
cajgh-313	69	63	,	,	PUNCT
cajgh-313	69	64	and	and	CCONJ
cajgh-313	69	65	100.25±201.4	100.25±201.4	NUM
cajgh-313	69	66	iu	iu	PROPN
cajgh-313	69	67	/	/	SYM
cajgh-313	69	68	l	l	NOUN
cajgh-313	69	69	,	,	PUNCT
cajgh-313	69	70	106.3±265.7	106.3±265.7	NOUN
cajgh-313	69	71	iu	iu	PROPN
cajgh-313	69	72	/	/	SYM
cajgh-313	69	73	l	l	NOUN
cajgh-313	69	74	,	,	PUNCT
cajgh-313	69	75	114.7±65.9	114.7±65.9	VERB
cajgh-313	69	76	iu	iu	ADP
cajgh-313	69	77	/	/	SYM
cajgh-313	69	78	ml	ml	NOUN
cajgh-313	69	79	,	,	PUNCT
cajgh-313	69	80	1.7±2.7mg	1.7±2.7mg	NUM
cajgh-313	69	81	/	/	SYM
cajgh-313	69	82	dl	dl	PROPN
cajgh-313	69	83	,	,	PUNCT
cajgh-313	69	84	1.05±2.7mg	1.05±2.7mg	NUM
cajgh-313	69	85	/	/	SYM
cajgh-313	69	86	dl	dl	PROPN
cajgh-313	69	87	,	,	PUNCT
cajgh-313	69	88	and	and	CCONJ
cajgh-313	69	89	0.7±0.7mg	0.7±0.7mg	NUM
cajgh-313	69	90	/	/	SYM
cajgh-313	69	91	dl	dl	PROPN
cajgh-313	69	92	respectively	respectively	ADV
cajgh-313	69	93	in	in	ADP
cajgh-313	69	94	hbv	hbv	NOUN
cajgh-313	69	95	/	/	SYM
cajgh-313	69	96	hcv	hcv	X
cajgh-313	69	97	co	co	ADJ
cajgh-313	69	98	-	-	ADJ
cajgh-313	69	99	infected	infected	ADJ
cajgh-313	69	100	patients	patient	NOUN
cajgh-313	69	101	.	.	PUNCT
cajgh-313	70	1	levels	level	NOUN
cajgh-313	70	2	of	of	ADP
cajgh-313	70	3	alt	alt	ADJ
cajgh-313	70	4	,	,	PUNCT
cajgh-313	70	5	ast	ast	PROPN
cajgh-313	70	6	,	,	PUNCT
cajgh-313	70	7	alp	alp	PROPN
cajgh-313	70	8	,	,	PUNCT
cajgh-313	70	9	and	and	CCONJ
cajgh-313	70	10	bilirubin	bilirubin	NOUN
cajgh-313	70	11	were	be	AUX
cajgh-313	70	12	significantly	significantly	ADV
cajgh-313	70	13	different	different	ADJ
cajgh-313	70	14	between	between	ADP
cajgh-313	70	15	hbv	hbv	NOUN
cajgh-313	70	16	/	/	SYM
cajgh-313	70	17	hcv	hcv	X
cajgh-313	70	18	co	co	ADJ
cajgh-313	70	19	-	-	ADJ
cajgh-313	70	20	infected	infected	ADJ
cajgh-313	70	21	patients	patient	NOUN
cajgh-313	70	22	and	and	CCONJ
cajgh-313	70	23	hbsag	hbsag	ADJ
cajgh-313	70	24	mono	mono	NOUN
cajgh-313	70	25	-	-	PUNCT
cajgh-313	70	26	infected	infect	VERB
cajgh-313	70	27	patients	patient	NOUN
cajgh-313	70	28	(	(	PUNCT
cajgh-313	70	29	p	p	X
cajgh-313	70	30	<	<	X
cajgh-313	70	31	0.001	0.001	NUM
cajgh-313	70	32	)	)	PUNCT
cajgh-313	70	33	(	(	PUNCT
cajgh-313	70	34	table2	table2	NOUN
cajgh-313	70	35	)	)	PUNCT
cajgh-313	70	36	.	.	PUNCT
cajgh-313	71	1	discussion	discussion	NOUN
cajgh-313	71	2	in	in	ADP
cajgh-313	71	3	this	this	DET
cajgh-313	71	4	study	study	NOUN
cajgh-313	71	5	,	,	PUNCT
cajgh-313	71	6	sero	sero	NOUN
cajgh-313	71	7	-	-	PUNCT
cajgh-313	71	8	occurrence	occurrence	NOUN
cajgh-313	71	9	of	of	ADP
cajgh-313	71	10	hcv	hcv	NOUN
cajgh-313	71	11	coinfection	coinfection	NOUN
cajgh-313	71	12	in	in	ADP
cajgh-313	71	13	hbv	hbv	NOUN
cajgh-313	71	14	patients	patient	NOUN
cajgh-313	71	15	was	be	AUX
cajgh-313	71	16	found	find	VERB
cajgh-313	71	17	to	to	PART
cajgh-313	71	18	be	be	AUX
cajgh-313	71	19	low	low	ADJ
cajgh-313	71	20	(	(	PUNCT
cajgh-313	71	21	1.67	1.67	NUM
cajgh-313	71	22	%	%	NOUN
cajgh-313	71	23	)	)	PUNCT
cajgh-313	71	24	compared	compare	VERB
cajgh-313	71	25	to	to	ADP
cajgh-313	71	26	global	global	ADJ
cajgh-313	71	27	data	datum	NOUN
cajgh-313	71	28	,	,	PUNCT
cajgh-313	71	29	but	but	CCONJ
cajgh-313	71	30	higher	high	ADJ
cajgh-313	71	31	than	than	SCONJ
cajgh-313	71	32	reported	report	VERB
cajgh-313	71	33	in	in	ADP
cajgh-313	71	34	other	other	ADJ
cajgh-313	71	35	parts	part	NOUN
cajgh-313	71	36	of	of	ADP
cajgh-313	71	37	india7,12,19	india7,12,19	NOUN
cajgh-313	71	38	.	.	PUNCT
cajgh-313	72	1	a	a	DET
cajgh-313	72	2	large	large	ADJ
cajgh-313	72	3	multicenter	multicenter	ADJ
cajgh-313	72	4	study	study	NOUN
cajgh-313	72	5	from	from	ADP
cajgh-313	72	6	the	the	DET
cajgh-313	72	7	united	united	PROPN
cajgh-313	72	8	states	states	PROPN
cajgh-313	72	9	assessed	assess	VERB
cajgh-313	72	10	the	the	DET
cajgh-313	72	11	prevalence	prevalence	NOUN
cajgh-313	72	12	of	of	ADP
cajgh-313	72	13	hbv	hbv	NOUN
cajgh-313	72	14	/	/	SYM
cajgh-313	72	15	hcv	hcv	NOUN
cajgh-313	72	16	coinfection	coinfection	NOUN
cajgh-313	72	17	and	and	CCONJ
cajgh-313	72	18	found	find	VERB
cajgh-313	72	19	anti	anti	ADJ
cajgh-313	72	20	-	-	ADJ
cajgh-313	72	21	hcv	hcv	ADJ
cajgh-313	72	22	was	be	AUX
cajgh-313	72	23	present	present	ADJ
cajgh-313	72	24	in	in	ADP
cajgh-313	72	25	7	7	NUM
cajgh-313	72	26	%	%	NOUN
cajgh-313	72	27	of	of	ADP
cajgh-313	72	28	chronic	chronic	ADJ
cajgh-313	72	29	hbv	hbv	NOUN
cajgh-313	72	30	carriers10	carriers10	NOUN
cajgh-313	72	31	.	.	PUNCT
cajgh-313	73	1	tesfa	tesfa	NOUN
cajgh-313	73	2	et.al	et.al	PROPN
cajgh-313	73	3	.	.	PUNCT
cajgh-313	73	4	reported	report	VERB
cajgh-313	73	5	a	a	DET
cajgh-313	73	6	6.39	6.39	NUM
cajgh-313	73	7	%	%	NOUN
cajgh-313	73	8	prevalence	prevalence	NOUN
cajgh-313	73	9	of	of	ADP
cajgh-313	73	10	hbv	hbv	NOUN
cajgh-313	73	11	/	/	SYM
cajgh-313	73	12	hcv	hcv	X
cajgh-313	73	13	co	co	NOUN
cajgh-313	73	14	-	-	NOUN
cajgh-313	73	15	infection	infection	NOUN
cajgh-313	73	16	in	in	ADP
cajgh-313	73	17	a	a	DET
cajgh-313	73	18	hospital	hospital	NOUN
cajgh-313	73	19	-	-	PUNCT
cajgh-313	73	20	based	base	VERB
cajgh-313	73	21	study	study	NOUN
cajgh-313	73	22	conducted	conduct	VERB
cajgh-313	73	23	in	in	ADP
cajgh-313	73	24	ethiopia20	ethiopia20	NOUN
cajgh-313	73	25	.	.	PUNCT
cajgh-313	74	1	studies	study	NOUN
cajgh-313	74	2	conducted	conduct	VERB
cajgh-313	74	3	in	in	ADP
cajgh-313	74	4	different	different	ADJ
cajgh-313	74	5	regions	region	NOUN
cajgh-313	74	6	of	of	ADP
cajgh-313	74	7	india	india	PROPN
cajgh-313	74	8	have	have	AUX
cajgh-313	74	9	reported	report	VERB
cajgh-313	74	10	diverse	diverse	ADJ
cajgh-313	74	11	prevalence	prevalence	NOUN
cajgh-313	74	12	rates	rate	NOUN
cajgh-313	74	13	of	of	ADP
cajgh-313	74	14	hbv	hbv	NOUN
cajgh-313	74	15	/	/	SYM
cajgh-313	74	16	hcv	hcv	X
cajgh-313	74	17	co	co	NOUN
cajgh-313	74	18	-	-	NOUN
cajgh-313	74	19	infection	infection	NOUN
cajgh-313	74	20	in	in	ADP
cajgh-313	74	21	drug	drug	NOUN
cajgh-313	74	22	abusers	abuser	NOUN
cajgh-313	74	23	having	have	VERB
cajgh-313	74	24	chronic	chronic	ADJ
cajgh-313	74	25	liver	liver	NOUN
cajgh-313	74	26	disease	disease	NOUN
cajgh-313	74	27	(	(	PUNCT
cajgh-313	74	28	1.5	1.5	NUM
cajgh-313	74	29	%	%	NOUN
cajgh-313	74	30	)	)	PUNCT
cajgh-313	74	31	,	,	PUNCT
cajgh-313	74	32	patients	patient	NOUN
cajgh-313	74	33	on	on	ADP
cajgh-313	74	34	hemodialysis	hemodialysis	NOUN
cajgh-313	74	35	(	(	PUNCT
cajgh-313	74	36	0.8	0.8	NUM
cajgh-313	74	37	%	%	NOUN
cajgh-313	74	38	)	)	PUNCT
cajgh-313	74	39	,	,	PUNCT
cajgh-313	74	40	and	and	CCONJ
cajgh-313	74	41	in	in	ADP
cajgh-313	74	42	patients	patient	NOUN
cajgh-313	74	43	with	with	ADP
cajgh-313	74	44	hiv	hiv	PROPN
cajgh-313	74	45	infection	infection	NOUN
cajgh-313	74	46	(	(	PUNCT
cajgh-313	74	47	3.0%)7,21	3.0%)7,21	NUM
cajgh-313	74	48	-	-	SYM
cajgh-313	74	49	22	22	NUM
cajgh-313	74	50	.	.	PUNCT
cajgh-313	75	1	while	while	SCONJ
cajgh-313	75	2	not	not	PART
cajgh-313	75	3	statistically	statistically	ADV
cajgh-313	75	4	significant	significant	ADJ
cajgh-313	75	5	,	,	PUNCT
cajgh-313	75	6	we	we	PRON
cajgh-313	75	7	found	find	VERB
cajgh-313	75	8	that	that	SCONJ
cajgh-313	75	9	the	the	DET
cajgh-313	75	10	seropositivity	seropositivity	NOUN
cajgh-313	75	11	rate	rate	NOUN
cajgh-313	75	12	of	of	ADP
cajgh-313	75	13	hbv	hbv	NOUN
cajgh-313	75	14	/	/	SYM
cajgh-313	75	15	hcv	hcv	X
cajgh-313	75	16	co	co	NOUN
cajgh-313	75	17	-	-	NOUN
cajgh-313	75	18	infection	infection	NOUN
cajgh-313	75	19	among	among	ADP
cajgh-313	75	20	males	male	NOUN
cajgh-313	75	21	was	be	AUX
cajgh-313	75	22	higher	high	ADJ
cajgh-313	75	23	than	than	ADP
cajgh-313	75	24	in	in	ADP
cajgh-313	75	25	females	female	NOUN
cajgh-313	75	26	.	.	PUNCT
cajgh-313	76	1	this	this	PRON
cajgh-313	76	2	is	be	AUX
cajgh-313	76	3	an	an	DET
cajgh-313	76	4	interesting	interesting	ADJ
cajgh-313	76	5	finding	finding	NOUN
cajgh-313	76	6	,	,	PUNCT
cajgh-313	76	7	as	as	SCONJ
cajgh-313	76	8	it	it	PRON
cajgh-313	76	9	corroborates	corroborate	VERB
cajgh-313	76	10	a	a	DET
cajgh-313	76	11	previous	previous	ADJ
cajgh-313	76	12	report	report	NOUN
cajgh-313	76	13	that	that	SCONJ
cajgh-313	76	14	male	male	ADJ
cajgh-313	76	15	subjects	subject	NOUN
cajgh-313	76	16	are	be	AUX
cajgh-313	76	17	at	at	ADP
cajgh-313	76	18	a	a	DET
cajgh-313	76	19	higher	high	ADJ
cajgh-313	76	20	risk	risk	NOUN
cajgh-313	76	21	of	of	ADP
cajgh-313	76	22	developing	develop	VERB
cajgh-313	76	23	hbv	hbv	NOUN
cajgh-313	76	24	/	/	SYM
cajgh-313	76	25	hcv	hcv	NOUN
cajgh-313	76	26	coinfection	coinfection	NOUN
cajgh-313	76	27	compared	compare	VERB
cajgh-313	76	28	to	to	ADP
cajgh-313	76	29	females23	females23	NOUN
cajgh-313	76	30	-	-	PUNCT
cajgh-313	76	31	24	24	NUM
cajgh-313	76	32	.	.	PUNCT
cajgh-313	77	1	the	the	DET
cajgh-313	77	2	reason	reason	NOUN
cajgh-313	77	3	for	for	ADP
cajgh-313	77	4	a	a	DET
cajgh-313	77	5	higher	high	ADJ
cajgh-313	77	6	frequency	frequency	NOUN
cajgh-313	77	7	of	of	ADP
cajgh-313	77	8	hbv	hbv	NOUN
cajgh-313	77	9	/	/	SYM
cajgh-313	77	10	hcv	hcv	X
cajgh-313	77	11	co	co	NOUN
cajgh-313	77	12	-	-	NOUN
cajgh-313	77	13	infection	infection	NOUN
cajgh-313	77	14	among	among	ADP
cajgh-313	77	15	male	male	ADJ
cajgh-313	77	16	patients	patient	NOUN
cajgh-313	77	17	could	could	AUX
cajgh-313	77	18	be	be	AUX
cajgh-313	77	19	a	a	DET
cajgh-313	77	20	result	result	NOUN
cajgh-313	77	21	of	of	ADP
cajgh-313	77	22	a	a	DET
cajgh-313	77	23	higher	high	ADJ
cajgh-313	77	24	level	level	NOUN
cajgh-313	77	25	of	of	ADP
cajgh-313	77	26	exposure	exposure	NOUN
cajgh-313	77	27	to	to	ADP
cajgh-313	77	28	risk	risk	NOUN
cajgh-313	77	29	factors	factor	NOUN
cajgh-313	77	30	associated	associate	VERB
cajgh-313	77	31	with	with	ADP
cajgh-313	77	32	co	co	NOUN
cajgh-313	77	33	-	-	NOUN
cajgh-313	77	34	infection	infection	NOUN
cajgh-313	77	35	,	,	PUNCT
cajgh-313	77	36	including	include	VERB
cajgh-313	77	37	drug	drug	NOUN
cajgh-313	77	38	abuse	abuse	NOUN
cajgh-313	77	39	,	,	PUNCT
cajgh-313	77	40	unprotected	unprotected	ADJ
cajgh-313	77	41	sex	sex	NOUN
cajgh-313	77	42	,	,	PUNCT
cajgh-313	77	43	and	and	CCONJ
cajgh-313	77	44	having	have	VERB
cajgh-313	77	45	more	more	ADJ
cajgh-313	77	46	than	than	ADP
cajgh-313	77	47	one	one	NUM
cajgh-313	77	48	sexual	sexual	ADJ
cajgh-313	77	49	partner25	partner25	NOUN
cajgh-313	77	50	.	.	PUNCT
cajgh-313	78	1	our	our	PRON
cajgh-313	78	2	study	study	NOUN
cajgh-313	78	3	showed	show	VERB
cajgh-313	78	4	that	that	SCONJ
cajgh-313	78	5	hbv	hbv	NOUN
cajgh-313	78	6	/	/	SYM
cajgh-313	78	7	hcv	hcv	X
cajgh-313	78	8	co	co	NOUN
cajgh-313	78	9	-	-	NOUN
cajgh-313	78	10	infection	infection	ADJ
cajgh-313	78	11	rates	rate	NOUN
cajgh-313	78	12	were	be	AUX
cajgh-313	78	13	highest	high	ADJ
cajgh-313	78	14	among	among	ADP
cajgh-313	78	15	individuals	individual	NOUN
cajgh-313	78	16	in	in	ADP
cajgh-313	78	17	the	the	DET
cajgh-313	78	18	age	age	NOUN
cajgh-313	78	19	group	group	NOUN
cajgh-313	78	20	of	of	ADP
cajgh-313	78	21	31	31	NUM
cajgh-313	78	22	-	-	SYM
cajgh-313	78	23	60	60	NUM
cajgh-313	78	24	(	(	PUNCT
cajgh-313	78	25	46.4	46.4	NUM
cajgh-313	78	26	%	%	NOUN
cajgh-313	78	27	)	)	PUNCT
cajgh-313	78	28	,	,	PUNCT
cajgh-313	78	29	followed	follow	VERB
cajgh-313	78	30	by	by	ADP
cajgh-313	78	31	the	the	DET
cajgh-313	78	32	age	age	NOUN
cajgh-313	78	33	group	group	NOUN
cajgh-313	78	34	of	of	ADP
cajgh-313	78	35	60	60	NUM
cajgh-313	78	36	years	year	NOUN
cajgh-313	78	37	and	and	CCONJ
cajgh-313	78	38	over	over	ADP
cajgh-313	78	39	(	(	PUNCT
cajgh-313	78	40	28.57	28.57	NUM
cajgh-313	78	41	%	%	NOUN
cajgh-313	78	42	)	)	PUNCT
cajgh-313	78	43	,	,	PUNCT
cajgh-313	78	44	which	which	PRON
cajgh-313	78	45	was	be	AUX
cajgh-313	78	46	similar	similar	ADJ
cajgh-313	78	47	to	to	ADP
cajgh-313	78	48	a	a	DET
cajgh-313	78	49	previously	previously	ADV
cajgh-313	78	50	published	publish	VERB
cajgh-313	78	51	study	study	NOUN
cajgh-313	78	52	in	in	ADP
cajgh-313	78	53	the	the	DET
cajgh-313	78	54	united	united	PROPN
cajgh-313	78	55	states10	states10	PROPN
cajgh-313	78	56	.	.	PUNCT
cajgh-313	79	1	a	a	DET
cajgh-313	79	2	higher	high	ADJ
cajgh-313	79	3	prevalence	prevalence	NOUN
cajgh-313	79	4	in	in	ADP
cajgh-313	79	5	the	the	DET
cajgh-313	79	6	31	31	NUM
cajgh-313	79	7	-	-	SYM
cajgh-313	79	8	60	60	NUM
cajgh-313	79	9	years	year	NOUN
cajgh-313	79	10	age	age	NOUN
cajgh-313	79	11	group	group	NOUN
cajgh-313	79	12	may	may	AUX
cajgh-313	79	13	be	be	AUX
cajgh-313	79	14	associated	associate	VERB
cajgh-313	79	15	with	with	ADP
cajgh-313	79	16	increased	increase	VERB
cajgh-313	79	17	exposure	exposure	NOUN
cajgh-313	79	18	to	to	ADP
cajgh-313	79	19	risk	risk	NOUN
cajgh-313	79	20	factors	factor	NOUN
cajgh-313	79	21	for	for	ADP
cajgh-313	79	22	hbv	hbv	NOUN
cajgh-313	79	23	/	/	SYM
cajgh-313	79	24	hcv	hcv	X
cajgh-313	79	25	co	co	NOUN
cajgh-313	79	26	-	-	NOUN
cajgh-313	79	27	infection	infection	NOUN
cajgh-313	79	28	.	.	PUNCT
cajgh-313	80	1	hbv	hbv	NOUN
cajgh-313	80	2	/	/	SYM
cajgh-313	80	3	hcv	hcv	X
cajgh-313	80	4	co	co	ADJ
cajgh-313	80	5	-	-	ADJ
cajgh-313	80	6	infected	infected	ADJ
cajgh-313	80	7	patients	patient	NOUN
cajgh-313	80	8	in	in	ADP
cajgh-313	80	9	this	this	DET
cajgh-313	80	10	study	study	NOUN
cajgh-313	80	11	had	have	VERB
cajgh-313	80	12	significantly	significantly	ADV
cajgh-313	80	13	higher	high	ADJ
cajgh-313	80	14	levels	level	NOUN
cajgh-313	80	15	of	of	ADP
cajgh-313	80	16	alt	alt	ADJ
cajgh-313	80	17	,	,	PUNCT
cajgh-313	80	18	ast	ast	ADJ
cajgh-313	80	19	,	,	PUNCT
cajgh-313	80	20	and	and	CCONJ
cajgh-313	80	21	alp	alp	NOUN
cajgh-313	80	22	compared	compare	VERB
cajgh-313	80	23	to	to	ADP
cajgh-313	80	24	hbsag	hbsag	NOUN
cajgh-313	80	25	and	and	CCONJ
cajgh-313	80	26	anti	anti	ADJ
cajgh-313	80	27	-	-	ADJ
cajgh-313	80	28	hcv	hcv	ADJ
cajgh-313	80	29	mono	mono	NOUN
cajgh-313	80	30	-	-	PUNCT
cajgh-313	80	31	infected	infect	VERB
cajgh-313	80	32	patients	patient	NOUN
cajgh-313	80	33	.	.	PUNCT
cajgh-313	81	1	higher	high	ADJ
cajgh-313	81	2	levels	level	NOUN
cajgh-313	81	3	of	of	ADP
cajgh-313	81	4	liver	liver	NOUN
cajgh-313	81	5	enzymes	enzyme	NOUN
cajgh-313	81	6	have	have	AUX
cajgh-313	81	7	been	be	AUX
cajgh-313	81	8	demographic	demographic	ADJ
cajgh-313	81	9	variables	variable	NOUN
cajgh-313	81	10	hbsag	hbsag	ADJ
cajgh-313	81	11	positive	positive	ADJ
cajgh-313	81	12	(	(	PUNCT
cajgh-313	81	13	%	%	NOUN
cajgh-313	81	14	)	)	PUNCT
cajgh-313	81	15	anti	anti	ADJ
cajgh-313	81	16	-	-	ADJ
cajgh-313	81	17	hcv	hcv	ADJ
cajgh-313	81	18	positive	positive	ADJ
cajgh-313	81	19	(	(	PUNCT
cajgh-313	81	20	%	%	NOUN
cajgh-313	81	21	)	)	PUNCT
cajgh-313	81	22	hbv	hbv	NOUN
cajgh-313	81	23	/	/	SYM
cajgh-313	81	24	hcv	hcv	X
cajgh-313	81	25	co	co	NOUN
cajgh-313	81	26	-	-	NOUN
cajgh-313	81	27	infection	infection	NOUN
cajgh-313	81	28	(	(	PUNCT
cajgh-313	81	29	%	%	NOUN
cajgh-313	81	30	)	)	PUNCT
cajgh-313	81	31	p	p	NOUN
cajgh-313	81	32	-	-	PUNCT
cajgh-313	81	33	value	value	NOUN
cajgh-313	81	34	*	*	PUNCT
cajgh-313	81	35	sex	sex	NOUN
cajgh-313	81	36	male	male	NOUN
cajgh-313	81	37	1,364	1,364	NUM
cajgh-313	81	38	(	(	PUNCT
cajgh-313	81	39	81.4	81.4	NUM
cajgh-313	81	40	)	)	PUNCT
cajgh-313	81	41	201	201	NUM
cajgh-313	81	42	(	(	PUNCT
cajgh-313	81	43	68.1	68.1	NUM
cajgh-313	81	44	)	)	PUNCT
cajgh-313	81	45	22	22	NUM
cajgh-313	81	46	(	(	PUNCT
cajgh-313	81	47	78.5	78.5	NUM
cajgh-313	81	48	)	)	PUNCT
cajgh-313	82	1	p	p	NOUN
cajgh-313	82	2	=	=	PUNCT
cajgh-313	82	3	0.8	0.8	NUM
cajgh-313	82	4	female	female	ADJ
cajgh-313	82	5	310	310	NUM
cajgh-313	82	6	(	(	PUNCT
cajgh-313	82	7	18.5	18.5	NUM
cajgh-313	82	8	)	)	PUNCT
cajgh-313	82	9	94	94	NUM
cajgh-313	82	10	(	(	PUNCT
cajgh-313	82	11	31.8	31.8	NUM
cajgh-313	82	12	)	)	PUNCT
cajgh-313	82	13	6	6	NUM
cajgh-313	82	14	(	(	PUNCT
cajgh-313	82	15	21.4	21.4	NUM
cajgh-313	82	16	)	)	PUNCT
cajgh-313	82	17	age	age	NOUN
cajgh-313	82	18	1	1	NUM
cajgh-313	82	19	-	-	SYM
cajgh-313	82	20	30	30	NUM
cajgh-313	82	21	257	257	NUM
cajgh-313	82	22	(	(	PUNCT
cajgh-313	82	23	15.35	15.35	NUM
cajgh-313	82	24	)	)	PUNCT
cajgh-313	82	25	75	75	NUM
cajgh-313	82	26	(	(	PUNCT
cajgh-313	82	27	25.4	25.4	NUM
cajgh-313	82	28	)	)	PUNCT
cajgh-313	82	29	7	7	NUM
cajgh-313	82	30	(	(	PUNCT
cajgh-313	82	31	25	25	NUM
cajgh-313	82	32	)	)	PUNCT
cajgh-313	82	33	p	p	NOUN
cajgh-313	83	1	=	=	NOUN
cajgh-313	83	2	0.001	0.001	NUM
cajgh-313	83	3	31	31	NUM
cajgh-313	83	4	-	-	SYM
cajgh-313	83	5	60	60	NUM
cajgh-313	83	6	754	754	NUM
cajgh-313	83	7	(	(	PUNCT
cajgh-313	83	8	45.04	45.04	NUM
cajgh-313	83	9	)	)	PUNCT
cajgh-313	83	10	105	105	NUM
cajgh-313	83	11	(	(	PUNCT
cajgh-313	83	12	35.5	35.5	NUM
cajgh-313	83	13	)	)	SYM
cajgh-313	83	14	13	13	NUM
cajgh-313	83	15	(	(	PUNCT
cajgh-313	83	16	46.4	46.4	NUM
cajgh-313	83	17	)	)	PUNCT
cajgh-313	83	18	>	>	PUNCT
cajgh-313	83	19	60	60	NUM
cajgh-313	83	20	663	663	NUM
cajgh-313	83	21	(	(	PUNCT
cajgh-313	83	22	39.60	39.60	NUM
cajgh-313	83	23	)	)	PUNCT
cajgh-313	83	24	115	115	NUM
cajgh-313	83	25	(	(	PUNCT
cajgh-313	83	26	38.93	38.93	NUM
cajgh-313	83	27	)	)	PUNCT
cajgh-313	83	28	8	8	NUM
cajgh-313	83	29	(	(	PUNCT
cajgh-313	83	30	28.6	28.6	NUM
cajgh-313	83	31	)	)	PUNCT
cajgh-313	83	32	*	*	PUNCT
cajgh-313	83	33	based	base	VERB
cajgh-313	83	34	on	on	ADP
cajgh-313	83	35	chi	chi	ADJ
cajgh-313	83	36	-	-	PUNCT
cajgh-313	83	37	squared	square	VERB
cajgh-313	83	38	test	test	NOUN
cajgh-313	83	39	http://www.library.pitt.edu/	http://www.library.pitt.edu/	PROPN
cajgh-313	83	40	http://www.pitt.edu/	http://www.pitt.edu/	NOUN
cajgh-313	83	41	http://www.library.pitt.edu/articles/digpubtype/index.html	http://www.library.pitt.edu/articles/digpubtype/index.html	PUNCT
cajgh-313	83	42	http://www.upress.pitt.edu/upressindex.aspx	http://www.upress.pitt.edu/upressindex.aspx	PRON
cajgh-313	83	43	desikan	desikan	NOUN
cajgh-313	83	44	this	this	DET
cajgh-313	83	45	work	work	NOUN
cajgh-313	83	46	is	be	AUX
cajgh-313	83	47	licensed	license	VERB
cajgh-313	83	48	under	under	ADP
cajgh-313	83	49	a	a	DET
cajgh-313	83	50	creative	creative	ADJ
cajgh-313	83	51	commons	common	NOUN
cajgh-313	83	52	attribution	attribution	NOUN
cajgh-313	83	53	4.0	4.0	NUM
cajgh-313	83	54	united	unite	VERB
cajgh-313	83	55	states	states	PROPN
cajgh-313	83	56	license	license	NOUN
cajgh-313	83	57	.	.	PUNCT
cajgh-313	84	1	this	this	DET
cajgh-313	84	2	journal	journal	NOUN
cajgh-313	84	3	is	be	AUX
cajgh-313	84	4	published	publish	VERB
cajgh-313	84	5	by	by	ADP
cajgh-313	84	6	theuniversity	theuniversity	NOUN
cajgh-313	84	7	library	library	NOUN
cajgh-313	84	8	system	system	NOUN
cajgh-313	84	9	of	of	ADP
cajgh-313	84	10	the	the	DET
cajgh-313	84	11	university	university	PROPN
cajgh-313	84	12	of	of	ADP
cajgh-313	84	13	pittsburgh	pittsburgh	PROPN
cajgh-313	84	14	as	as	ADP
cajgh-313	84	15	part	part	NOUN
cajgh-313	84	16	of	of	ADP
cajgh-313	84	17	its	its	PRON
cajgh-313	84	18	d	d	NOUN
cajgh-313	84	19	-	-	PUNCT
cajgh-313	84	20	scribe	scribe	VERB
cajgh-313	84	21	digital	digital	ADJ
cajgh-313	84	22	publishing	publishing	NOUN
cajgh-313	84	23	program	program	NOUN
cajgh-313	84	24	and	and	CCONJ
cajgh-313	84	25	is	be	AUX
cajgh-313	84	26	cosponsored	cosponsor	VERB
cajgh-313	84	27	by	by	ADP
cajgh-313	84	28	the	the	DET
cajgh-313	84	29	university	university	PROPN
cajgh-313	84	30	of	of	ADP
cajgh-313	84	31	pittsburgh	pittsburgh	PROPN
cajgh-313	84	32	press	press	NOUN
cajgh-313	84	33	.	.	PUNCT
cajgh-313	85	1	central	central	ADJ
cajgh-313	85	2	asian	asian	ADJ
cajgh-313	85	3	journal	journal	NOUN
cajgh-313	85	4	of	of	ADP
cajgh-313	85	5	global	global	ADJ
cajgh-313	85	6	health	health	NOUN
cajgh-313	85	7	volume	volume	NOUN
cajgh-313	85	8	8	8	NUM
cajgh-313	85	9	,	,	PUNCT
cajgh-313	85	10	no	no	INTJ
cajgh-313	85	11	.	.	NOUN
cajgh-313	85	12	1	1	NUM
cajgh-313	85	13	(	(	PUNCT
cajgh-313	85	14	2019	2019	NUM
cajgh-313	85	15	)	)	PUNCT
cajgh-313	85	16	|	|	ADV
cajgh-313	85	17	issn	issn	VERB
cajgh-313	85	18	2166	2166	NUM
cajgh-313	85	19	-	-	SYM
cajgh-313	85	20	7403	7403	NUM
cajgh-313	85	21	(	(	PUNCT
cajgh-313	85	22	online	online	ADJ
cajgh-313	85	23	)	)	PUNCT
cajgh-313	85	24	|	|	ADV
cajgh-313	85	25	doi	doi	X
cajgh-313	85	26	10.5195	10.5195	NUM
cajgh-313	85	27	/	/	SYM
cajgh-313	85	28	cajgh.2019.313|http://cajgh.pitt.edu	cajgh.2019.313|http://cajgh.pitt.edu	NOUN
cajgh-313	85	29	table	table	NOUN
cajgh-313	85	30	2	2	NUM
cajgh-313	85	31	.	.	PUNCT
cajgh-313	85	32	liver	liver	NOUN
cajgh-313	85	33	function	function	NOUN
cajgh-313	85	34	profile	profile	NOUN
cajgh-313	85	35	in	in	ADP
cajgh-313	85	36	hbv	hbv	NOUN
cajgh-313	85	37	mono	mono	NOUN
cajgh-313	85	38	-	-	PUNCT
cajgh-313	85	39	infected	infect	VERB
cajgh-313	85	40	patients	patient	NOUN
cajgh-313	85	41	and	and	CCONJ
cajgh-313	85	42	those	those	PRON
cajgh-313	85	43	with	with	ADP
cajgh-313	85	44	hbv	hbv	NOUN
cajgh-313	85	45	/	/	SYM
cajgh-313	85	46	hcv	hcv	X
cajgh-313	85	47	co	co	ADJ
cajgh-313	85	48	-	-	ADJ
cajgh-313	85	49	infected	infected	ADJ
cajgh-313	85	50	patients	patient	NOUN
cajgh-313	85	51	.	.	PUNCT
cajgh-313	86	1	reported	report	VERB
cajgh-313	86	2	in	in	ADP
cajgh-313	86	3	hbv	hbv	NOUN
cajgh-313	86	4	/	/	SYM
cajgh-313	86	5	hcv	hcv	X
cajgh-313	86	6	co	co	ADJ
cajgh-313	86	7	-	-	ADJ
cajgh-313	86	8	infected	infected	ADJ
cajgh-313	86	9	patients	patient	NOUN
cajgh-313	86	10	compared	compare	VERB
cajgh-313	86	11	to	to	ADP
cajgh-313	86	12	those	those	PRON
cajgh-313	86	13	having	have	VERB
cajgh-313	86	14	hbv	hbv	NOUN
cajgh-313	86	15	and	and	CCONJ
cajgh-313	86	16	hcv	hcv	VERB
cajgh-313	86	17	mono	mono	NOUN
cajgh-313	86	18	-	-	PUNCT
cajgh-313	86	19	infection26	infection26	NOUN
cajgh-313	86	20	.	.	PUNCT
cajgh-313	87	1	bilirubin	bilirubin	NOUN
cajgh-313	87	2	concentrations	concentration	NOUN
cajgh-313	87	3	were	be	AUX
cajgh-313	87	4	found	find	VERB
cajgh-313	87	5	to	to	PART
cajgh-313	87	6	be	be	AUX
cajgh-313	87	7	highest	high	ADJ
cajgh-313	87	8	in	in	ADP
cajgh-313	87	9	co	co	ADJ
cajgh-313	87	10	-	-	ADJ
cajgh-313	87	11	infected	infected	ADJ
cajgh-313	87	12	patients	patient	NOUN
cajgh-313	87	13	in	in	ADP
cajgh-313	87	14	this	this	DET
cajgh-313	87	15	study	study	NOUN
cajgh-313	87	16	.	.	PUNCT
cajgh-313	88	1	a	a	DET
cajgh-313	88	2	study	study	NOUN
cajgh-313	88	3	conducted	conduct	VERB
cajgh-313	88	4	in	in	ADP
cajgh-313	88	5	tribal	tribal	ADJ
cajgh-313	88	6	populations	population	NOUN
cajgh-313	88	7	of	of	ADP
cajgh-313	88	8	central	central	ADJ
cajgh-313	88	9	india	india	PROPN
cajgh-313	88	10	also	also	ADV
cajgh-313	88	11	found	find	VERB
cajgh-313	88	12	an	an	DET
cajgh-313	88	13	elevated	elevated	ADJ
cajgh-313	88	14	level	level	NOUN
cajgh-313	88	15	of	of	ADP
cajgh-313	88	16	bilirubin	bilirubin	NOUN
cajgh-313	88	17	in	in	ADP
cajgh-313	88	18	hbv	hbv	NOUN
cajgh-313	88	19	/	/	SYM
cajgh-313	88	20	hcv	hcv	X
cajgh-313	88	21	co	co	ADJ
cajgh-313	88	22	-	-	ADJ
cajgh-313	88	23	infected	infected	ADJ
cajgh-313	88	24	patients27	patients27	NOUN
cajgh-313	88	25	-	-	NUM
cajgh-313	88	26	28	28	NUM
cajgh-313	88	27	.	.	PUNCT
cajgh-313	89	1	it	it	PRON
cajgh-313	89	2	is	be	AUX
cajgh-313	89	3	documented	document	VERB
cajgh-313	89	4	that	that	SCONJ
cajgh-313	89	5	elevated	elevated	ADJ
cajgh-313	89	6	levels	level	NOUN
cajgh-313	89	7	of	of	ADP
cajgh-313	89	8	liver	liver	NOUN
cajgh-313	89	9	enzymes	enzyme	NOUN
cajgh-313	89	10	in	in	ADP
cajgh-313	89	11	hbv	hbv	NOUN
cajgh-313	89	12	infected	infect	VERB
cajgh-313	89	13	patients	patient	NOUN
cajgh-313	89	14	are	be	AUX
cajgh-313	89	15	associated	associate	VERB
cajgh-313	89	16	with	with	ADP
cajgh-313	89	17	higher	high	ADJ
cajgh-313	89	18	risk	risk	NOUN
cajgh-313	89	19	of	of	ADP
cajgh-313	89	20	liver	liver	NOUN
cajgh-313	89	21	cirrhosis	cirrhosis	NOUN
cajgh-313	89	22	and	and	CCONJ
cajgh-313	89	23	hcc29	hcc29	NOUN
cajgh-313	89	24	.	.	PUNCT
cajgh-313	90	1	once	once	SCONJ
cajgh-313	90	2	hbv	hbv	NOUN
cajgh-313	90	3	infection	infection	NOUN
cajgh-313	90	4	is	be	AUX
cajgh-313	90	5	detected	detect	VERB
cajgh-313	90	6	during	during	ADP
cajgh-313	90	7	a	a	DET
cajgh-313	90	8	diagnostic	diagnostic	ADJ
cajgh-313	90	9	workup	workup	NOUN
cajgh-313	90	10	of	of	ADP
cajgh-313	90	11	hepatitis	hepatitis	NOUN
cajgh-313	90	12	,	,	PUNCT
cajgh-313	90	13	it	it	PRON
cajgh-313	90	14	is	be	AUX
cajgh-313	90	15	possible	possible	ADJ
cajgh-313	90	16	that	that	SCONJ
cajgh-313	90	17	hepatitis	hepatitis	NOUN
cajgh-313	90	18	may	may	AUX
cajgh-313	90	19	be	be	AUX
cajgh-313	90	20	attributed	attribute	VERB
cajgh-313	90	21	to	to	ADP
cajgh-313	90	22	hbv	hbv	NOUN
cajgh-313	90	23	infection	infection	NOUN
cajgh-313	90	24	alone	alone	ADV
cajgh-313	90	25	and	and	CCONJ
cajgh-313	90	26	further	further	ADJ
cajgh-313	90	27	etiological	etiological	ADJ
cajgh-313	90	28	diagnoses	diagnosis	NOUN
cajgh-313	90	29	may	may	AUX
cajgh-313	90	30	not	not	PART
cajgh-313	90	31	be	be	AUX
cajgh-313	90	32	carried	carry	VERB
cajgh-313	90	33	out	out	ADP
cajgh-313	90	34	.	.	PUNCT
cajgh-313	91	1	this	this	PRON
cajgh-313	91	2	may	may	AUX
cajgh-313	91	3	lead	lead	VERB
cajgh-313	91	4	to	to	ADP
cajgh-313	91	5	underreporting	underreporte	VERB
cajgh-313	91	6	of	of	ADP
cajgh-313	91	7	co	co	NOUN
cajgh-313	91	8	-	-	NOUN
cajgh-313	91	9	infection	infection	NOUN
cajgh-313	91	10	with	with	ADP
cajgh-313	91	11	hcv	hcv	PROPN
cajgh-313	91	12	.	.	PUNCT
cajgh-313	92	1	therefore	therefore	ADV
cajgh-313	92	2	,	,	PUNCT
cajgh-313	92	3	detection	detection	NOUN
cajgh-313	92	4	of	of	ADP
cajgh-313	92	5	co	co	NOUN
cajgh-313	92	6	-	-	NOUN
cajgh-313	92	7	infection	infection	NOUN
cajgh-313	92	8	may	may	AUX
cajgh-313	92	9	enable	enable	VERB
cajgh-313	92	10	timely	timely	ADJ
cajgh-313	92	11	intervention	intervention	NOUN
cajgh-313	92	12	to	to	PART
cajgh-313	92	13	prevent	prevent	VERB
cajgh-313	92	14	progression	progression	NOUN
cajgh-313	92	15	to	to	ADP
cajgh-313	92	16	hcc	hcc	PROPN
cajgh-313	92	17	.	.	PUNCT
cajgh-313	93	1	this	this	DET
cajgh-313	93	2	pilot	pilot	NOUN
cajgh-313	93	3	investigation	investigation	NOUN
cajgh-313	93	4	is	be	AUX
cajgh-313	93	5	the	the	DET
cajgh-313	93	6	first	first	ADJ
cajgh-313	93	7	study	study	NOUN
cajgh-313	93	8	to	to	PART
cajgh-313	93	9	show	show	VERB
cajgh-313	93	10	sero	sero	NOUN
cajgh-313	93	11	-	-	PUNCT
cajgh-313	93	12	occurrence	occurrence	NOUN
cajgh-313	93	13	of	of	ADP
cajgh-313	93	14	hbv	hbv	NOUN
cajgh-313	93	15	/	/	SYM
cajgh-313	93	16	hcv	hcv	NOUN
cajgh-313	93	17	coinfection	coinfection	NOUN
cajgh-313	93	18	within	within	ADP
cajgh-313	93	19	the	the	DET
cajgh-313	93	20	central	central	ADJ
cajgh-313	93	21	zone	zone	NOUN
cajgh-313	93	22	of	of	ADP
cajgh-313	93	23	india	india	PROPN
cajgh-313	93	24	,	,	PUNCT
cajgh-313	93	25	along	along	ADP
cajgh-313	93	26	with	with	ADP
cajgh-313	93	27	the	the	DET
cajgh-313	93	28	comparison	comparison	NOUN
cajgh-313	93	29	of	of	ADP
cajgh-313	93	30	liver	liver	NOUN
cajgh-313	93	31	enzymes	enzyme	NOUN
cajgh-313	93	32	data	datum	NOUN
cajgh-313	93	33	among	among	ADP
cajgh-313	93	34	these	these	DET
cajgh-313	93	35	patients	patient	NOUN
cajgh-313	93	36	.	.	PUNCT
cajgh-313	94	1	our	our	PRON
cajgh-313	94	2	findings	finding	NOUN
cajgh-313	94	3	indicate	indicate	VERB
cajgh-313	94	4	that	that	SCONJ
cajgh-313	94	5	there	there	PRON
cajgh-313	94	6	is	be	VERB
cajgh-313	94	7	a	a	DET
cajgh-313	94	8	potentially	potentially	ADV
cajgh-313	94	9	higher	high	ADJ
cajgh-313	94	10	level	level	NOUN
cajgh-313	94	11	of	of	ADP
cajgh-313	94	12	liver	liver	NOUN
cajgh-313	94	13	damage	damage	NOUN
cajgh-313	94	14	in	in	ADP
cajgh-313	94	15	patients	patient	NOUN
cajgh-313	94	16	with	with	ADP
cajgh-313	94	17	hbv	hbv	NOUN
cajgh-313	94	18	/	/	SYM
cajgh-313	94	19	hcv	hcv	X
cajgh-313	94	20	co	co	NOUN
cajgh-313	94	21	-	-	NOUN
cajgh-313	94	22	infection	infection	NOUN
cajgh-313	94	23	,	,	PUNCT
cajgh-313	94	24	warranting	warrant	VERB
cajgh-313	94	25	that	that	SCONJ
cajgh-313	94	26	those	those	PRON
cajgh-313	94	27	diagnosed	diagnose	VERB
cajgh-313	94	28	with	with	ADP
cajgh-313	94	29	either	either	DET
cajgh-313	94	30	hbv	hbv	NOUN
cajgh-313	94	31	or	or	CCONJ
cajgh-313	94	32	hcv	hcv	PROPN
cajgh-313	94	33	should	should	AUX
cajgh-313	94	34	also	also	ADV
cajgh-313	94	35	be	be	AUX
cajgh-313	94	36	tested	test	VERB
cajgh-313	94	37	for	for	ADP
cajgh-313	94	38	the	the	DET
cajgh-313	94	39	other	other	ADJ
cajgh-313	94	40	hepatitis	hepatitis	PROPN
cajgh-313	94	41	virus	virus	NOUN
cajgh-313	94	42	.	.	PUNCT
cajgh-313	95	1	screening	screen	VERB
cajgh-313	95	2	of	of	ADP
cajgh-313	95	3	hbv	hbv	NOUN
cajgh-313	95	4	infection	infection	NOUN
cajgh-313	95	5	can	can	AUX
cajgh-313	95	6	be	be	AUX
cajgh-313	95	7	made	make	VERB
cajgh-313	95	8	more	more	ADV
cajgh-313	95	9	widespread	widespread	ADJ
cajgh-313	95	10	through	through	ADP
cajgh-313	95	11	molecular	molecular	ADJ
cajgh-313	95	12	testing	testing	NOUN
cajgh-313	95	13	of	of	ADP
cajgh-313	95	14	hbv	hbv	NOUN
cajgh-313	95	15	dna	dna	PROPN
cajgh-313	95	16	by	by	ADP
cajgh-313	95	17	polymerase	polymerase	NOUN
cajgh-313	95	18	chain	chain	NOUN
cajgh-313	95	19	reaction	reaction	NOUN
cajgh-313	95	20	to	to	PART
cajgh-313	95	21	detect	detect	VERB
cajgh-313	95	22	occult	occult	NOUN
cajgh-313	95	23	hepatitis	hepatitis	PROPN
cajgh-313	95	24	b	b	NOUN
cajgh-313	95	25	infection	infection	NOUN
cajgh-313	95	26	.	.	PUNCT
cajgh-313	96	1	there	there	PRON
cajgh-313	96	2	were	be	VERB
cajgh-313	96	3	several	several	ADJ
cajgh-313	96	4	limitations	limitation	NOUN
cajgh-313	96	5	to	to	ADP
cajgh-313	96	6	our	our	PRON
cajgh-313	96	7	study	study	NOUN
cajgh-313	96	8	.	.	PUNCT
cajgh-313	97	1	there	there	PRON
cajgh-313	97	2	were	be	VERB
cajgh-313	97	3	no	no	DET
cajgh-313	97	4	available	available	ADJ
cajgh-313	97	5	data	datum	NOUN
cajgh-313	97	6	on	on	ADP
cajgh-313	97	7	occult	occult	NOUN
cajgh-313	97	8	hbv	hbv	NOUN
cajgh-313	97	9	infection	infection	NOUN
cajgh-313	97	10	since	since	SCONJ
cajgh-313	97	11	hbv	hbv	NOUN
cajgh-313	97	12	dna	dna	PROPN
cajgh-313	97	13	assays	assay	NOUN
cajgh-313	97	14	were	be	AUX
cajgh-313	97	15	not	not	PART
cajgh-313	97	16	performed	perform	VERB
cajgh-313	97	17	.	.	PUNCT
cajgh-313	98	1	this	this	PRON
cajgh-313	98	2	might	might	AUX
cajgh-313	98	3	underestimate	underestimate	VERB
cajgh-313	98	4	the	the	DET
cajgh-313	98	5	real	real	ADJ
cajgh-313	98	6	burden	burden	NOUN
cajgh-313	98	7	of	of	ADP
cajgh-313	98	8	hbv	hbv	NOUN
cajgh-313	98	9	in	in	ADP
cajgh-313	98	10	this	this	DET
cajgh-313	98	11	study	study	NOUN
cajgh-313	98	12	population	population	NOUN
cajgh-313	98	13	.	.	PUNCT
cajgh-313	99	1	the	the	DET
cajgh-313	99	2	hbv	hbv	NOUN
cajgh-313	99	3	immunization	immunization	NOUN
cajgh-313	99	4	status	status	NOUN
cajgh-313	99	5	of	of	ADP
cajgh-313	99	6	patients	patient	NOUN
cajgh-313	99	7	was	be	AUX
cajgh-313	99	8	also	also	ADV
cajgh-313	99	9	unknown	unknown	ADJ
cajgh-313	99	10	,	,	PUNCT
cajgh-313	99	11	which	which	PRON
cajgh-313	99	12	is	be	AUX
cajgh-313	99	13	something	something	PRON
cajgh-313	99	14	we	we	PRON
cajgh-313	99	15	can	can	AUX
cajgh-313	99	16	address	address	VERB
cajgh-313	99	17	in	in	ADP
cajgh-313	99	18	our	our	PRON
cajgh-313	99	19	future	future	ADJ
cajgh-313	99	20	investigations	investigation	NOUN
cajgh-313	99	21	.	.	PUNCT
cajgh-313	100	1	in	in	ADP
cajgh-313	100	2	this	this	DET
cajgh-313	100	3	study	study	NOUN
cajgh-313	100	4	,	,	PUNCT
cajgh-313	100	5	the	the	DET
cajgh-313	100	6	majority	majority	NOUN
cajgh-313	100	7	of	of	ADP
cajgh-313	100	8	hbsag	hbsag	NOUN
cajgh-313	100	9	and	and	CCONJ
cajgh-313	100	10	anti	anti	ADJ
cajgh-313	100	11	-	-	ADJ
cajgh-313	100	12	hcv	hcv	ADJ
cajgh-313	100	13	cases	case	NOUN
cajgh-313	100	14	were	be	AUX
cajgh-313	100	15	initially	initially	ADV
cajgh-313	100	16	diagnosed	diagnose	VERB
cajgh-313	100	17	by	by	ADP
cajgh-313	100	18	clinical	clinical	ADJ
cajgh-313	100	19	suspicion	suspicion	NOUN
cajgh-313	100	20	of	of	ADP
cajgh-313	100	21	an	an	DET
cajgh-313	100	22	underlying	underlie	VERB
cajgh-313	100	23	disease	disease	NOUN
cajgh-313	100	24	,	,	PUNCT
cajgh-313	100	25	which	which	PRON
cajgh-313	100	26	is	be	AUX
cajgh-313	100	27	likely	likely	ADJ
cajgh-313	100	28	to	to	PART
cajgh-313	100	29	underestimate	underestimate	VERB
cajgh-313	100	30	the	the	DET
cajgh-313	100	31	total	total	ADJ
cajgh-313	100	32	number	number	NOUN
cajgh-313	100	33	of	of	ADP
cajgh-313	100	34	viral	viral	ADJ
cajgh-313	100	35	hepatitis	hepatitis	NOUN
cajgh-313	100	36	infections	infection	NOUN
cajgh-313	100	37	in	in	ADP
cajgh-313	100	38	our	our	PRON
cajgh-313	100	39	population	population	NOUN
cajgh-313	100	40	,	,	PUNCT
cajgh-313	100	41	due	due	ADP
cajgh-313	100	42	to	to	ADP
cajgh-313	100	43	the	the	DET
cajgh-313	100	44	presence	presence	NOUN
cajgh-313	100	45	of	of	ADP
cajgh-313	100	46	subclinical	subclinical	ADJ
cajgh-313	100	47	or	or	CCONJ
cajgh-313	100	48	asymptomatic	asymptomatic	ADJ
cajgh-313	100	49	infections	infection	NOUN
cajgh-313	100	50	.	.	PUNCT
cajgh-313	101	1	this	this	DET
cajgh-313	101	2	study	study	NOUN
cajgh-313	101	3	is	be	AUX
cajgh-313	101	4	limited	limit	VERB
cajgh-313	101	5	to	to	ADP
cajgh-313	101	6	the	the	DET
cajgh-313	101	7	review	review	NOUN
cajgh-313	101	8	of	of	ADP
cajgh-313	101	9	medical	medical	ADJ
cajgh-313	101	10	records	record	NOUN
cajgh-313	101	11	;	;	PUNCT
cajgh-313	101	12	no	no	DET
cajgh-313	101	13	information	information	NOUN
cajgh-313	101	14	was	be	AUX
cajgh-313	101	15	gathered	gather	VERB
cajgh-313	101	16	directly	directly	ADV
cajgh-313	101	17	from	from	ADP
cajgh-313	101	18	the	the	DET
cajgh-313	101	19	patients	patient	NOUN
cajgh-313	101	20	.	.	PUNCT
cajgh-313	102	1	variables	variable	NOUN
cajgh-313	102	2	hbsag	hbsag	ADJ
cajgh-313	102	3	mono	mono	PROPN
cajgh-313	102	4	infection	infection	NOUN
cajgh-313	102	5	hbv	hbv	NOUN
cajgh-313	102	6	/	/	SYM
cajgh-313	102	7	hcv	hcv	NOUN
cajgh-313	102	8	coinfection	coinfection	NOUN
cajgh-313	102	9	p	p	NOUN
cajgh-313	102	10	value	value	NOUN
cajgh-313	102	11	*	*	PUNCT
cajgh-313	102	12	alt	alt	ADJ
cajgh-313	102	13	,	,	PUNCT
cajgh-313	102	14	mean±sd	mean±sd	ADP
cajgh-313	102	15	114.4±403.8	114.4±403.8	NOUN
cajgh-313	102	16	100.25±201.4	100.25±201.4	NUM
cajgh-313	102	17	0.001	0.001	NUM
cajgh-313	102	18	alt	alt	ADJ
cajgh-313	102	19	abnormal	abnormal	ADJ
cajgh-313	102	20	high	high	ADJ
cajgh-313	102	21	(	(	PUNCT
cajgh-313	102	22	n%	n%	NOUN
cajgh-313	102	23	)	)	PUNCT
cajgh-313	102	24	156	156	NUM
cajgh-313	102	25	(	(	PUNCT
cajgh-313	102	26	20.1	20.1	NUM
cajgh-313	102	27	%	%	NOUN
cajgh-313	102	28	)	)	PUNCT
cajgh-313	102	29	14	14	NUM
cajgh-313	102	30	(	(	PUNCT
cajgh-313	102	31	50.0	50.0	NUM
cajgh-313	102	32	%	%	NOUN
cajgh-313	102	33	)	)	PUNCT
cajgh-313	103	1	ast	ast	ADV
cajgh-313	103	2	,	,	PUNCT
cajgh-313	103	3	mean±sd	mean±sd	ADP
cajgh-313	103	4	94.7±344.8	94.7±344.8	NUM
cajgh-313	103	5	106.3±265.7	106.3±265.7	NOUN
cajgh-313	103	6	0.001	0.001	NUM
cajgh-313	103	7	ast	ast	NOUN
cajgh-313	103	8	abnormal	abnormal	ADJ
cajgh-313	103	9	high	high	ADJ
cajgh-313	103	10	(	(	PUNCT
cajgh-313	103	11	n%	n%	NOUN
cajgh-313	103	12	)	)	PUNCT
cajgh-313	103	13	140	140	NUM
cajgh-313	103	14	(	(	PUNCT
cajgh-313	103	15	18.1	18.1	NUM
cajgh-313	103	16	%	%	NOUN
cajgh-313	103	17	)	)	PUNCT
cajgh-313	103	18	8	8	NUM
cajgh-313	103	19	(	(	PUNCT
cajgh-313	103	20	28.5	28.5	NUM
cajgh-313	103	21	%	%	NOUN
cajgh-313	103	22	)	)	PUNCT
cajgh-313	104	1	alp	alp	PROPN
cajgh-313	104	2	mean±sd	mean±sd	ADP
cajgh-313	104	3	101.4	101.4	NUM
cajgh-313	104	4	±	±	NUM
cajgh-313	105	1	71.6	71.6	NUM
cajgh-313	105	2	114.7±65.9	114.7±65.9	NOUN
cajgh-313	105	3	0.001	0.001	NUM
cajgh-313	105	4	alp	alp	PROPN
cajgh-313	105	5	abnormal	abnormal	ADJ
cajgh-313	105	6	high	high	ADJ
cajgh-313	105	7	(	(	PUNCT
cajgh-313	105	8	n%	n%	NOUN
cajgh-313	105	9	)	)	PUNCT
cajgh-313	105	10	132	132	NUM
cajgh-313	105	11	(	(	PUNCT
cajgh-313	105	12	17.7	17.7	NUM
cajgh-313	105	13	%	%	NOUN
cajgh-313	105	14	)	)	PUNCT
cajgh-313	105	15	11	11	NUM
cajgh-313	105	16	(	(	PUNCT
cajgh-313	105	17	39.2	39.2	NUM
cajgh-313	105	18	%	%	NOUN
cajgh-313	105	19	)	)	PUNCT
cajgh-313	105	20	bilirubin	bilirubin	NOUN
cajgh-313	105	21	total	total	NOUN
cajgh-313	105	22	mean±sd	mean±sd	ADP
cajgh-313	105	23	1.4±2.9	1.4±2.9	NUM
cajgh-313	105	24	1.7±2.7	1.7±2.7	NUM
cajgh-313	105	25	0.001	0.001	NUM
cajgh-313	105	26	bilirubin	bilirubin	NOUN
cajgh-313	105	27	total	total	NOUN
cajgh-313	105	28	abnormal	abnormal	ADJ
cajgh-313	105	29	high	high	ADJ
cajgh-313	105	30	(	(	PUNCT
cajgh-313	105	31	n%	n%	NOUN
cajgh-313	105	32	)	)	PUNCT
cajgh-313	105	33	151	151	NUM
cajgh-313	105	34	(	(	PUNCT
cajgh-313	105	35	19.5	19.5	NUM
cajgh-313	105	36	%	%	NOUN
cajgh-313	105	37	)	)	PUNCT
cajgh-313	105	38	11	11	NUM
cajgh-313	105	39	(	(	PUNCT
cajgh-313	105	40	39.2	39.2	NUM
cajgh-313	105	41	%	%	NOUN
cajgh-313	105	42	)	)	PUNCT
cajgh-313	105	43	bilirubin	bilirubin	NOUN
cajgh-313	105	44	direct	direct	ADJ
cajgh-313	105	45	mean±sd	mean±sd	ADP
cajgh-313	105	46	0.7±2.7	0.7±2.7	NUM
cajgh-313	105	47	1.05±2.7	1.05±2.7	NUM
cajgh-313	105	48	0.001	0.001	NUM
cajgh-313	105	49	bilirubin	bilirubin	NOUN
cajgh-313	105	50	direct	direct	ADJ
cajgh-313	105	51	abnormal	abnormal	ADJ
cajgh-313	105	52	high	high	ADJ
cajgh-313	105	53	(	(	PUNCT
cajgh-313	105	54	n%	n%	NOUN
cajgh-313	105	55	)	)	PUNCT
cajgh-313	105	56	368	368	NUM
cajgh-313	105	57	(	(	PUNCT
cajgh-313	105	58	47.6	47.6	NUM
cajgh-313	105	59	%	%	NOUN
cajgh-313	105	60	)	)	PUNCT
cajgh-313	105	61	15	15	NUM
cajgh-313	105	62	(	(	PUNCT
cajgh-313	105	63	53.3	53.3	NUM
cajgh-313	105	64	%	%	NOUN
cajgh-313	105	65	)	)	PUNCT
cajgh-313	105	66	bilirubin	bilirubin	NOUN
cajgh-313	105	67	indirect	indirect	ADJ
cajgh-313	105	68	mean±sd	mean±sd	ADP
cajgh-313	105	69	0.7±1.7	0.7±1.7	PRON
cajgh-313	105	70	0.7±1.7	0.7±1.7	NUM
cajgh-313	105	71	0.001	0.001	NUM
cajgh-313	105	72	bilirubin	bilirubin	NOUN
cajgh-313	105	73	indirect	indirect	ADJ
cajgh-313	105	74	abnormal	abnormal	ADJ
cajgh-313	105	75	high	high	ADJ
cajgh-313	105	76	(	(	PUNCT
cajgh-313	105	77	n%	n%	NOUN
cajgh-313	105	78	)	)	PUNCT
cajgh-313	105	79	110	110	NUM
cajgh-313	105	80	(	(	PUNCT
cajgh-313	105	81	14.2	14.2	NUM
cajgh-313	105	82	%	%	NOUN
cajgh-313	105	83	)	)	PUNCT
cajgh-313	105	84	7	7	NUM
cajgh-313	105	85	(	(	PUNCT
cajgh-313	105	86	25.0	25.0	NUM
cajgh-313	105	87	%	%	NOUN
cajgh-313	105	88	)	)	PUNCT
cajgh-313	106	1	*	*	PUNCT
cajgh-313	106	2	student	student	NOUN
cajgh-313	106	3	’s	’s	PART
cajgh-313	106	4	t	t	PROPN
cajgh-313	106	5	-	-	PUNCT
cajgh-313	106	6	test	test	NOUN
cajgh-313	106	7	http://www.library.pitt.edu/	http://www.library.pitt.edu/	PROPN
cajgh-313	106	8	http://www.pitt.edu/	http://www.pitt.edu/	NOUN
cajgh-313	106	9	http://www.library.pitt.edu/articles/digpubtype/index.html	http://www.library.pitt.edu/articles/digpubtype/index.html	PUNCT
cajgh-313	106	10	http://www.upress.pitt.edu/upressindex.aspx	http://www.upress.pitt.edu/upressindex.aspx	NUM
cajgh-313	106	11	central	central	ADJ
cajgh-313	106	12	asian	asian	ADJ
cajgh-313	106	13	journal	journal	NOUN
cajgh-313	106	14	of	of	ADP
cajgh-313	106	15	global	global	ADJ
cajgh-313	106	16	health	health	NOUN
cajgh-313	106	17	this	this	DET
cajgh-313	106	18	work	work	NOUN
cajgh-313	106	19	is	be	AUX
cajgh-313	106	20	licensed	license	VERB
cajgh-313	106	21	under	under	ADP
cajgh-313	106	22	a	a	DET
cajgh-313	106	23	creative	creative	ADJ
cajgh-313	106	24	commons	common	NOUN
cajgh-313	106	25	attribution	attribution	NOUN
cajgh-313	106	26	4.0	4.0	NUM
cajgh-313	106	27	united	unite	VERB
cajgh-313	106	28	states	states	PROPN
cajgh-313	106	29	license	license	NOUN
cajgh-313	106	30	.	.	PUNCT
cajgh-313	107	1	this	this	DET
cajgh-313	107	2	journal	journal	NOUN
cajgh-313	107	3	is	be	AUX
cajgh-313	107	4	published	publish	VERB
cajgh-313	107	5	by	by	ADP
cajgh-313	107	6	theuniversity	theuniversity	NOUN
cajgh-313	107	7	library	library	NOUN
cajgh-313	107	8	system	system	NOUN
cajgh-313	107	9	of	of	ADP
cajgh-313	107	10	the	the	DET
cajgh-313	107	11	university	university	PROPN
cajgh-313	107	12	of	of	ADP
cajgh-313	107	13	pittsburgh	pittsburgh	PROPN
cajgh-313	107	14	as	as	ADP
cajgh-313	107	15	part	part	NOUN
cajgh-313	107	16	of	of	ADP
cajgh-313	107	17	its	its	PRON
cajgh-313	107	18	d	d	NOUN
cajgh-313	107	19	-	-	PUNCT
cajgh-313	107	20	scribe	scribe	VERB
cajgh-313	107	21	digital	digital	ADJ
cajgh-313	107	22	publishing	publishing	NOUN
cajgh-313	107	23	program	program	NOUN
cajgh-313	107	24	and	and	CCONJ
cajgh-313	107	25	is	be	AUX
cajgh-313	107	26	cosponsored	cosponsor	VERB
cajgh-313	107	27	by	by	ADP
cajgh-313	107	28	the	the	DET
cajgh-313	107	29	university	university	PROPN
cajgh-313	107	30	of	of	ADP
cajgh-313	107	31	pittsburgh	pittsburgh	PROPN
cajgh-313	107	32	press	press	NOUN
cajgh-313	107	33	.	.	PUNCT
cajgh-313	108	1	central	central	ADJ
cajgh-313	108	2	asian	asian	ADJ
cajgh-313	108	3	journal	journal	NOUN
cajgh-313	108	4	of	of	ADP
cajgh-313	108	5	global	global	ADJ
cajgh-313	108	6	health	health	NOUN
cajgh-313	108	7	volume	volume	NOUN
cajgh-313	108	8	8	8	NUM
cajgh-313	108	9	,	,	PUNCT
cajgh-313	108	10	no	no	INTJ
cajgh-313	108	11	.	.	NOUN
cajgh-313	108	12	1	1	NUM
cajgh-313	108	13	(	(	PUNCT
cajgh-313	108	14	2019	2019	NUM
cajgh-313	108	15	)	)	PUNCT
cajgh-313	108	16	|	|	ADV
cajgh-313	108	17	issn	issn	VERB
cajgh-313	108	18	2166	2166	NUM
cajgh-313	108	19	-	-	SYM
cajgh-313	108	20	7403	7403	NUM
cajgh-313	108	21	(	(	PUNCT
cajgh-313	108	22	online	online	ADJ
cajgh-313	108	23	)	)	PUNCT
cajgh-313	108	24	|	|	ADV
cajgh-313	108	25	doi	doi	X
cajgh-313	108	26	10.5195	10.5195	NUM
cajgh-313	108	27	/	/	SYM
cajgh-313	108	28	cajgh.2019.313|http://cajgh.pitt.edu	cajgh.2019.313|http://cajgh.pitt.edu	NOUN
cajgh-313	108	29	our	our	PRON
cajgh-313	108	30	results	result	NOUN
cajgh-313	108	31	may	may	AUX
cajgh-313	108	32	be	be	AUX
cajgh-313	108	33	useful	useful	ADJ
cajgh-313	108	34	for	for	ADP
cajgh-313	108	35	making	make	VERB
cajgh-313	108	36	estimates	estimate	NOUN
cajgh-313	108	37	and	and	CCONJ
cajgh-313	108	38	projections	projection	NOUN
cajgh-313	108	39	about	about	ADP
cajgh-313	108	40	future	future	ADJ
cajgh-313	108	41	liver	liver	NOUN
cajgh-313	108	42	disease	disease	NOUN
cajgh-313	108	43	burden	burden	NOUN
cajgh-313	108	44	.	.	PUNCT
cajgh-313	109	1	a	a	DET
cajgh-313	109	2	recently	recently	ADV
cajgh-313	109	3	developed	develop	VERB
cajgh-313	109	4	mathematical	mathematical	ADJ
cajgh-313	109	5	model	model	NOUN
cajgh-313	109	6	by	by	ADP
cajgh-313	109	7	el	el	PROPN
cajgh-313	109	8	-	-	PUNCT
cajgh-313	109	9	bouzedi30	bouzedi30	NOUN
cajgh-313	109	10	,	,	PUNCT
cajgh-313	109	11	that	that	PRON
cajgh-313	109	12	uses	use	VERB
cajgh-313	109	13	available	available	ADJ
cajgh-313	109	14	epidemiological	epidemiological	ADJ
cajgh-313	109	15	data	datum	NOUN
cajgh-313	109	16	on	on	ADP
cajgh-313	109	17	viral	viral	ADJ
cajgh-313	109	18	hepatitis	hepatitis	NOUN
cajgh-313	109	19	to	to	PART
cajgh-313	109	20	estimate	estimate	VERB
cajgh-313	109	21	future	future	ADJ
cajgh-313	109	22	consequences	consequence	NOUN
cajgh-313	109	23	of	of	ADP
cajgh-313	109	24	hepatitis	hepatitis	NOUN
cajgh-313	109	25	infection	infection	NOUN
cajgh-313	109	26	,	,	PUNCT
cajgh-313	109	27	can	can	AUX
cajgh-313	109	28	be	be	AUX
cajgh-313	109	29	incorporated	incorporate	VERB
cajgh-313	109	30	in	in	ADP
cajgh-313	109	31	our	our	PRON
cajgh-313	109	32	future	future	ADJ
cajgh-313	109	33	research	research	NOUN
cajgh-313	109	34	.	.	PUNCT
cajgh-313	110	1	such	such	ADJ
cajgh-313	110	2	models	model	NOUN
cajgh-313	110	3	will	will	AUX
cajgh-313	110	4	help	help	VERB
cajgh-313	110	5	to	to	PART
cajgh-313	110	6	inform	inform	VERB
cajgh-313	110	7	health	health	NOUN
cajgh-313	110	8	policy	policy	NOUN
cajgh-313	110	9	,	,	PUNCT
cajgh-313	110	10	resource	resource	NOUN
cajgh-313	110	11	distribution	distribution	NOUN
cajgh-313	110	12	,	,	PUNCT
cajgh-313	110	13	and	and	CCONJ
cajgh-313	110	14	healthcare	healthcare	NOUN
cajgh-313	110	15	delivery	delivery	NOUN
cajgh-313	110	16	in	in	ADP
cajgh-313	110	17	india	india	PROPN
cajgh-313	110	18	,	,	PUNCT
cajgh-313	110	19	as	as	ADV
cajgh-313	110	20	well	well	ADV
cajgh-313	110	21	as	as	ADP
cajgh-313	110	22	other	other	ADJ
cajgh-313	110	23	countries	country	NOUN
cajgh-313	110	24	.	.	PUNCT
cajgh-313	111	1	these	these	DET
cajgh-313	111	2	types	type	NOUN
cajgh-313	111	3	of	of	ADP
cajgh-313	111	4	studies	study	NOUN
cajgh-313	111	5	can	can	AUX
cajgh-313	111	6	also	also	ADV
cajgh-313	111	7	lead	lead	VERB
cajgh-313	111	8	to	to	ADP
cajgh-313	111	9	improved	improved	ADJ
cajgh-313	111	10	management	management	NOUN
cajgh-313	111	11	of	of	ADP
cajgh-313	111	12	patients	patient	NOUN
cajgh-313	111	13	with	with	ADP
cajgh-313	111	14	viral	viral	ADJ
cajgh-313	111	15	hepatitis	hepatitis	NOUN
cajgh-313	111	16	and	and	CCONJ
cajgh-313	111	17	inform	inform	VERB
cajgh-313	111	18	health	health	NOUN
cajgh-313	111	19	policy	policy	NOUN
cajgh-313	111	20	.	.	PUNCT
cajgh-313	112	1	references	reference	NOUN
cajgh-313	112	2	1	1	NUM
cajgh-313	112	3	.	.	PUNCT
cajgh-313	112	4	laraba	laraba	PROPN
cajgh-313	112	5	a	a	PRON
cajgh-313	112	6	,	,	PUNCT
cajgh-313	112	7	wadzali	wadzali	ADJ
cajgh-313	112	8	g	g	PROPN
cajgh-313	112	9	,	,	PUNCT
cajgh-313	112	10	sunday	sunday	PROPN
cajgh-313	112	11	b	b	PROPN
cajgh-313	112	12	,	,	PUNCT
cajgh-313	112	13	et	et	PROPN
cajgh-313	112	14	al	al	PROPN
cajgh-313	112	15	.	.	PROPN
cajgh-313	112	16	,	,	PUNCT
cajgh-313	112	17	hepatitis	hepatitis	PROPN
cajgh-313	112	18	c	c	PROPN
cajgh-313	112	19	virus	virus	NOUN
cajgh-313	112	20	infection	infection	NOUN
cajgh-313	112	21	innigerianswith	innigerianswith	PROPN
cajgh-313	112	22	chronic	chronic	ADJ
cajgh-313	112	23	liver	liver	NOUN
cajgh-313	112	24	disease	disease	NOUN
cajgh-313	112	25	.	.	PUNCT
cajgh-313	113	1	internet	internet	PROPN
cajgh-313	113	2	j	j	PROPN
cajgh-313	113	3	gastroenterol	gastroenterol	PROPN
cajgh-313	113	4	2009	2009	NUM
cajgh-313	113	5	;	;	PUNCT
cajgh-313	113	6	9(1):1	9(1):1	X
cajgh-313	113	7	-	-	SYM
cajgh-313	113	8	3	3	NUM
cajgh-313	113	9	.	.	NOUN
cajgh-313	113	10	2	2	NUM
cajgh-313	113	11	.	.	X
cajgh-313	114	1	konstantinou	konstantinou	PROPN
cajgh-313	114	2	d	d	PROPN
cajgh-313	114	3	,	,	PUNCT
cajgh-313	114	4	deutsch	deutsch	NOUN
cajgh-313	114	5	m.	m.	VERB
cajgh-313	114	6	the	the	DET
cajgh-313	114	7	spectrum	spectrum	NOUN
cajgh-313	114	8	of	of	ADP
cajgh-313	114	9	hbv	hbv	NOUN
cajgh-313	114	10	/	/	SYM
cajgh-313	114	11	hcv	hcv	NOUN
cajgh-313	114	12	coinfection	coinfection	NOUN
cajgh-313	114	13	:	:	PUNCT
cajgh-313	114	14	epidemiology	epidemiology	NOUN
cajgh-313	114	15	,	,	PUNCT
cajgh-313	114	16	clinical	clinical	ADJ
cajgh-313	114	17	characteristics	characteristic	NOUN
cajgh-313	114	18	,	,	PUNCT
cajgh-313	114	19	viralinteractions	viralinteraction	NOUN
cajgh-313	114	20	and	and	CCONJ
cajgh-313	114	21	management	management	NOUN
cajgh-313	114	22	.	.	PUNCT
cajgh-313	115	1	annals	annal	NOUN
cajgh-313	115	2	of	of	ADP
cajgh-313	115	3	gastroenterology	gastroenterology	NOUN
cajgh-313	115	4	:	:	PUNCT
cajgh-313	115	5	quarterly	quarterly	ADJ
cajgh-313	115	6	publication	publication	NOUN
cajgh-313	115	7	of	of	ADP
cajgh-313	115	8	the	the	DET
cajgh-313	115	9	hellenic	hellenic	ADJ
cajgh-313	115	10	society	society	NOUN
cajgh-313	115	11	of	of	ADP
cajgh-313	115	12	gastroenterology	gastroenterology	NOUN
cajgh-313	115	13	.	.	PUNCT
cajgh-313	116	1	2015;28(2):221	2015;28(2):221	NOUN
cajgh-313	116	2	-	-	SYM
cajgh-313	116	3	228	228	NUM
cajgh-313	116	4	.	.	PUNCT
cajgh-313	117	1	3	3	X
cajgh-313	117	2	.	.	PUNCT
cajgh-313	117	3	donato	donato	PROPN
cajgh-313	117	4	f	f	PROPN
cajgh-313	117	5	,	,	PUNCT
cajgh-313	117	6	boffetta	boffetta	NOUN
cajgh-313	118	1	p	p	NOUN
cajgh-313	118	2	,	,	PUNCT
cajgh-313	118	3	puoti	puoti	NOUN
cajgh-313	118	4	m.	m.	NOUN
cajgh-313	118	5	a	a	DET
cajgh-313	118	6	meta	meta	ADJ
cajgh-313	118	7	-	-	PUNCT
cajgh-313	118	8	analysis	analysis	NOUN
cajgh-313	118	9	of	of	ADP
cajgh-313	118	10	epidemiological	epidemiological	ADJ
cajgh-313	118	11	studies	study	NOUN
cajgh-313	118	12	on	on	ADP
cajgh-313	118	13	the	the	DET
cajgh-313	118	14	combined	combined	ADJ
cajgh-313	118	15	effect	effect	NOUN
cajgh-313	118	16	of	of	ADP
cajgh-313	118	17	hepatitis	hepatitis	PROPN
cajgh-313	118	18	b	b	PROPN
cajgh-313	118	19	and	and	CCONJ
cajgh-313	118	20	c	c	PROPN
cajgh-313	118	21	virus	virus	NOUN
cajgh-313	118	22	infections	infection	NOUN
cajgh-313	118	23	in	in	ADP
cajgh-313	118	24	causing	cause	VERB
cajgh-313	118	25	hepatocellular	hepatocellular	ADJ
cajgh-313	118	26	carcinoma	carcinoma	NOUN
cajgh-313	118	27	.	.	PUNCT
cajgh-313	119	1	int	int	NOUN
cajgh-313	119	2	j	j	PROPN
cajgh-313	119	3	cancer	cancer	NOUN
cajgh-313	119	4	.	.	PUNCT
cajgh-313	120	1	1998;75:347–354	1998;75:347–354	X
cajgh-313	120	2	.	.	NOUN
cajgh-313	120	3	4	4	NUM
cajgh-313	120	4	.	.	X
cajgh-313	121	1	shi	shi	PROPN
cajgh-313	121	2	j	j	PROPN
cajgh-313	121	3	,	,	PUNCT
cajgh-313	121	4	zhu	zhu	PROPN
cajgh-313	121	5	l	l	PROPN
cajgh-313	121	6	,	,	PUNCT
cajgh-313	121	7	liu	liu	PROPN
cajgh-313	121	8	s	s	PROPN
cajgh-313	121	9	,	,	PUNCT
cajgh-313	121	10	xie	xie	PROPN
cajgh-313	121	11	wf	wf	PROPN
cajgh-313	121	12	.	.	PUNCT
cajgh-313	122	1	a	a	DET
cajgh-313	122	2	meta	meta	ADJ
cajgh-313	122	3	-	-	PUNCT
cajgh-313	122	4	analysis	analysis	NOUN
cajgh-313	122	5	of	of	ADP
cajgh-313	122	6	case	case	NOUN
cajgh-313	122	7	-	-	PUNCT
cajgh-313	122	8	control	control	NOUN
cajgh-313	122	9	studies	study	NOUN
cajgh-313	122	10	on	on	ADP
cajgh-313	122	11	the	the	DET
cajgh-313	122	12	combined	combine	VERB
cajgh-313	122	13	effect	effect	NOUN
cajgh-313	122	14	of	of	ADP
cajgh-313	122	15	hepatitis	hepatitis	PROPN
cajgh-313	122	16	b	b	PROPN
cajgh-313	122	17	and	and	CCONJ
cajgh-313	122	18	c	c	PROPN
cajgh-313	122	19	virus	virus	NOUN
cajgh-313	122	20	infections	infection	NOUN
cajgh-313	122	21	in	in	ADP
cajgh-313	122	22	causing	cause	VERB
cajgh-313	122	23	hepatocellular	hepatocellular	ADJ
cajgh-313	122	24	carcinoma	carcinoma	NOUN
cajgh-313	122	25	in	in	ADP
cajgh-313	122	26	china	china	PROPN
cajgh-313	122	27	.	.	PUNCT
cajgh-313	123	1	br	br	PROPN
cajgh-313	123	2	j	j	PROPN
cajgh-313	123	3	cancer	cancer	NOUN
cajgh-313	123	4	.	.	PUNCT
cajgh-313	124	1	2005;92:607–612	2005;92:607–612	NOUN
cajgh-313	124	2	.	.	PUNCT
cajgh-313	125	1	5	5	NUM
cajgh-313	125	2	.	.	X
cajgh-313	125	3	cho	cho	PROPN
cajgh-313	125	4	ly	ly	PROPN
cajgh-313	125	5	,	,	PUNCT
cajgh-313	125	6	yang	yang	PROPN
cajgh-313	125	7	jj	jj	PROPN
cajgh-313	125	8	,	,	PUNCT
cajgh-313	125	9	ko	ko	PROPN
cajgh-313	125	10	kp	kp	PROPN
cajgh-313	125	11	,	,	PUNCT
cajgh-313	125	12	et	et	PROPN
cajgh-313	125	13	al	al	PROPN
cajgh-313	125	14	.	.	PROPN
cajgh-313	126	1	coinfection	coinfection	NOUN
cajgh-313	126	2	of	of	ADP
cajgh-313	126	3	hepatitis	hepatitis	PROPN
cajgh-313	126	4	b	b	PROPN
cajgh-313	126	5	and	and	CCONJ
cajgh-313	126	6	c	c	PROPN
cajgh-313	126	7	viruses	virus	NOUN
cajgh-313	126	8	and	and	CCONJ
cajgh-313	126	9	risk	risk	NOUN
cajgh-313	126	10	of	of	ADP
cajgh-313	126	11	hepatocellular	hepatocellular	ADJ
cajgh-313	126	12	carcinoma	carcinoma	NOUN
cajgh-313	126	13	:	:	PUNCT
cajgh-313	126	14	systematic	systematic	ADJ
cajgh-313	126	15	review	review	NOUN
cajgh-313	126	16	and	and	CCONJ
cajgh-313	126	17	meta	meta	ADJ
cajgh-313	126	18	-	-	PUNCT
cajgh-313	126	19	analysis	analysis	NOUN
cajgh-313	126	20	.	.	PUNCT
cajgh-313	127	1	int	int	NOUN
cajgh-313	127	2	j	j	PROPN
cajgh-313	127	3	cancer	cancer	NOUN
cajgh-313	127	4	.	.	PUNCT
cajgh-313	128	1	2011;128:176	2011;128:176	NUM
cajgh-313	128	2	–	–	PUNCT
cajgh-313	128	3	184	184	NUM
cajgh-313	128	4	.	.	NOUN
cajgh-313	129	1	6	6	NUM
cajgh-313	129	2	.	.	X
cajgh-313	129	3	caccamo	caccamo	VERB
cajgh-313	129	4	g	g	PROPN
cajgh-313	129	5	,	,	PUNCT
cajgh-313	129	6	saffioti	saffioti	PROPN
cajgh-313	129	7	f	f	PROPN
cajgh-313	129	8	,	,	PUNCT
cajgh-313	129	9	raimondo	raimondo	PROPN
cajgh-313	129	10	g.	g.	PROPN
cajgh-313	129	11	hepatitis	hepatitis	PROPN
cajgh-313	129	12	b	b	PROPN
cajgh-313	129	13	virus	virus	NOUN
cajgh-313	129	14	and	and	CCONJ
cajgh-313	129	15	hepatitis	hepatitis	PROPN
cajgh-313	129	16	c	c	PROPN
cajgh-313	129	17	virus	virus	NOUN
cajgh-313	129	18	dual	dual	ADJ
cajgh-313	129	19	infection	infection	NOUN
cajgh-313	129	20	.	.	PUNCT
cajgh-313	130	1	world	world	PROPN
cajgh-313	130	2	journal	journal	PROPN
cajgh-313	130	3	of	of	ADP
cajgh-313	130	4	gastroenterology	gastroenterology	NOUN
cajgh-313	130	5	 	 	SPACE
cajgh-313	130	6	:	:	PUNCT
cajgh-313	131	1	wjg	wjg	VERB
cajgh-313	131	2	.	.	PUNCT
cajgh-313	132	1	2014;20(40):14559	2014;20(40):14559	NUM
cajgh-313	132	2	-	-	SYM
cajgh-313	132	3	14567	14567	NUM
cajgh-313	132	4	.	.	PUNCT
cajgh-313	133	1	7	7	X
cajgh-313	133	2	.	.	X
cajgh-313	133	3	malhotra	malhotra	PROPN
cajgh-313	133	4	r	r	PROPN
cajgh-313	133	5	,	,	PUNCT
cajgh-313	133	6	soin	soin	PROPN
cajgh-313	133	7	d	d	PROPN
cajgh-313	133	8	,	,	PUNCT
cajgh-313	133	9	grover	grover	NOUN
cajgh-313	133	10	p	p	NOUN
cajgh-313	133	11	,	,	PUNCT
cajgh-313	133	12	galhotra	galhotra	PROPN
cajgh-313	133	13	s	s	PROPN
cajgh-313	133	14	,	,	PUNCT
cajgh-313	133	15	khutan	khutan	PROPN
cajgh-313	133	16	h	h	NOUN
cajgh-313	133	17	,	,	PUNCT
cajgh-313	133	18	kaur	kaur	PROPN
cajgh-313	133	19	n.	n.	PROPN
cajgh-313	133	20	hepatitis	hepatitis	PROPN
cajgh-313	133	21	b	b	PROPN
cajgh-313	133	22	virus	virus	NOUN
cajgh-313	133	23	and	and	CCONJ
cajgh-313	133	24	hepatitis	hepatitis	PROPN
cajgh-313	133	25	c	c	PROPN
cajgh-313	133	26	virus	virus	PROPN
cajgh-313	133	27	co	co	NOUN
cajgh-313	133	28	-	-	NOUN
cajgh-313	133	29	infection	infection	NOUN
cajgh-313	133	30	in	in	ADP
cajgh-313	133	31	hemodialysis	hemodialysis	NOUN
cajgh-313	133	32	patients	patient	NOUN
cajgh-313	133	33	:	:	PUNCT
cajgh-313	133	34	a	a	DET
cajgh-313	133	35	retrospective	retrospective	ADJ
cajgh-313	133	36	study	study	NOUN
cajgh-313	133	37	from	from	ADP
cajgh-313	133	38	a	a	DET
cajgh-313	133	39	tertiary	tertiary	ADJ
cajgh-313	133	40	care	care	NOUN
cajgh-313	133	41	hospital	hospital	NOUN
cajgh-313	133	42	of	of	ADP
cajgh-313	133	43	north	north	PROPN
cajgh-313	133	44	india	india	PROPN
cajgh-313	133	45	.	.	PUNCT
cajgh-313	133	46	journal	journal	PROPN
cajgh-313	133	47	of	of	ADP
cajgh-313	133	48	natural	natural	ADJ
cajgh-313	133	49	science	science	NOUN
cajgh-313	133	50	,	,	PUNCT
cajgh-313	133	51	biology	biology	NOUN
cajgh-313	133	52	,	,	PUNCT
cajgh-313	133	53	and	and	CCONJ
cajgh-313	133	54	medicine	medicine	NOUN
cajgh-313	133	55	.	.	PUNCT
cajgh-313	134	1	2016;7(1):7274	2016;7(1):7274	NUM
cajgh-313	134	2	.	.	NOUN
cajgh-313	134	3	8	8	NUM
cajgh-313	134	4	.	.	PUNCT
cajgh-313	135	1	desikan	desikan	PROPN
cajgh-313	135	2	p	p	X
cajgh-313	135	3	,	,	PUNCT
cajgh-313	135	4	khan	khan	PROPN
cajgh-313	135	5	z.	z.	PROPN
cajgh-313	135	6	prevalence	prevalence	NOUN
cajgh-313	135	7	of	of	ADP
cajgh-313	135	8	hepatitis	hepatitis	PROPN
cajgh-313	135	9	b	b	PROPN
cajgh-313	135	10	and	and	CCONJ
cajgh-313	135	11	hepatitis	hepatitis	PROPN
cajgh-313	135	12	c	c	PROPN
cajgh-313	135	13	virus	virus	PROPN
cajgh-313	135	14	co	co	NOUN
cajgh-313	135	15	-	-	NOUN
cajgh-313	135	16	infection	infection	NOUN
cajgh-313	135	17	in	in	ADP
cajgh-313	135	18	india	india	PROPN
cajgh-313	135	19	:	:	PUNCT
cajgh-313	135	20	a	a	DET
cajgh-313	135	21	systematic	systematic	ADJ
cajgh-313	135	22	review	review	NOUN
cajgh-313	135	23	and	and	CCONJ
cajgh-313	135	24	meta	meta	ADJ
cajgh-313	135	25	-	-	PUNCT
cajgh-313	135	26	analysis	analysis	NOUN
cajgh-313	135	27	.	.	PUNCT
cajgh-313	136	1	indian	indian	PROPN
cajgh-313	136	2	j	j	PROPN
cajgh-313	136	3	med	med	PROPN
cajgh-313	136	4	microbiol	microbiol	PROPN
cajgh-313	136	5	.	.	PUNCT
cajgh-313	137	1	2017;35:332	2017;35:332	NUM
cajgh-313	137	2	-	-	SYM
cajgh-313	137	3	9	9	NUM
cajgh-313	137	4	9	9	NUM
cajgh-313	137	5	.	.	PUNCT
cajgh-313	137	6	lahariya	lahariya	NOUN
cajgh-313	137	7	c	c	PROPN
cajgh-313	137	8	,	,	PUNCT
cajgh-313	137	9	subramanya	subramanya	PROPN
cajgh-313	137	10	b	b	PROPN
cajgh-313	137	11	p	p	PROPN
cajgh-313	137	12	,	,	PUNCT
cajgh-313	137	13	sosler	sosler	PROPN
cajgh-313	137	14	s.	s.	PROPN
cajgh-313	138	1	an	an	DET
cajgh-313	138	2	assessment	assessment	NOUN
cajgh-313	138	3	of	of	ADP
cajgh-313	138	4	hepatitis	hepatitis	PROPN
cajgh-313	138	5	b	b	PROPN
cajgh-313	138	6	vaccine	vaccine	NOUN
cajgh-313	138	7	introduction	introduction	NOUN
cajgh-313	138	8	in	in	ADP
cajgh-313	138	9	india	india	PROPN
cajgh-313	138	10	:	:	PUNCT
cajgh-313	138	11	lessons	lesson	NOUN
cajgh-313	138	12	for	for	ADP
cajgh-313	138	13	roll	roll	NOUN
cajgh-313	138	14	out	out	ADP
cajgh-313	138	15	and	and	CCONJ
cajgh-313	138	16	scale	scale	VERB
cajgh-313	138	17	up	up	ADP
cajgh-313	138	18	of	of	ADP
cajgh-313	138	19	new	new	ADJ
cajgh-313	138	20	vaccines	vaccine	NOUN
cajgh-313	138	21	in	in	ADP
cajgh-313	138	22	immunization	immunization	NOUN
cajgh-313	138	23	programs	program	NOUN
cajgh-313	138	24	.	.	PUNCT
cajgh-313	139	1	indian	indian	PROPN
cajgh-313	139	2	j	j	PROPN
cajgh-313	139	3	public	public	ADJ
cajgh-313	139	4	health	health	NOUN
cajgh-313	139	5	2013;57:8	2013;57:8	NUM
cajgh-313	139	6	-	-	SYM
cajgh-313	139	7	14	14	NUM
cajgh-313	139	8	.	.	PUNCT
cajgh-313	139	9	10	10	NUM
cajgh-313	139	10	.	.	PUNCT
cajgh-313	140	1	bini	bini	PROPN
cajgh-313	140	2	ej	ej	PROPN
cajgh-313	140	3	,	,	PUNCT
cajgh-313	140	4	perumalswami	perumalswami	NOUN
cajgh-313	140	5	pv	pv	NOUN
cajgh-313	140	6	.	.	PUNCT
cajgh-313	141	1	hepatitis	hepatitis	PROPN
cajgh-313	141	2	b	b	PROPN
cajgh-313	141	3	virus	virus	NOUN
cajgh-313	141	4	infection	infection	NOUN
cajgh-313	141	5	among	among	ADP
cajgh-313	141	6	american	american	ADJ
cajgh-313	141	7	patients	patient	NOUN
cajgh-313	141	8	with	with	ADP
cajgh-313	141	9	chronic	chronic	ADJ
cajgh-313	141	10	hepatitis	hepatitis	PROPN
cajgh-313	141	11	c	c	PROPN
cajgh-313	141	12	virus	virus	NOUN
cajgh-313	141	13	infection	infection	NOUN
cajgh-313	141	14	:	:	PUNCT
cajgh-313	141	15	prevalence	prevalence	NOUN
cajgh-313	141	16	,	,	PUNCT
cajgh-313	141	17	racial	racial	ADJ
cajgh-313	141	18	/	/	SYM
cajgh-313	141	19	ethnic	ethnic	ADJ
cajgh-313	141	20	differences	difference	NOUN
cajgh-313	141	21	,	,	PUNCT
cajgh-313	141	22	and	and	CCONJ
cajgh-313	141	23	viral	viral	ADJ
cajgh-313	141	24	interactions	interaction	NOUN
cajgh-313	141	25	.	.	PUNCT
cajgh-313	142	1	hepatology	hepatology	NOUN
cajgh-313	142	2	.	.	PUNCT
cajgh-313	143	1	2010;51:759–766	2010;51:759–766	NOUN
cajgh-313	143	2	.	.	PUNCT
cajgh-313	144	1	11	11	NUM
cajgh-313	144	2	.	.	PUNCT
cajgh-313	145	1	gaeta	gaeta	PROPN
cajgh-313	145	2	gb	gb	PROPN
cajgh-313	145	3	,	,	PUNCT
cajgh-313	145	4	stornaiuolo	stornaiuolo	ADJ
cajgh-313	145	5	g	g	PROPN
cajgh-313	145	6	,	,	PUNCT
cajgh-313	145	7	precone	precone	PROPN
cajgh-313	145	8	df	df	PROPN
cajgh-313	145	9	,	,	PUNCT
cajgh-313	145	10	et	et	PROPN
cajgh-313	145	11	al	al	PROPN
cajgh-313	145	12	.	.	PROPN
cajgh-313	145	13	epidemiological	epidemiological	ADJ
cajgh-313	145	14	and	and	CCONJ
cajgh-313	145	15	clinical	clinical	ADJ
cajgh-313	145	16	burden	burden	NOUN
cajgh-313	145	17	of	of	ADP
cajgh-313	145	18	chronic	chronic	ADJ
cajgh-313	145	19	hepatitis	hepatitis	PROPN
cajgh-313	145	20	b	b	PROPN
cajgh-313	145	21	virus	virus	PROPN
cajgh-313	145	22	/	/	SYM
cajgh-313	145	23	hepatitis	hepatitis	PROPN
cajgh-313	145	24	c	c	PROPN
cajgh-313	145	25	virus	virus	NOUN
cajgh-313	145	26	infection	infection	NOUN
cajgh-313	145	27	.	.	PUNCT
cajgh-313	146	1	a	a	DET
cajgh-313	146	2	multicenter	multicenter	ADJ
cajgh-313	146	3	italian	italian	ADJ
cajgh-313	146	4	study	study	NOUN
cajgh-313	146	5	.	.	PUNCT
cajgh-313	147	1	j	j	PROPN
cajgh-313	147	2	hepatol	hepatol	ADJ
cajgh-313	147	3	.	.	PUNCT
cajgh-313	148	1	2003;39:1036–1041	2003;39:1036–1041	NUM
cajgh-313	148	2	.	.	PUNCT
cajgh-313	149	1	12	12	NUM
cajgh-313	149	2	.	.	PUNCT
cajgh-313	149	3	tripathi	tripathi	PROPN
cajgh-313	149	4	ak	ak	PROPN
cajgh-313	149	5	,	,	PUNCT
cajgh-313	149	6	khanna	khanna	PROPN
cajgh-313	149	7	m	m	PROPN
cajgh-313	149	8	,	,	PUNCT
cajgh-313	149	9	gupta	gupta	PROPN
cajgh-313	149	10	n	n	CCONJ
cajgh-313	149	11	,	,	PUNCT
cajgh-313	149	12	chandra	chandra	PROPN
cajgh-313	149	13	m.low	m.low	NOUN
cajgh-313	149	14	prevalence	prevalence	NOUN
cajgh-313	149	15	of	of	ADP
cajgh-313	149	16	hepatitis	hepatitis	PROPN
cajgh-313	149	17	b	b	PROPN
cajgh-313	149	18	virus	virus	NOUN
cajgh-313	149	19	and	and	CCONJ
cajgh-313	149	20	hepatitis	hepatitis	PROPN
cajgh-313	149	21	c	c	PROPN
cajgh-313	149	22	virus	virus	PROPN
cajgh-313	149	23	co	co	NOUN
cajgh-313	149	24	-	-	NOUN
cajgh-313	149	25	infection	infection	NOUN
cajgh-313	149	26	in	in	ADP
cajgh-313	149	27	patients	patient	NOUN
cajgh-313	149	28	with	with	ADP
cajgh-313	149	29	human	human	ADJ
cajgh-313	149	30	immunodeficiency	immunodeficiency	NOUN
cajgh-313	149	31	virus	virus	NOUN
cajgh-313	149	32	in	in	ADP
cajgh-313	149	33	northern	northern	ADJ
cajgh-313	149	34	india.jassoc	india.jassoc	PROPN
cajgh-313	149	35	physicians	physician	NOUN
cajgh-313	149	36	india	india	PROPN
cajgh-313	149	37	.	.	PUNCT
cajgh-313	149	38	2007	2007	NUM
cajgh-313	149	39	jun;55:429	jun;55:429	PROPN
cajgh-313	149	40	-	-	SYM
cajgh-313	149	41	31	31	NUM
cajgh-313	149	42	.	.	PUNCT
cajgh-313	150	1	13	13	NUM
cajgh-313	150	2	.	.	PUNCT
cajgh-313	151	1	sagnelli	sagnelli	PROPN
cajgh-313	151	2	e	e	PROPN
cajgh-313	151	3	,	,	PUNCT
cajgh-313	151	4	coppola	coppola	PROPN
cajgh-313	151	5	n	n	CCONJ
cajgh-313	151	6	,	,	PUNCT
cajgh-313	151	7	pisaturo	pisaturo	PROPN
cajgh-313	151	8	m	m	PROPN
cajgh-313	151	9	,	,	PUNCT
cajgh-313	151	10	masiello	masiello	VERB
cajgh-313	151	11	a	a	PRON
cajgh-313	151	12	,	,	PUNCT
cajgh-313	151	13	tonziello	tonziello	NOUN
cajgh-313	151	14	g	g	NOUN
cajgh-313	151	15	,	,	PUNCT
cajgh-313	151	16	sagnelli	sagnelli	PROPN
cajgh-313	151	17	c	c	X
cajgh-313	151	18	,	,	PUNCT
cajgh-313	151	19	messina	messina	PROPN
cajgh-313	151	20	v	v	PROPN
cajgh-313	151	21	,	,	PUNCT
cajgh-313	151	22	filippini	filippini	ADJ
cajgh-313	151	23	p.	p.	PROPN
cajgh-313	151	24	hbv	hbv	PROPN
cajgh-313	151	25	superinfection	superinfection	NOUN
cajgh-313	151	26	in	in	ADP
cajgh-313	151	27	hcv	hcv	NOUN
cajgh-313	151	28	chronic	chronic	ADJ
cajgh-313	151	29	carriers	carrier	NOUN
cajgh-313	151	30	:	:	PUNCT
cajgh-313	151	31	a	a	DET
cajgh-313	151	32	disease	disease	NOUN
cajgh-313	151	33	that	that	PRON
cajgh-313	151	34	is	be	AUX
cajgh-313	151	35	frequently	frequently	ADV
cajgh-313	151	36	severe	severe	ADJ
cajgh-313	151	37	but	but	CCONJ
cajgh-313	151	38	associated	associate	VERB
cajgh-313	151	39	with	with	ADP
cajgh-313	151	40	the	the	DET
cajgh-313	151	41	eradication	eradication	NOUN
cajgh-313	151	42	of	of	ADP
cajgh-313	151	43	hcv	hcv	PROPN
cajgh-313	151	44	.	.	PUNCT
cajgh-313	152	1	hepatology	hepatology	NOUN
cajgh-313	152	2	.	.	PUNCT
cajgh-313	153	1	2009	2009	NUM
cajgh-313	153	2	apr;49(4):1090	apr;49(4):1090	NOUN
cajgh-313	153	3	-	-	PUNCT
cajgh-313	153	4	7	7	PROPN
cajgh-313	153	5	.	.	PUNCT
cajgh-313	154	1	http://www.library.pitt.edu/	http://www.library.pitt.edu/	PROPN
cajgh-313	154	2	http://www.pitt.edu/	http://www.pitt.edu/	NOUN
cajgh-313	154	3	http://www.library.pitt.edu/articles/digpubtype/index.html	http://www.library.pitt.edu/articles/digpubtype/index.html	PUNCT
cajgh-313	154	4	http://www.upress.pitt.edu/upressindex.aspx	http://www.upress.pitt.edu/upressindex.aspx	PRON
cajgh-313	154	5	desikan	desikan	NOUN
cajgh-313	154	6	this	this	DET
cajgh-313	154	7	work	work	NOUN
cajgh-313	154	8	is	be	AUX
cajgh-313	154	9	licensed	license	VERB
cajgh-313	154	10	under	under	ADP
cajgh-313	154	11	a	a	DET
cajgh-313	154	12	creative	creative	ADJ
cajgh-313	154	13	commons	common	NOUN
cajgh-313	154	14	attribution	attribution	NOUN
cajgh-313	154	15	4.0	4.0	NUM
cajgh-313	154	16	united	unite	VERB
cajgh-313	154	17	states	states	PROPN
cajgh-313	154	18	license	license	NOUN
cajgh-313	154	19	.	.	PUNCT
cajgh-313	155	1	this	this	DET
cajgh-313	155	2	journal	journal	NOUN
cajgh-313	155	3	is	be	AUX
cajgh-313	155	4	published	publish	VERB
cajgh-313	155	5	by	by	ADP
cajgh-313	155	6	theuniversity	theuniversity	NOUN
cajgh-313	155	7	library	library	NOUN
cajgh-313	155	8	system	system	NOUN
cajgh-313	155	9	of	of	ADP
cajgh-313	155	10	the	the	DET
cajgh-313	155	11	university	university	PROPN
cajgh-313	155	12	of	of	ADP
cajgh-313	155	13	pittsburgh	pittsburgh	PROPN
cajgh-313	155	14	as	as	ADP
cajgh-313	155	15	part	part	NOUN
cajgh-313	155	16	of	of	ADP
cajgh-313	155	17	its	its	PRON
cajgh-313	155	18	d	d	NOUN
cajgh-313	155	19	-	-	PUNCT
cajgh-313	155	20	scribe	scribe	VERB
cajgh-313	155	21	digital	digital	ADJ
cajgh-313	155	22	publishing	publishing	NOUN
cajgh-313	155	23	program	program	NOUN
cajgh-313	155	24	and	and	CCONJ
cajgh-313	155	25	is	be	AUX
cajgh-313	155	26	cosponsored	cosponsor	VERB
cajgh-313	155	27	by	by	ADP
cajgh-313	155	28	the	the	DET
cajgh-313	155	29	university	university	PROPN
cajgh-313	155	30	of	of	ADP
cajgh-313	155	31	pittsburgh	pittsburgh	PROPN
cajgh-313	155	32	press	press	NOUN
cajgh-313	155	33	.	.	PUNCT
cajgh-313	156	1	central	central	ADJ
cajgh-313	156	2	asian	asian	ADJ
cajgh-313	156	3	journal	journal	NOUN
cajgh-313	156	4	of	of	ADP
cajgh-313	156	5	global	global	ADJ
cajgh-313	156	6	health	health	NOUN
cajgh-313	156	7	volume	volume	NOUN
cajgh-313	156	8	8	8	NUM
cajgh-313	156	9	,	,	PUNCT
cajgh-313	156	10	no	no	INTJ
cajgh-313	156	11	.	.	NOUN
cajgh-313	156	12	1	1	NUM
cajgh-313	156	13	(	(	PUNCT
cajgh-313	156	14	2019	2019	NUM
cajgh-313	156	15	)	)	PUNCT
cajgh-313	156	16	|	|	ADV
cajgh-313	156	17	issn	issn	VERB
cajgh-313	156	18	2166	2166	NUM
cajgh-313	156	19	-	-	SYM
cajgh-313	156	20	7403	7403	NUM
cajgh-313	156	21	(	(	PUNCT
cajgh-313	156	22	online	online	ADJ
cajgh-313	156	23	)	)	PUNCT
cajgh-313	156	24	|	|	ADV
cajgh-313	156	25	doi	doi	X
cajgh-313	156	26	10.5195	10.5195	NUM
cajgh-313	156	27	/	/	SYM
cajgh-313	156	28	cajgh.2019.313|http://cajgh.pitt.edu	cajgh.2019.313|http://cajgh.pitt.edu	NOUN
cajgh-313	156	29	14	14	NUM
cajgh-313	156	30	.	.	PUNCT
cajgh-313	157	1	yang	yang	PROPN
cajgh-313	157	2	s	s	PROPN
cajgh-313	157	3	,	,	PUNCT
cajgh-313	157	4	wang	wang	PROPN
cajgh-313	157	5	d	d	PROPN
cajgh-313	157	6	,	,	PUNCT
cajgh-313	157	7	zhang	zhang	PROPN
cajgh-313	157	8	y	y	PROPN
cajgh-313	157	9	,	,	PUNCT
cajgh-313	157	10	et	et	PROPN
cajgh-313	157	11	al	al	PROPN
cajgh-313	157	12	.	.	PUNCT
cajgh-313	157	13	transmission	transmission	NOUN
cajgh-313	157	14	of	of	ADP
cajgh-313	157	15	hepatitis	hepatitis	PROPN
cajgh-313	157	16	b	b	PROPN
cajgh-313	157	17	and	and	CCONJ
cajgh-313	157	18	c	c	PROPN
cajgh-313	157	19	virus	virus	NOUN
cajgh-313	157	20	infection	infection	NOUN
cajgh-313	157	21	through	through	ADP
cajgh-313	157	22	body	body	NOUN
cajgh-313	157	23	piercing	piercing	NOUN
cajgh-313	157	24	:	:	PUNCT
cajgh-313	157	25	a	a	DET
cajgh-313	157	26	systematic	systematic	ADJ
cajgh-313	157	27	review	review	NOUN
cajgh-313	157	28	and	and	CCONJ
cajgh-313	157	29	metaanalysis	metaanalysis	NOUN
cajgh-313	157	30	.	.	PUNCT
cajgh-313	158	1	martin	martin	PROPN
cajgh-313	158	2	.	.	PUNCT
cajgh-313	159	1	s	s	X
cajgh-313	159	2	,	,	PUNCT
cajgh-313	159	3	ed	ed	NOUN
cajgh-313	159	4	.	.	PUNCT
cajgh-313	159	5	medicine	medicine	NOUN
cajgh-313	159	6	.	.	PUNCT
cajgh-313	160	1	2015;94(47):e1893	2015;94(47):e1893	X
cajgh-313	160	2	.	.	PUNCT
cajgh-313	161	1	15	15	NUM
cajgh-313	161	2	.	.	PUNCT
cajgh-313	162	1	ringehan	ringehan	PROPN
cajgh-313	162	2	m	m	PROPN
cajgh-313	162	3	,	,	PUNCT
cajgh-313	162	4	mckeating	mckeate	VERB
cajgh-313	162	5	ja	ja	PROPN
cajgh-313	162	6	,	,	PUNCT
cajgh-313	162	7	protzer	protzer	PROPN
cajgh-313	162	8	u.	u.	PROPN
cajgh-313	162	9	viral	viral	ADJ
cajgh-313	162	10	hepatitis	hepatitis	NOUN
cajgh-313	162	11	and	and	CCONJ
cajgh-313	162	12	liver	liver	NOUN
cajgh-313	162	13	cancer	cancer	NOUN
cajgh-313	162	14	.	.	PUNCT
cajgh-313	163	1	philosophical	philosophical	ADJ
cajgh-313	163	2	transactions	transaction	NOUN
cajgh-313	163	3	of	of	ADP
cajgh-313	163	4	the	the	DET
cajgh-313	163	5	royal	royal	ADJ
cajgh-313	163	6	society	society	NOUN
cajgh-313	163	7	b	b	PROPN
cajgh-313	163	8	:	:	PUNCT
cajgh-313	163	9	biological	biological	ADJ
cajgh-313	163	10	sciences.2017;372(1732):20160274	sciences.2017;372(1732):20160274	NOUN
cajgh-313	163	11	.	.	PUNCT
cajgh-313	164	1	16	16	NUM
cajgh-313	164	2	.	.	PUNCT
cajgh-313	164	3	sama	sama	PROPN
cajgh-313	164	4	lf	lf	PROPN
cajgh-313	164	5	,	,	PUNCT
cajgh-313	164	6	nganoudjinou	nganoudjinou	PROPN
cajgh-313	164	7	oi	oi	PROPN
cajgh-313	164	8	,	,	PUNCT
cajgh-313	164	9	wam	wam	PROPN
cajgh-313	164	10	ec	ec	PROPN
cajgh-313	164	11	,	,	PUNCT
cajgh-313	164	12	bamou	bamou	ADP
cajgh-313	164	13	r	r	PROPN
cajgh-313	164	14	,	,	PUNCT
cajgh-313	164	15	ali	ali	PROPN
cajgh-313	165	1	i	i	PROPN
cajgh-313	165	2	m	m	PROPN
cajgh-313	165	3	,	,	PUNCT
cajgh-313	165	4	et	et	PROPN
cajgh-313	165	5	al	al	PROPN
cajgh-313	165	6	.	.	PROPN
cajgh-313	166	1	(	(	PUNCT
cajgh-313	166	2	2017	2017	NUM
cajgh-313	166	3	)	)	PUNCT
cajgh-313	166	4	sero	sero	NOUN
cajgh-313	166	5	-	-	PUNCT
cajgh-313	166	6	prevalence	prevalence	NOUN
cajgh-313	166	7	of	of	ADP
cajgh-313	166	8	hepatitis	hepatitis	PROPN
cajgh-313	166	9	b	b	PROPN
cajgh-313	166	10	and	and	CCONJ
cajgh-313	166	11	c	c	PROPN
cajgh-313	166	12	virus	virus	NOUN
cajgh-313	166	13	and	and	CCONJ
cajgh-313	166	14	high	high	ADJ
cajgh-313	166	15	risk	risk	NOUN
cajgh-313	166	16	of	of	ADP
cajgh-313	166	17	hepatotoxicity	hepatotoxicity	NOUN
cajgh-313	166	18	amongtb	amongtb	PROPN
cajgh-313	166	19	/	/	SYM
cajgh-313	166	20	hiv	hiv	PROPN
cajgh-313	166	21	positive	positive	ADJ
cajgh-313	166	22	and	and	CCONJ
cajgh-313	166	23	hiv	hiv	PROPN
cajgh-313	166	24	negative	negative	ADJ
cajgh-313	166	25	population	population	NOUN
cajgh-313	166	26	in	in	ADP
cajgh-313	166	27	western	western	ADJ
cajgh-313	166	28	cameroon	cameroon	PROPN
cajgh-313	166	29	.	.	PUNCT
cajgh-313	167	1	glob	glob	PROPN
cajgh-313	167	2	j	j	PROPN
cajgh-313	167	3	infect	infect	PROPN
cajgh-313	167	4	dis	dis	PROPN
cajgh-313	167	5	clin	clin	PROPN
cajgh-313	167	6	res	res	PROPN
cajgh-313	167	7	3(1	3(1	NUM
cajgh-313	167	8	):	):	PUNCT
cajgh-313	167	9	001	001	NUM
cajgh-313	167	10	-	-	SYM
cajgh-313	167	11	008	008	NUM
cajgh-313	167	12	17	17	NUM
cajgh-313	167	13	.	.	PUNCT
cajgh-313	168	1	dean	dean	PROPN
cajgh-313	168	2	ag	ag	PROPN
cajgh-313	168	3	,	,	PUNCT
cajgh-313	168	4	sullivan	sullivan	PROPN
cajgh-313	168	5	km	km	PROPN
cajgh-313	168	6	,	,	PUNCT
cajgh-313	169	1	soe	soe	PROPN
cajgh-313	169	2	mm	mm	PROPN
cajgh-313	169	3	.	.	PUNCT
cajgh-313	169	4	openepi	openepi	PROPN
cajgh-313	169	5	:	:	PUNCT
cajgh-313	169	6	open	open	ADJ
cajgh-313	169	7	source	source	NOUN
cajgh-313	169	8	epidemiologic	epidemiologic	ADJ
cajgh-313	169	9	statistics	statistic	NOUN
cajgh-313	169	10	for	for	ADP
cajgh-313	169	11	public	public	ADJ
cajgh-313	169	12	health	health	NOUN
cajgh-313	169	13	,	,	PUNCT
cajgh-313	169	14	version	version	NOUN
cajgh-313	169	15	.	.	PUNCT
cajgh-313	170	1	www.openepi.com	www.openepi.com	X
cajgh-313	170	2	)	)	PUNCT
cajgh-313	170	3	.	.	PUNCT
cajgh-313	171	1	accessed	access	VERB
cajgh-313	171	2	on	on	ADP
cajgh-313	171	3	march	march	PROPN
cajgh-313	171	4	29	29	NUM
cajgh-313	171	5	,	,	PUNCT
cajgh-313	171	6	2019	2019	NUM
cajgh-313	171	7	18	18	NUM
cajgh-313	171	8	.	.	PUNCT
cajgh-313	172	1	national	national	ADJ
cajgh-313	172	2	health	health	PROPN
cajgh-313	172	3	and	and	CCONJ
cajgh-313	172	4	nutrition	nutrition	NOUN
cajgh-313	172	5	examination	examination	NOUN
cajgh-313	172	6	survey	survey	NOUN
cajgh-313	172	7	(	(	PUNCT
cajgh-313	172	8	nhanes	nhanes	PROPN
cajgh-313	172	9	)	)	PUNCT
cajgh-313	172	10	iii	iii	PROPN
cajgh-313	172	11	.	.	PUNCT
cajgh-313	173	1	https://wwwn.cdc.gov/nchs/nhanes/20072008/biopro_e.htm	https://wwwn.cdc.gov/nchs/nhanes/20072008/biopro_e.htm	X
cajgh-313	173	2	.	.	PROPN
cajgh-313	173	3	accessed	access	VERB
cajgh-313	173	4	on	on	ADP
cajgh-313	173	5	march	march	PROPN
cajgh-313	173	6	29	29	NUM
cajgh-313	173	7	,	,	PUNCT
cajgh-313	173	8	2019	2019	NUM
cajgh-313	173	9	19	19	NUM
cajgh-313	173	10	.	.	PUNCT
cajgh-313	174	1	jamil	jamil	PROPN
cajgh-313	174	2	m	m	PROPN
cajgh-313	174	3	,	,	PUNCT
cajgh-313	174	4	bhattacharya	bhattacharya	PROPN
cajgh-313	174	5	pk	pk	PROPN
cajgh-313	174	6	,	,	PUNCT
cajgh-313	174	7	yunus	yunus	PROPN
cajgh-313	174	8	m	m	PROPN
cajgh-313	174	9	,	,	PUNCT
cajgh-313	174	10	lyngdoh	lyngdoh	PROPN
cajgh-313	174	11	cj	cj	PROPN
cajgh-313	174	12	,	,	PUNCT
cajgh-313	174	13	roy	roy	PROPN
cajgh-313	174	14	a	a	PRON
cajgh-313	174	15	,	,	PUNCT
cajgh-313	174	16	talukdar	talukdar	NOUN
cajgh-313	174	17	kk	kk	PROPN
cajgh-313	174	18	.	.	PROPN
cajgh-313	174	19	prevalence	prevalence	NOUN
cajgh-313	174	20	of	of	ADP
cajgh-313	174	21	hepatitis	hepatitis	PROPN
cajgh-313	174	22	b	b	PROPN
cajgh-313	174	23	and	and	CCONJ
cajgh-313	174	24	hepatitis	hepatitis	PROPN
cajgh-313	174	25	c	c	PROPN
cajgh-313	174	26	in	in	ADP
cajgh-313	174	27	haemodialysis	haemodialysis	NOUN
cajgh-313	174	28	population	population	NOUN
cajgh-313	174	29	in	in	ADP
cajgh-313	174	30	atertiary	atertiary	PROPN
cajgh-313	174	31	care	care	NOUN
cajgh-313	174	32	centre	centre	NOUN
cajgh-313	174	33	in	in	ADP
cajgh-313	174	34	north	north	PROPN
cajgh-313	174	35	eastern	eastern	PROPN
cajgh-313	174	36	india	india	PROPN
cajgh-313	174	37	.	.	PUNCT
cajgh-313	175	1	international	international	ADJ
cajgh-313	175	2	journal	journal	PROPN
cajgh-313	175	3	of	of	ADP
cajgh-313	175	4	biomedical	biomedical	ADJ
cajgh-313	175	5	and	and	CCONJ
cajgh-313	175	6	advance	advance	NOUN
cajgh-313	175	7	research	research	NOUN
cajgh-313	175	8	2016;7(6	2016;7(6	NUM
cajgh-313	175	9	):	):	PUNCT
cajgh-313	175	10	267	267	NUM
cajgh-313	175	11	-	-	SYM
cajgh-313	175	12	269	269	NUM
cajgh-313	175	13	.	.	NOUN
cajgh-313	175	14	20	20	NUM
cajgh-313	175	15	.	.	PUNCT
cajgh-313	176	1	tesfa	tesfa	NOUN
cajgh-313	176	2	h	h	PROPN
cajgh-313	176	3	,	,	PUNCT
cajgh-313	176	4	biadgo	biadgo	NOUN
cajgh-313	176	5	b	b	NOUN
cajgh-313	176	6	,	,	PUNCT
cajgh-313	176	7	getachew	getachew	VERB
cajgh-313	176	8	f	f	NUM
cajgh-313	176	9	,	,	PUNCT
cajgh-313	176	10	tegegne	tegegne	PROPN
cajgh-313	176	11	k	k	NOUN
cajgh-313	176	12	,	,	PUNCT
cajgh-313	176	13	yismaw	yismaw	NOUN
cajgh-313	176	14	g	g	PROPN
cajgh-313	176	15	and	and	CCONJ
cajgh-313	176	16	muluye	muluye	PROPN
cajgh-313	176	17	d.	d.	PROPN
cajgh-313	176	18	seroprevalence	seroprevalence	NOUN
cajgh-313	176	19	of	of	ADP
cajgh-313	176	20	hepatitis	hepatitis	PROPN
cajgh-313	176	21	b	b	PROPN
cajgh-313	176	22	and	and	CCONJ
cajgh-313	176	23	c	c	PROPN
cajgh-313	176	24	virus	virus	NOUN
cajgh-313	176	25	infection	infection	NOUN
cajgh-313	176	26	among	among	ADP
cajgh-313	176	27	patients	patient	NOUN
cajgh-313	176	28	attending	attend	VERB
cajgh-313	176	29	serology	serology	NOUN
cajgh-313	176	30	laboratory	laboratory	NOUN
cajgh-313	176	31	of	of	ADP
cajgh-313	176	32	gondar	gondar	PROPN
cajgh-313	176	33	university	university	NOUN
cajgh-313	176	34	hospital	hospital	NOUN
cajgh-313	176	35	.	.	PUNCT
cajgh-313	177	1	bmc	bmc	PROPN
cajgh-313	177	2	research	research	NOUN
cajgh-313	177	3	notes	note	NOUN
cajgh-313	177	4	2013	2013	NUM
cajgh-313	177	5	,	,	PUNCT
cajgh-313	177	6	6:164	6:164	NOUN
cajgh-313	177	7	.	.	PUNCT
cajgh-313	178	1	21	21	NUM
cajgh-313	178	2	.	.	PUNCT
cajgh-313	178	3	ray	ray	PROPN
cajgh-313	178	4	saraswati	saraswati	PROPN
cajgh-313	178	5	l	l	PROPN
cajgh-313	178	6	,	,	PUNCT
cajgh-313	178	7	sarna	sarna	PROPN
cajgh-313	178	8	a	a	PRON
cajgh-313	178	9	,	,	PUNCT
cajgh-313	178	10	sebastian	sebastian	PROPN
cajgh-313	178	11	mp	mp	PROPN
cajgh-313	178	12	,	,	PUNCT
cajgh-313	178	13	et	et	PROPN
cajgh-313	178	14	al	al	PROPN
cajgh-313	178	15	.	.	PUNCT
cajgh-313	179	1	hiv	hiv	PROPN
cajgh-313	179	2	,	,	PUNCT
cajgh-313	179	3	hepatitis	hepatitis	PROPN
cajgh-313	179	4	b	b	PROPN
cajgh-313	179	5	and	and	CCONJ
cajgh-313	179	6	c	c	PROPN
cajgh-313	179	7	among	among	ADP
cajgh-313	179	8	people	people	NOUN
cajgh-313	179	9	who	who	PRON
cajgh-313	179	10	inject	inject	VERB
cajgh-313	179	11	drugs	drug	NOUN
cajgh-313	179	12	:	:	PUNCT
cajgh-313	179	13	high	high	ADJ
cajgh-313	179	14	prevalence	prevalence	NOUN
cajgh-313	179	15	of	of	ADP
cajgh-313	179	16	hiv	hiv	PROPN
cajgh-313	179	17	and	and	CCONJ
cajgh-313	179	18	hepatitis	hepatitis	PROPN
cajgh-313	179	19	c	c	PROPN
cajgh-313	180	1	rna	rna	PROPN
cajgh-313	180	2	positive	positive	ADJ
cajgh-313	180	3	infections	infection	NOUN
cajgh-313	180	4	observed	observe	VERB
cajgh-313	180	5	in	in	ADP
cajgh-313	180	6	delhi	delhi	PROPN
cajgh-313	180	7	,	,	PUNCT
cajgh-313	180	8	india	india	PROPN
cajgh-313	180	9	.	.	PUNCT
cajgh-313	181	1	bmc	bmc	PROPN
cajgh-313	181	2	public	public	ADJ
cajgh-313	181	3	health	health	NOUN
cajgh-313	181	4	.	.	PUNCT
cajgh-313	182	1	2015;15:726	2015;15:726	X
cajgh-313	182	2	.	.	NOUN
cajgh-313	182	3	22	22	NUM
cajgh-313	182	4	.	.	PUNCT
cajgh-313	183	1	arora	arora	PROPN
cajgh-313	183	2	u	u	PROPN
cajgh-313	183	3	and	and	CCONJ
cajgh-313	183	4	mann	mann	PROPN
cajgh-313	183	5	a.	a.	NOUN
cajgh-313	183	6	prevalence	prevalence	NOUN
cajgh-313	183	7	of	of	ADP
cajgh-313	183	8	hepatitis	hepatitis	PROPN
cajgh-313	183	9	b	b	PROPN
cajgh-313	183	10	virus	virus	NOUN
cajgh-313	183	11	,	,	PUNCT
cajgh-313	183	12	hepatitis	hepatitis	PROPN
cajgh-313	183	13	c	c	PROPN
cajgh-313	183	14	virus	virus	NOUN
cajgh-313	183	15	,	,	PUNCT
cajgh-313	183	16	and	and	CCONJ
cajgh-313	183	17	hiv	hiv	PROPN
cajgh-313	183	18	in	in	ADP
cajgh-313	183	19	patients	patient	NOUN
cajgh-313	183	20	of	of	ADP
cajgh-313	183	21	chronic	chronic	ADJ
cajgh-313	183	22	liver	liver	NOUN
cajgh-313	183	23	disease	disease	NOUN
cajgh-313	183	24	in	in	ADP
cajgh-313	183	25	amritsar	amritsar	PROPN
cajgh-313	183	26	.	.	PUNCT
cajgh-313	184	1	jiacm	jiacm	PROPN
cajgh-313	184	2	2007	2007	NUM
cajgh-313	184	3	;	;	PUNCT
cajgh-313	184	4	8(1	8(1	NOUN
cajgh-313	184	5	):	):	PUNCT
cajgh-313	184	6	29	29	NUM
cajgh-313	184	7	-	-	SYM
cajgh-313	184	8	3	3	NUM
cajgh-313	184	9	.	.	NOUN
cajgh-313	184	10	23	23	NUM
cajgh-313	184	11	.	.	PUNCT
cajgh-313	185	1	chowdhury	chowdhury	PROPN
cajgh-313	185	2	a	a	PRON
cajgh-313	185	3	,	,	PUNCT
cajgh-313	185	4	santra	santra	PROPN
cajgh-313	185	5	a	a	X
cajgh-313	185	6	,	,	PUNCT
cajgh-313	185	7	chaudhuri	chaudhuri	PROPN
cajgh-313	185	8	s	s	PROPN
cajgh-313	185	9	,	,	PUNCT
cajgh-313	185	10	ghosh	ghosh	PROPN
cajgh-313	185	11	a	a	PROPN
cajgh-313	185	12	,	,	PUNCT
cajgh-313	185	13	banerjee	banerjee	PROPN
cajgh-313	185	14	p	p	NOUN
cajgh-313	185	15	,	,	PUNCT
cajgh-313	185	16	mazumder	mazumder	NOUN
cajgh-313	185	17	dn	dn	PROPN
cajgh-313	185	18	.	.	PUNCT
cajgh-313	186	1	prevalence	prevalence	NOUN
cajgh-313	186	2	of	of	ADP
cajgh-313	186	3	hepatitis	hepatitis	PROPN
cajgh-313	186	4	b	b	PROPN
cajgh-313	186	5	infection	infection	NOUN
cajgh-313	186	6	in	in	ADP
cajgh-313	186	7	the	the	DET
cajgh-313	186	8	general	general	ADJ
cajgh-313	186	9	population	population	NOUN
cajgh-313	186	10	:	:	PUNCT
cajgh-313	186	11	a	a	DET
cajgh-313	186	12	rural	rural	ADJ
cajgh-313	186	13	community	community	NOUN
cajgh-313	186	14	based	base	VERB
cajgh-313	186	15	study	study	NOUN
cajgh-313	186	16	.	.	PUNCT
cajgh-313	187	1	trop	trop	X
cajgh-313	187	2	gastroenterol	gastroenterol	PROPN
cajgh-313	187	3	.	.	PUNCT
cajgh-313	188	1	1999	1999	NUM
cajgh-313	188	2	apr	apr	PROPN
cajgh-313	188	3	-	-	PUNCT
cajgh-313	188	4	jun;20(2):75	jun;20(2):75	PROPN
cajgh-313	188	5	-	-	PUNCT
cajgh-313	188	6	7	7	NUM
cajgh-313	188	7	.	.	NUM
cajgh-313	188	8	24	24	NUM
cajgh-313	188	9	.	.	PUNCT
cajgh-313	188	10	anbazhagan	anbazhagan	PROPN
cajgh-313	188	11	gk	gk	PROPN
cajgh-313	188	12	,	,	PUNCT
cajgh-313	188	13	ks	ks	NOUN
cajgh-313	188	14	,	,	PUNCT
cajgh-313	188	15	and	and	CCONJ
cajgh-313	188	16	thiyagarajan	thiyagarajan	PROPN
cajgh-313	188	17	t	t	PROPN
cajgh-313	188	18	seroprevalence	seroprevalence	NOUN
cajgh-313	188	19	of	of	ADP
cajgh-313	188	20	hcv	hcv	PROPN
cajgh-313	188	21	and	and	CCONJ
cajgh-313	188	22	its	its	PRON
cajgh-313	188	23	co	co	NOUN
cajgh-313	188	24	-	-	NOUN
cajgh-313	188	25	infection	infection	NOUN
cajgh-313	188	26	with	with	ADP
cajgh-313	188	27	hbv	hbv	NOUN
cajgh-313	188	28	and	and	CCONJ
cajgh-313	188	29	hiv	hiv	PROPN
cajgh-313	188	30	among	among	ADP
cajgh-313	188	31	liver	liver	NOUN
cajgh-313	188	32	disease	disease	NOUN
cajgh-313	188	33	patients	patient	NOUN
cajgh-313	188	34	of	of	ADP
cajgh-313	188	35	south	south	PROPN
cajgh-313	188	36	tamil	tamil	PROPN
cajgh-313	188	37	nadu	nadu	PROPN
cajgh-313	188	38	.	.	PUNCT
cajgh-313	189	1	world	world	PROPN
cajgh-313	189	2	j	j	PROPN
cajgh-313	189	3	hepatol	hepatol	ADJ
cajgh-313	189	4	.	.	PUNCT
cajgh-313	190	1	2010	2010	NUM
cajgh-313	190	2	jan	jan	NOUN
cajgh-313	190	3	27	27	NUM
cajgh-313	190	4	;	;	PUNCT
cajgh-313	190	5	2(1	2(1	NUM
cajgh-313	190	6	):	):	PUNCT
cajgh-313	190	7	42–48	42–48	PROPN
cajgh-313	190	8	.	.	PUNCT
cajgh-313	191	1	25	25	NUM
cajgh-313	191	2	.	.	PUNCT
cajgh-313	192	1	halim	halim	PROPN
cajgh-313	192	2	m.d	m.d	PROPN
cajgh-313	192	3	,	,	PUNCT
cajgh-313	192	4	offor	offor	ADP
cajgh-313	192	5	e	e	NOUN
cajgh-313	192	6	,	,	PUNCT
cajgh-313	192	7	ajayi	ajayi	NOUN
cajgh-313	192	8	o.i	o.i	NOUN
cajgh-313	192	9	(	(	PUNCT
cajgh-313	192	10	1992	1992	NUM
cajgh-313	192	11	)	)	PUNCT
cajgh-313	192	12	.	.	PUNCT
cajgh-313	193	1	epidemiologic	epidemiologic	ADJ
cajgh-313	193	2	study	study	NOUN
cajgh-313	193	3	of	of	ADP
cajgh-313	193	4	the	the	DET
cajgh-313	193	5	seroprevalence	seroprevalence	NOUN
cajgh-313	193	6	of	of	ADP
cajgh-313	193	7	hepatitis	hepatitis	PROPN
cajgh-313	193	8	b	b	PROPN
cajgh-313	193	9	surface	surface	NOUN
cajgh-313	193	10	antigen	antigen	NOUN
cajgh-313	193	11	and	and	CCONJ
cajgh-313	193	12	hiv-1	hiv-1	PUNCT
cajgh-313	193	13	in	in	ADP
cajgh-313	193	14	blood	blood	NOUN
cajgh-313	193	15	donors	donor	NOUN
cajgh-313	193	16	.	.	PUNCT
cajgh-313	194	1	niger	niger	PROPN
cajgh-313	194	2	.	.	PUNCT
cajgh-313	195	1	j.	j.	PROPN
cajgh-313	195	2	clin	clin	PROPN
cajgh-313	195	3	.	.	PUNCT
cajgh-313	196	1	pract	pract	PROPN
cajgh-313	196	2	.	.	PUNCT
cajgh-313	197	1	:	:	PUNCT
cajgh-313	197	2	2	2	NUM
cajgh-313	197	3	;	;	PUNCT
cajgh-313	197	4	45	45	NUM
cajgh-313	197	5	-	-	SYM
cajgh-313	197	6	55	55	NUM
cajgh-313	197	7	.	.	PUNCT
cajgh-313	198	1	26	26	NUM
cajgh-313	198	2	.	.	PUNCT
cajgh-313	199	1	wondimeneh	wondimeneh	PROPN
cajgh-313	200	1	y	y	PROPN
cajgh-313	200	2	,	,	PUNCT
cajgh-313	200	3	alem	alem	PROPN
cajgh-313	200	4	m	m	PROPN
cajgh-313	200	5	,	,	PUNCT
cajgh-313	200	6	asfaw	asfaw	PROPN
cajgh-313	200	7	f	f	PROPN
cajgh-313	200	8	,	,	PUNCT
cajgh-313	200	9	belyhun	belyhun	PROPN
cajgh-313	200	10	y.	y.	PROPN
cajgh-313	200	11	hbv	hbv	PROPN
cajgh-313	200	12	and	and	CCONJ
cajgh-313	200	13	hcv	hcv	X
cajgh-313	200	14	seroprevalence	seroprevalence	NOUN
cajgh-313	200	15	and	and	CCONJ
cajgh-313	200	16	their	their	PRON
cajgh-313	200	17	correlation	correlation	NOUN
cajgh-313	200	18	with	with	ADP
cajgh-313	200	19	cd4	cd4	PROPN
cajgh-313	200	20	cells	cell	NOUN
cajgh-313	200	21	and	and	CCONJ
cajgh-313	200	22	liver	liver	NOUN
cajgh-313	200	23	enzymes	enzyme	NOUN
cajgh-313	200	24	among	among	ADP
cajgh-313	200	25	hiv	hiv	PROPN
cajgh-313	200	26	positive	positive	ADJ
cajgh-313	200	27	individuals	individual	NOUN
cajgh-313	200	28	at	at	ADP
cajgh-313	200	29	university	university	NOUN
cajgh-313	200	30	of	of	ADP
cajgh-313	200	31	gondar	gondar	PROPN
cajgh-313	200	32	teaching	teaching	NOUN
cajgh-313	200	33	hospital	hospital	NOUN
cajgh-313	200	34	,	,	PUNCT
cajgh-313	200	35	northwest	northwest	PROPN
cajgh-313	200	36	ethiopia	ethiopia	PROPN
cajgh-313	200	37	.	.	PUNCT
cajgh-313	201	1	virology	virology	NOUN
cajgh-313	201	2	journal	journal	NOUN
cajgh-313	201	3	.	.	PUNCT
cajgh-313	202	1	2013;10:171	2013;10:171	X
cajgh-313	202	2	.	.	PUNCT
cajgh-313	203	1	27	27	NUM
cajgh-313	203	2	.	.	X
cajgh-313	203	3	khuntep	khuntep	PROPN
cajgh-313	203	4	,	,	PUNCT
cajgh-313	203	5	khare	khare	PROPN
cajgh-313	203	6	rl	rl	PROPN
cajgh-313	203	7	,	,	PUNCT
cajgh-313	203	8	beck	beck	PROPN
cajgh-313	203	9	p	p	PROPN
cajgh-313	203	10	,	,	PUNCT
cajgh-313	203	11	kumar	kumar	PROPN
cajgh-313	203	12	s.	s.	PROPN
cajgh-313	203	13	prevalence	prevalence	NOUN
cajgh-313	203	14	of	of	ADP
cajgh-313	203	15	hepatitis	hepatitis	PROPN
cajgh-313	203	16	b	b	PROPN
cajgh-313	203	17	virus	virus	NOUN
cajgh-313	203	18	and	and	CCONJ
cajgh-313	203	19	hepatitis	hepatitis	PROPN
cajgh-313	203	20	c	c	PROPN
cajgh-313	203	21	virus	virus	PROPN
cajgh-313	203	22	co	co	NOUN
cajgh-313	203	23	-	-	NOUN
cajgh-313	203	24	infection	infection	NOUN
cajgh-313	203	25	in	in	ADP
cajgh-313	203	26	human	human	ADJ
cajgh-313	203	27	immunodeficiency	immunodeficiency	NOUN
cajgh-313	203	28	virus	virus	NOUN
cajgh-313	203	29	positive	positive	ADJ
cajgh-313	203	30	patients	patient	NOUN
cajgh-313	203	31	:	:	PUNCT
cajgh-313	203	32	a	a	DET
cajgh-313	203	33	study	study	NOUN
cajgh-313	203	34	from	from	ADP
cajgh-313	203	35	tribal	tribal	ADJ
cajgh-313	203	36	area	area	NOUN
cajgh-313	203	37	of	of	ADP
cajgh-313	203	38	central	central	PROPN
cajgh-313	203	39	india	india	PROPN
cajgh-313	203	40	.	.	PUNCT
cajgh-313	204	1	int	int	PROPN
cajgh-313	204	2	j	j	PROPN
cajgh-313	204	3	res	res	PROPN
cajgh-313	204	4	med	med	PROPN
cajgh-313	204	5	sci	sci	PROPN
cajgh-313	204	6	.	.	PROPN
cajgh-313	204	7	2015	2015	NUM
cajgh-313	204	8	sep;3(9):2311	sep;3(9):2311	NOUN
cajgh-313	204	9	-	-	PUNCT
cajgh-313	204	10	2315	2315	NUM
cajgh-313	204	11	.	.	PUNCT
cajgh-313	205	1	28	28	NUM
cajgh-313	205	2	.	.	PUNCT
cajgh-313	205	3	ionita	ionita	VERB
cajgh-313	205	4	g	g	PROPN
cajgh-313	205	5	,	,	PUNCT
cajgh-313	205	6	malviya	malviya	PROPN
cajgh-313	205	7	a	a	PROPN
cajgh-313	205	8	,	,	PUNCT
cajgh-313	205	9	rajbhandaricr	rajbhandaricr	PROPN
cajgh-313	205	10	,	,	PUNCT
cajgh-313	205	11	william	william	PROPN
cajgh-313	205	12	w	w	PROPN
cajgh-313	205	13	,	,	PUNCT
cajgh-313	205	14	schluter	schluter	PROPN
cajgh-313	205	15	g	g	PROPN
cajgh-313	205	16	,	,	PUNCT
cajgh-313	205	17	sharmae	sharmae	PROPN
cajgh-313	205	18	s	s	PROPN
cajgh-313	205	19	,	,	PUNCT
cajgh-313	205	20	kakchapatic	kakchapatic	PROPN
cajgh-313	205	21	s.	s.	PROPN
cajgh-313	205	22	rijalf	rijalf	PROPN
cajgh-313	205	23	s	s	PROPN
cajgh-313	205	24	,	,	PUNCT
cajgh-313	205	25	dixit	dixit	PROPN
cajgh-313	205	26	s.	s.	PROPN
cajgh-313	205	27	seroprevalence	seroprevalence	NOUN
cajgh-313	205	28	of	of	ADP
cajgh-313	205	29	hepatitis	hepatitis	PROPN
cajgh-313	205	30	b	b	PROPN
cajgh-313	205	31	virus	virus	NOUN
cajgh-313	205	32	and	and	CCONJ
cajgh-313	205	33	hepatitis	hepatitis	PROPN
cajgh-313	205	34	c	c	PROPN
cajgh-313	205	35	virus	virus	PROPN
cajgh-313	205	36	co	co	NOUN
cajgh-313	205	37	-	-	NOUN
cajgh-313	205	38	infection	infection	NOUN
cajgh-313	205	39	among	among	ADP
cajgh-313	205	40	people	people	NOUN
cajgh-313	205	41	living	live	VERB
cajgh-313	205	42	with	with	ADP
cajgh-313	205	43	hiv	hiv	PROPN
cajgh-313	205	44	/	/	SYM
cajgh-313	205	45	aids	aids	PROPN
cajgh-313	205	46	visiting	visit	VERB
cajgh-313	205	47	antiretroviral	antiretroviral	ADJ
cajgh-313	205	48	therapy	therapy	NOUN
cajgh-313	205	49	centres	centre	NOUN
cajgh-313	205	50	in	in	ADP
cajgh-313	205	51	nepal	nepal	ADJ
cajgh-313	205	52	:	:	PUNCT
cajgh-313	205	53	a	a	DET
cajgh-313	205	54	first	first	ADJ
cajgh-313	205	55	nationally	nationally	ADV
cajgh-313	205	56	representative	representative	ADJ
cajgh-313	205	57	study	study	NOUN
cajgh-313	205	58	.	.	PUNCT
cajgh-313	206	1	international	international	ADJ
cajgh-313	206	2	journal	journal	NOUN
cajgh-313	206	3	of	of	ADP
cajgh-313	206	4	infectious	infectious	ADJ
cajgh-313	206	5	diseases	disease	NOUN
cajgh-313	206	6	.	.	PUNCT
cajgh-313	207	1	2017,60:64	2017,60:64	NUM
cajgh-313	207	2	-	-	SYM
cajgh-313	207	3	69	69	NUM
cajgh-313	207	4	.	.	PUNCT
cajgh-313	208	1	http://www.library.pitt.edu/	http://www.library.pitt.edu/	PROPN
cajgh-313	208	2	http://www.pitt.edu/	http://www.pitt.edu/	NOUN
cajgh-313	208	3	http://www.library.pitt.edu/articles/digpubtype/index.html	http://www.library.pitt.edu/articles/digpubtype/index.html	PUNCT
cajgh-313	209	1	http://www.upress.pitt.edu/upressindex.aspx	http://www.upress.pitt.edu/upressindex.aspx	PRON
cajgh-313	209	2	http://www.openepi.com/	http://www.openepi.com/	NOUN
cajgh-313	209	3	https://wwwn.cdc.gov/nchs/nhanes/2007-2008/biopro_e.htm	https://wwwn.cdc.gov/nchs/nhanes/2007-2008/biopro_e.htm	PRON
cajgh-313	209	4	https://wwwn.cdc.gov/nchs/nhanes/2007-2008/biopro_e.htm	https://wwwn.cdc.gov/nchs/nhanes/2007-2008/biopro_e.htm	PRON
cajgh-313	209	5	central	central	ADJ
cajgh-313	209	6	asian	asian	ADJ
cajgh-313	209	7	journal	journal	NOUN
cajgh-313	209	8	of	of	ADP
cajgh-313	209	9	global	global	ADJ
cajgh-313	209	10	health	health	NOUN
cajgh-313	209	11	this	this	DET
cajgh-313	209	12	work	work	NOUN
cajgh-313	209	13	is	be	AUX
cajgh-313	209	14	licensed	license	VERB
cajgh-313	209	15	under	under	ADP
cajgh-313	209	16	a	a	DET
cajgh-313	209	17	creative	creative	ADJ
cajgh-313	209	18	commons	common	NOUN
cajgh-313	209	19	attribution	attribution	NOUN
cajgh-313	209	20	4.0	4.0	NUM
cajgh-313	209	21	united	unite	VERB
cajgh-313	209	22	states	states	PROPN
cajgh-313	209	23	license	license	NOUN
cajgh-313	209	24	.	.	PUNCT
cajgh-313	210	1	this	this	DET
cajgh-313	210	2	journal	journal	NOUN
cajgh-313	210	3	is	be	AUX
cajgh-313	210	4	published	publish	VERB
cajgh-313	210	5	by	by	ADP
cajgh-313	210	6	theuniversity	theuniversity	NOUN
cajgh-313	210	7	library	library	NOUN
cajgh-313	210	8	system	system	NOUN
cajgh-313	210	9	of	of	ADP
cajgh-313	210	10	the	the	DET
cajgh-313	210	11	university	university	PROPN
cajgh-313	210	12	of	of	ADP
cajgh-313	210	13	pittsburgh	pittsburgh	PROPN
cajgh-313	210	14	as	as	ADP
cajgh-313	210	15	part	part	NOUN
cajgh-313	210	16	of	of	ADP
cajgh-313	210	17	its	its	PRON
cajgh-313	210	18	d	d	NOUN
cajgh-313	210	19	-	-	PUNCT
cajgh-313	210	20	scribe	scribe	VERB
cajgh-313	210	21	digital	digital	ADJ
cajgh-313	210	22	publishing	publishing	NOUN
cajgh-313	210	23	program	program	NOUN
cajgh-313	210	24	and	and	CCONJ
cajgh-313	210	25	is	be	AUX
cajgh-313	210	26	cosponsored	cosponsor	VERB
cajgh-313	210	27	by	by	ADP
cajgh-313	210	28	the	the	DET
cajgh-313	210	29	university	university	PROPN
cajgh-313	210	30	of	of	ADP
cajgh-313	210	31	pittsburgh	pittsburgh	PROPN
cajgh-313	210	32	press	press	NOUN
cajgh-313	210	33	.	.	PUNCT
cajgh-313	211	1	central	central	ADJ
cajgh-313	211	2	asian	asian	ADJ
cajgh-313	211	3	journal	journal	NOUN
cajgh-313	211	4	of	of	ADP
cajgh-313	211	5	global	global	ADJ
cajgh-313	211	6	health	health	NOUN
cajgh-313	211	7	volume	volume	NOUN
cajgh-313	211	8	8	8	NUM
cajgh-313	211	9	,	,	PUNCT
cajgh-313	211	10	no	no	INTJ
cajgh-313	211	11	.	.	NOUN
cajgh-313	211	12	1	1	NUM
cajgh-313	211	13	(	(	PUNCT
cajgh-313	211	14	2019	2019	NUM
cajgh-313	211	15	)	)	PUNCT
cajgh-313	211	16	|	|	ADV
cajgh-313	211	17	issn	issn	VERB
cajgh-313	211	18	2166	2166	NUM
cajgh-313	211	19	-	-	SYM
cajgh-313	211	20	7403	7403	NUM
cajgh-313	211	21	(	(	PUNCT
cajgh-313	211	22	online	online	ADJ
cajgh-313	211	23	)	)	PUNCT
cajgh-313	211	24	|	|	ADV
cajgh-313	211	25	doi	doi	X
cajgh-313	211	26	10.5195	10.5195	NUM
cajgh-313	211	27	/	/	SYM
cajgh-313	211	28	cajgh.2019.313|http://cajgh.pitt.edu	cajgh.2019.313|http://cajgh.pitt.edu	NOUN
cajgh-313	211	29	29	29	NUM
cajgh-313	211	30	.	.	PUNCT
cajgh-313	212	1	hann	hann	PROPN
cajgh-313	212	2	h	h	PROPN
cajgh-313	212	3	-	-	PUNCT
cajgh-313	212	4	w	w	PROPN
cajgh-313	212	5	,	,	PUNCT
cajgh-313	212	6	wan	wan	PROPN
cajgh-313	212	7	s	s	PROPN
cajgh-313	212	8	,	,	PUNCT
cajgh-313	212	9	myers	myers	PROPN
cajgh-313	212	10	re	re	PROPN
cajgh-313	212	11	,	,	PUNCT
cajgh-313	212	12	et	et	PROPN
cajgh-313	212	13	al	al	PROPN
cajgh-313	212	14	.	.	PROPN
cajgh-313	212	15	comprehensive	comprehensive	ADJ
cajgh-313	212	16	analysis	analysis	NOUN
cajgh-313	212	17	of	of	ADP
cajgh-313	212	18	common	common	ADJ
cajgh-313	212	19	serum	serum	NOUN
cajgh-313	212	20	liver	liver	NOUN
cajgh-313	212	21	enzymes	enzyme	NOUN
cajgh-313	212	22	as	as	ADP
cajgh-313	212	23	prospective	prospective	ADJ
cajgh-313	212	24	predictors	predictor	NOUN
cajgh-313	212	25	of	of	ADP
cajgh-313	212	26	hepatocellular	hepatocellular	ADJ
cajgh-313	212	27	carcinoma	carcinoma	NOUN
cajgh-313	212	28	in	in	ADP
cajgh-313	212	29	hbv	hbv	NOUN
cajgh-313	212	30	patients	patient	NOUN
cajgh-313	212	31	.	.	PUNCT
cajgh-313	213	1	camerondw	camerondw	NOUN
cajgh-313	213	2	,	,	PUNCT
cajgh-313	213	3	ed	ed	PROPN
cajgh-313	213	4	.	.	PUNCT
cajgh-313	214	1	plos	plos	PROPN
cajgh-313	214	2	one	one	NUM
cajgh-313	214	3	.	.	PUNCT
cajgh-313	215	1	2012;7(10):e47687	2012;7(10):e47687	NOUN
cajgh-313	215	2	.	.	PUNCT
cajgh-313	216	1	30	30	NUM
cajgh-313	216	2	.	.	PUNCT
cajgh-313	217	1	el	el	NOUN
cajgh-313	217	2	-	-	PUNCT
cajgh-313	217	3	bouzedi	bouzedi	PROPN
cajgh-313	217	4	a.	a.	NOUN
cajgh-313	217	5	investigation	investigation	NOUN
cajgh-313	217	6	and	and	CCONJ
cajgh-313	217	7	modeling	model	VERB
cajgh-313	217	8	the	the	DET
cajgh-313	217	9	epidemiology	epidemiology	NOUN
cajgh-313	217	10	of	of	ADP
cajgh-313	217	11	hepatitis	hepatitis	PROPN
cajgh-313	217	12	c	c	PROPN
cajgh-313	217	13	virus	virus	NOUN
cajgh-313	217	14	in	in	ADP
cajgh-313	217	15	libya	libya	PROPN
cajgh-313	217	16	,	,	PUNCT
cajgh-313	217	17	phd	phd	NOUN
cajgh-313	217	18	thesis	thesis	NOUN
cajgh-313	217	19	.	.	PUNCT
cajgh-313	218	1	united	united	PROPN
cajgh-313	218	2	kingdom	kingdom	PROPN
cajgh-313	218	3	:	:	PUNCT
cajgh-313	218	4	university	university	NOUN
cajgh-313	218	5	of	of	ADP
cajgh-313	218	6	glamorgan	glamorgan	NOUN
cajgh-313	218	7	,	,	PUNCT
cajgh-313	218	8	faculty	faculty	NOUN
cajgh-313	218	9	of	of	ADP
cajgh-313	218	10	advanced	advanced	ADJ
cajgh-313	218	11	technology	technology	NOUN
cajgh-313	218	12	;	;	PUNCT
cajgh-313	218	13	2012	2012	NUM
cajgh-313	218	14	.	.	PUNCT
cajgh-313	219	1	http://www.library.pitt.edu/	http://www.library.pitt.edu/	PROPN
cajgh-313	219	2	http://www.pitt.edu/	http://www.pitt.edu/	NOUN
cajgh-313	219	3	http://www.library.pitt.edu/articles/digpubtype/index.html	http://www.library.pitt.edu/articles/digpubtype/index.html	X
cajgh-313	219	4	http://www.upress.pitt.edu/upressindex.aspx	http://www.upress.pitt.edu/upressindex.aspx	NUM
cajgh-313	219	5	sero	sero	NOUN
cajgh-313	219	6	-	-	PUNCT
cajgh-313	219	7	occurrence	occurrence	NOUN
cajgh-313	219	8	of	of	ADP
cajgh-313	219	9	hbv	hbv	NOUN
cajgh-313	219	10	/	/	SYM
cajgh-313	219	11	hcv	hcv	X
cajgh-313	219	12	co	co	NOUN
cajgh-313	219	13	-	-	NOUN
cajgh-313	219	14	infection	infection	NOUN
cajgh-313	219	15	and	and	CCONJ
cajgh-313	219	16	levels	level	NOUN
cajgh-313	219	17	of	of	ADP
cajgh-313	219	18	liver	liver	NOUN
cajgh-313	219	19	enzymes	enzyme	NOUN
cajgh-313	219	20	among	among	ADP
cajgh-313	219	21	patients	patient	NOUN
cajgh-313	219	22	at	at	ADP
cajgh-313	219	23	a	a	DET
cajgh-313	219	24	tertiary	tertiary	ADJ
cajgh-313	219	25	care	care	NOUN
cajgh-313	219	26	hospital	hospital	NOUN
cajgh-313	219	27	in	in	ADP
cajgh-313	219	28	central	central	ADJ
cajgh-313	219	29	india	india	PROPN
cajgh-313	219	30	:	:	PUNCT
cajgh-313	219	31	a	a	DET
cajgh-313	219	32	pilot	pilot	NOUN
cajgh-313	219	33	study	study	NOUN
cajgh-313	219	34	abstract	abstract	ADJ
cajgh-313	219	35	keywords	keyword	NOUN
cajgh-313	219	36	:	:	PUNCT
cajgh-313	219	37	hepatitis	hepatitis	PROPN
cajgh-313	219	38	b	b	PROPN
cajgh-313	219	39	;	;	PUNCT
cajgh-313	219	40	hepatitis	hepatitis	NOUN
cajgh-313	219	41	c	c	NOUN
cajgh-313	219	42	;	;	PUNCT
cajgh-313	219	43	co	co	NOUN
cajgh-313	219	44	-	-	NOUN
cajgh-313	219	45	infection	infection	NOUN
cajgh-313	219	46	;	;	PUNCT
cajgh-313	219	47	india	india	PROPN
cajgh-313	219	48	sero	sero	NOUN
cajgh-313	219	49	-	-	PUNCT
cajgh-313	219	50	occurrence	occurrence	NOUN
cajgh-313	219	51	of	of	ADP
cajgh-313	219	52	hbv	hbv	NOUN
cajgh-313	219	53	/	/	SYM
cajgh-313	219	54	hcv	hcv	X
cajgh-313	219	55	co	co	NOUN
cajgh-313	219	56	-	-	NOUN
cajgh-313	219	57	infection	infection	NOUN
cajgh-313	219	58	and	and	CCONJ
cajgh-313	219	59	levels	level	NOUN
cajgh-313	219	60	of	of	ADP
cajgh-313	219	61	liver	liver	NOUN
cajgh-313	219	62	enzymes	enzyme	NOUN
cajgh-313	219	63	among	among	ADP
cajgh-313	219	64	patients	patient	NOUN
cajgh-313	219	65	at	at	ADP
cajgh-313	219	66	a	a	DET
cajgh-313	219	67	tertiary	tertiary	ADJ
cajgh-313	219	68	care	care	NOUN
cajgh-313	219	69	hospital	hospital	NOUN
cajgh-313	219	70	in	in	ADP
cajgh-313	219	71	central	central	ADJ
cajgh-313	219	72	india	india	PROPN
cajgh-313	219	73	:	:	PUNCT
cajgh-313	219	74	a	a	DET
cajgh-313	219	75	pilot	pilot	NOUN
cajgh-313	219	76	study	study	NOUN
cajgh-313	219	77	research	research	NOUN